Madrid 08.08.2011 D. Juan Antonio López-Blanco Subdirector General de Ordenación Profesional Ministerio de Sanidad Política Social e Igualdad Estimado Subdirector General, Habiéndose iniciado el periodo de presentación de Alegaciones al Real Decreto de Troncalidad le adjunto el dossier de Alegaciones elaborado por la Comisión Nacional de Inmunología en relación con el Tronco de Laboratorio y Diagnóstico Clínico: Programa Troncal Especialidad de Inmunología. Este documento tiene el consenso de las Sociedades Españolas de Inmunología (Sociedad Española de Inmunología-SEI, Sociedad de Inmunología de la Comunidad de Madrid-SICAM y Sociedad Catalana de Inmunología). A la espera de su atención y resolución sobre este tema importante para la Especialidad de Inmunología y para el Tronco de Laboratorio y Diagnóstico Clínico. Le saluda atentamente
Eduardo Fernández-Cruz Presidente de la Comisión Nacional
D. JUAN ANTONIO LOPEZ BLANCO SUBDIRECTOR GENERAL DE ORDENACION PROFESIONAL MINISTERIO DE SANIDAD, POLÍTICA SOCIAL E IGUALDAD
Madrid, a 4 de Agosto de 2011.
Estimado Subdirector General de Ordenación Profesional
Le adjunto un dossier que incluye las Alegaciones en relación con el Proyecto de Real Decreto Troncalidad y, de forma específica, con el Tronco de Laboratorio y Diagnóstico Clínico y el Programa Troncal de la Especialidad de Inmunología.
Según me indicó en la última reunión mantenida el 6 de Junio de 2011 en la Subdirección General de Ordenación Profesional del Ministerio de Sanidad, Política Social e Igualdad se aporta el documento de Alegaciones con la justificación documentada de la necesidad de la implantación de un itinerario formativo medico en el programa troncal para la especialidad de Inmunología, así como la justificación de la modificación del TRONCO DE LABORATORIO Y DIAGNOSTICO CLINICO Este documento de Alegaciones incluye la siguiente información en cinco ANEXOS: 1) Programa formativo vigente de la Especialidad, donde consta un itinerario formativo medico y otro de laboratorio diferenciados para la Especialidad de Inmunología (ANEXO I); 2) Definición de las competencias Médicas de la Especialidad de Inmunología (ANEXO II); 3) Recopilación actualizada de la actividad médica de esta Especialidad, en la práctica habitual en las Unidades Docentes acreditadas en España (ANEXO III); 4) Cartas de Expertos internacionales y de los Presidentes de las principales Sociedades Europeas de Inmunología (Alemania, Inglaterra, Italia) apoyando la implantación en España de un programa formativo en Inmunología Clínica con las características que se especifican en el dossier (ANEXO IV); y 5) documentación sobre la actividad de la Inmunología Médica en el entorno Europeo (programas formativos de Inglaterra, Alemania e Italia) como elemento de referencia (ANEXO V).
Como expresé en la reunión mencionada de la Subdirección General para el desarrollo de la Troncalidad es básico contar con el consenso profesional representado por la Comisión Nacional y las Sociedades Científicas (SEI), por lo que en este escrito de Alegaciones se Solicita:
Que la formación troncal para la Especialidad de Inmunología pueda tener dos programa formativos diferenciados: uno que contemple la formación médica para los MIR, que les capacite fundamentalmente en el manejo clínico y terapéutico de los enfermos con patologías inmunológicas, y cuyo itinerario estaría vinculado principalmente al tronco médico (durante el periodo troncal); y otro programa formativo para el especialista inmunólogo multidisciplinar de diferentes licenciaturas (Biólogo, Bioquímico y Farmacéutico) que garantice la adquisición de competencias transversales genéricas, comunes y específicas del laboratorio especializado de inmunología, y cuyo itinerario estaría vinculado al tronco de laboratorio de diagnóstico clínico (siempre que se modifique el Tronco de Laboratorio y Diagnóstico Clínico del Anteproyecto respecto a lo mencionado anteriormente).
En espera de su pronta atención a estas Alegaciones para que tras el trámite de audiencia pública puedan ser incorporadas al Proyecto Real Decreto de Troncalidad, Le saluda atentamente Eduardo Fernández-Cruz Presidente de la Comisión Nacional de Inmunología
ALEGACIONES AL PROYECTO “REAL DECRETO DE
TRONCALIDAD”: TRONCO DE LABORATORIO Y
DIAGNOSTICO CLINICO-PROGRAMA TRONCAL DE LA
ESPECIALIDAD DE INMUNOLOGÍA.
COMISION NACIONAL DE LA ESPECIALIDAD DE INMUNOLOGIA (CNI) Presidente: Dr Eduardo Fernández-Cruz 4 de Agosto de 2011
ALEGACIONES AL PROYECTO “REAL DECRETO DE TRONCALIDAD”: TRONCO DE LABORATORIO Y DIAGNOSTICO CLINICO- PROGRAMA TRONCAL DE LA ESPECIALIDAD DE INMUNOLOGÍA. Índice: 1.- Documento Alegaciones al Proyecto “Real Decreto Troncalidad”: Tronco de Laboratorio y Diagnostico Clinico-Programa Troncal de la Especialidad de Inmunología. 2.- Anexos:
• Anexo I.- Guía de Formación de Especialistas de Inmunología actualmente vigente.
• Anexo II.- Definición de las competencias transversales del Inmunólogo Médico.
• Anexo III.- Actividad Asistencial Médica y de Laboratorio de la especialidad de Inmunología en las Unidades Docentes acreditadas en España:
o Anexo III.1: Actividad Asistencial en Inmunología Clínica de las Unidades Docentes Acreditadas de la Especialidad de Inmunología en los Hospitales del SNS del Estado Español.
o Anexo III.2: Cartera de Servicios de Laboratorio Diagnóstico de Inmunología Consensuada por las Unidades Docentes de Inmunología acreditadas en la Comunidad de Madrid.
o Anexo III.3: Cartera de Servicios de Inmunología Clínica del Hospital General Universitario Gregorio Marañón (HGUGM).
o Anexo III.4: Referencia a la WEBSITE del Registro de Inmunodeficiencias Primarias de España (REDIP).
• Anexo IV.- Cartas de expertos internacionales apoyando la implantación en España de un programa formativo en Inmunología Clínica.
• Anexo V.- Programas Formativos Europeos en Inmunología Clínica y de Laboratorio Diagnóstico
1
DOSSIER ALEGACIONES AL PROYECTO REAL DECRETO DE TRONCALIDAD:
PROGRAMA TRONCAL DE LA ESPECIALIDAD DE INMUNOLOGIA
A.- JUSTIFICACIÓN DOCUMENTADA DE LA NECESIDAD DE IMPLANTACIÓN DE UN ITINERARIO FORMATIVO EN EL TRONCO MEDICO EN EL PROGRAMA TRONCAL PARA LA ESPECIALIDAD DE INMUNOLOGÍA
En la última reunión mantenida el 6 de Junio de 2011 en la Subdirección General de Ordenación Profesional del Ministerio de Sanidad, Política Social e Igualdad como Presidente de la Comisión Nacional de Inmunología (CNI) expresé, una vez más, la preocupación de la CNI y de los inmunólogos españoles con respecto a la integración de la Especialidad de Inmunología en el Tronco específico de Laboratorio y Diagnóstico Clínico, según aparece en el Anteproyecto de Troncalidad. La razón principal de nuestra no conformidad es que la estructura de dicho tronco no se adecua a las necesidades formativas que exige el perfil amplio actual del especialista en Inmunología, obviando fundamentalmente el marcado componente clínico de esta especialidad.
La Comisión Nacional de Inmunología ya ha expresado oficialmente su opinión sobre este asunto como consta en: el escrito de Alegaciones incluido como Anexo al Acta de 16 de Marzo de 2010; el Pleno del Consejo Nacional del 7 de Julio del 2010; la reunión del 27.09.2010 en la Subdirección General de Ordenación Profesional (en esta visita entregué una carta oficial de la Presidenta de la Sociedad Española de Inmunología); el escrito presentado por registro el 17.10.2010; y posteriormente en la última reunión del Pleno del Consejo Nacional el 20.07.2011, durante la cual solicité la rectificación del planteamiento del Tronco de Laboratorio y Diagnóstico Clínico en relación con la especialidad de Inmunología, anticipando, a su vez, que presentaríamos un escrito de alegaciones al respecto.
En la mencionada reunión del 6 de Junio de 2011 en la Subdirección General con D. Juan Antonio López Blanco, esencialmente revisamos la problemática que plantea el hecho de que la especialidad de Inmunología tiene dos vertientes o ramas, una de diagnóstico clínico de laboratorio y la otra médica asistencial. Esta circunstancia, ocurre también en algunas otras especialidades con componente de laboratorio, entre las que se encuentra la Hematología. En nuestra especialidad, el manejo clínico del paciente se realiza por el especialista (inmunólogo médico), el cual solicita pruebas específicas al laboratorio especializado de diagnóstico clínico, que se realizan por el especialista de laboratorio (inmunólogo multidisciplinar). Ambos aspectos, médico-asistencial y de laboratorio diagnóstico, se recogen en la Guía de Formación de especialistas de Inmunología actualmente vigente (Anexo I).
En la reunión con el Subdirector General se evidenció que había un acuerdo respecto a que para el desarrollo de la Troncalidad es básico contar con el consenso profesional, por lo que planteamos la posibilidad de que la formación troncal para la Especialidad de Inmunología pueda tener dos programa formativos diferenciados: uno que contemple la formación médica para los MIR, que les capacite fundamentalmente en el manejo clínico y terapéutico de los enfermos con patologías inmunológicas, y cuyo itinerario estaría vinculado principalmente al tronco médico (durante el periodo troncal); y otro programa formativo para el especialista inmunólogo multidisciplinar de diferentes licenciaturas (Biólogo, Bioquímico y Farmacéutico) que garantice la adquisición de competencias transversales genéricas, comunes y específicas del laboratorio especializado de inmunología, y cuyo itinerario estaría vinculado al tronco de laboratorio de diagnóstico clínico (siempre que se modifique el Tronco de Laboratorio y Diagnóstico Clínico del Anteproyecto respecto a lo mencionado anteriormente y a lo que se explicita sobre dicho tronco en el apartado B de este documento).
Para la posibilidad de desarrollar el planteamiento anteriormente mencionado el Subdirector General nos solicitó a la CN la preparación de un dossier que incluyese
2
la siguiente información: 1) Definir las competencias Médicas de la Especialidad de Inmunología; 2) Recoger la actividad médica de esta Especialidad, en el programa formativo y en la práctica habitual en las Unidades Docentes acreditadas en España; y 3) Recoger la actividad de la Inmunología Médica en el entorno Europeo (programas formativos) como elemento de referencia y aportar cartas de expertos internacionales apoyando la implantación en España de un programa formativo con las características anteriormente mencionadas. A.1 PRUEBAS DOCUMENTALES QUE JUSTIFICAN LA NECESIDAD DE LA IMPLANTACIÓN DE UN ITINERARIO FORMATIVO MEDICO EN EL PROGRAMA TRONCAL PARA LA ESPECIALIDAD DE INMUNOLOGÍA ANEXO I. Guía de Formación de Especialistas de Inmunología actualmente vigente (BOE
Núm 252, 21 Octubre 2006, Orden SCO/3255/2006). Ver ANEXO Programa Oficial de la Especialidad de Inmunología apartados: 4.2.2; 5.1; 5.3; 6.1; 6.2; 6.3; 6.6.2 y 8 (Inmunología Clínica) ANEXO II. Definición de las competencias transversales del inmunólogo médico.
Se propone la formación de un profesional Médico (MIR) especialista en Inmunología que pueda adquirir las competencias transversales médicas, compatibles con el conjunto de especialidades afines adscritas en el tronco Médico, así como las competencias específicas relativas al tronco de Laboratorio y Diagnóstico Clínico- Inmunología. Ver ANEXOS II.1, II.2, y II.3.
ANEXO III. Actividad Asistencial Médica y de Laboratorio de la especialidad de Inmunología en las Unidades Docentes acreditadas en España.
La actividad Clínica en Inmunología es una realidad emergente por su continuo progreso aunque ya consolidada y con amplia implantación en el SNS en nuestro país. Trece de las 26 Unidades Docentes desarrollan este tipo de actividad clínica (el 80% de las 5 nuevas unidades docentes tienen una unidad clínica especializada, por lo que ratifica que es un proceso en constante expansión). Ello obedece al enorme avance en el conocimiento de la inmunopatogenia de muchas enfermedades de diversos órganos y sistemas, y en la expansión del manejo de las terapias biológicas y tratamientos inmunológicos.
Anexo III.1: Actividad Asistencial en Inmunología Clínica de las Unidades Docentes Acreditadas de la Especialidad de Inmunología en los Hospitales del SNS del Estado Español.
Anexos III.2, III.3: Incluyen la Cartera de Servicios Clínica de Inmunología (SICAR) oficial de la Comunidad de Madrid adscrita al Hospital General Universitario Gregorio marañón (HGUGM) y las Carteras de Servicios de las pruebas de Diagnóstico Clínico Inmunológico de los laboratorios de Inmunología existentes en las Unidades de Inmunología docentes acreditadas (Cartera de Servicios de Laboratorio Diagnóstico consensuada por los 8 Hospitales de la Comunidad de Madrid y registrada en la Consejería de Sanidad).
Anexo III.4: WEBSITE del Registro de Inmunodeficiencias Primarias de España (REDIP): web.hsd.es/redip/
Esta WEBSITE está gestionada por Inmunólogos en colaboración con la Sociedad Española de Inmunología, y está vinculada al Servicio de Inmunología del Hospital Universitario de Son Espases (Son Dureta) de Palma de Mallorca, bajo la supervisión de la Dra. Nuria Matamoros. El Registro REDIP incluye todos los casos españoles de Inmunodeficiencias Primarias acreditados de acuerdo a los criterios internacionales vigentes, y son aportados, en su mayoría, por Inmunólogos Clínicos integrados en
3
Unidades Clínicas de Inmunología que son responsables directos del diagnóstico y manejo de estos procesos patológicos.
ANEXO IV.- Cartas de expertos Europeos de Inglaterra, Alemania e Italia apoyando la implantación en España de un Programa Formativo de Inmunología Clínica.
La actividad Médica y de Laboratorio de la especialidad de Inmunología está implantada en la gran mayoría de Hospitales europeos e internacionales de tercer nivel desde hace más de una década. La utilidad demostrada de la actividad clínica en los centros médicos se basa en la implantación, desde hace años, en esos países de programas formativos específicos como el que solicitamos se debiera implantar en España. Adjuntamos las cartas recibidas de líderes Europeos de la Inmunología Clínica de Inglaterra, Alemania e Italia, del Presidente de la Unión internacional de las Sociedades Inmunológicas y de los Presidentes de las Sociedades de Inmunología de Alemania e Italia (estamos pendientes de la recepción de los documentos de varios líderes profesionales de Francia).
A continuación se significan los aspectos más importantes contenidos en las cartas de apoyo remitidas por los expertos internacionales:
IV.1.-Professor Helen Chapel Oxford Centre for Clinical Immunology A FOCIS designated centre of excellence PiA UK Centre of Excellence Clinical Immunology Unit Nuffield Department of Medicine John Radcliffe Hospital Campus University of Oxford “I would like to express my strong support for the developing of a specific Training Programme in “Clinical Immunology” in Spain, along the lines of those in other European countries” “In the UK, it has been mandatory for the training of medical residents to become consultants in Clinical Immunology in the future”.
“Clinical Immunology has evolved over the past three decades from a predominant laboratory based specialty to a clinical section of medicine…. In addition, Consultant Immunologists remain responsible for directing diagnostic immunology services in terms of clinical usefulness”.
“As you know, Clinical Immunology is widely established in different European countries ….. I understand that the UK training programme has been accepted as a model for Europe by UEMS”.
“…is highly desirable that Spain rapidly develops a similar programme, not least so that the new medical interventions in immunology (including monoclonal antibodies and cytokine therapies) can be used appropriately for relevant patients with immunological disease in a cost effective manner”.
IV.2 Professor Dieter Kabelitz President, German Society for Immunology Institute of Immunology UKS-H Campus Kiel D-Kiel. Germany
“.....As the President of the German Society for Immunology (DGFI) I would like to express our strong support for your plans to establish a specific Training Program for Clinical Immunology in Spain.”
“The immune system is increasingly targeted by modern and innovative therapeutic strategies. Therefore, a thorough understanding of basic and clinical aspects of immunology is mandatory for medical residents who aim at a career as consultants in
4
clinical immunology.…the DGFI has established a program for certified education and training..”
“….the German Society for Immunology strongly supports your activities to establish a Training Program in Clinical Immunology in Spain.”
IV.3.- Gianpietro Semenzato President. Italian Society of Immunology, Clinical Immunology and Allergy (SIICA) Clinica e Sperimentale “G. Patrassi” Università degli Studi di Padova Padova. Italy “As the President of the Italian Society of Immunology, Clinical Immunology and Allergy, I would like to express our strong support for the developing in Spain of a specific Training Program in “Clinical Immunology”.
“The establishment of this is mandatory for the training of medical residents that will eventually become consultants in Clinical Immunology”.
“…Clinical immunology is a new branch of medicine which is transverse to all sciences and involves diseases of different systems, including the skin, the lung, gastrointestinal ……etc.”
“The possibility to develop a specific Training Program in “Clinical Immunology” in Spain will certainly let young people to face this interesting area of medicine”.
“This speciality is widely represented in different European countries and it is highly desirable that Spain falls into line”.
IV.4.- Prof. Dr. med. R.E. Schmidt
Chairman of the Clinical Immunology Committee of International Union Immunological Societies (IUIS).
Head of Department of Clinical Immunology and Rheumatology Medizinische Hochschule Hannover Hannover. Germany ….The German Society for Immunology has already established a program during the past six years and is providing specialists with the respective certificate ….We also have established training centres for clinical immunology”.
“The establishment of a clinical immunology program should be mandatory for medical residence that will eventually become consultants in clinical immunology”.
IV.5 Dr.G.P.Spickett Head of Regional Immunology Services Regional Department of Medicine, Royal Victoria Infirmary
Consultant & Senior Lecturer in Clinical Immunology
Newcastle upon Tyne. United kingdom.
..” I am writing to express my strong support for the development of a specific postgraduate training programme in Clinical Immunology, to enable junior doctors to train in the speciality and become consultants in Clinical Immunology”.
“Clinical Immunology encompasses both clinical and laboratory dimensions and it is essential that consultant immunologists have indepth training in both aspects”.
“…the Immunology Laboratory has a fundamental role in the diagnosis and management of these diseases. Organ-based specialists require guidance on
5
appropriate test selection and results interpretation and this is best carried out by physicians with an understanding of immunological disease”.
“Clinical Immunology is a well-established discipline in the UK and has had a training programme which spans both clinical and laboratory aspects for the last 20 years”.
“In order to ensure harmonisation of postgraduate medical in the European Union, it is essential that Spain has an equivalent training programme”.
IV.6 Professor. Bodo Grimbacher Past Secretary of the European Society for Immunodeficiencies Dept of Immunology and Molecular, Royal Free Hospital, University College Division of infection & immunity London. United Kingdom “….As the Past Secretary of the European Society for Immunodeficiencies (ESID, www.esid.org), and consultant of one of the largest adult primary immune deficiency centres in Europe, I would like to express my strong support for developing a specific training program in Clinical Immunology in Spain”.
“……I have noticed that the care for these patients varies considerably in between European countries. One reason for this is the different training physicians receive, but also the different affiliations and “homes” Clinical Immunology has in the different countries”.
“I therefore strongly support Prof. Fernandez-Cruz’ initiative to overhaul the training program for Clinical Immunology in Spain moving it to a Clinical- and Laboratory-based speciality”.
ANEXO V.- Programas Formativos Europeos en Inmunología Clínica y de Laboratorio Diagnóstico.
Anexos V.1, V.2 y V.3: Incluyen los programas formativos vigentes en el Reino Unido, Italia y Alemania, respectivamente [estamos pendientes de la recepción del programa formativo de Francia que anticipamos es similar].
B) LA ESPECIALIDAD DE INMUNOLOGÍA ANTE EL TRONCO DE LABORATORIO Y DIAGNOSTICO CLINICO
La adscripción de Inmunología dentro del tronco común de Laboratorio y Diagnóstico Clínico que aparece en el borrador de RD es inadecuada en dos aspectos:
1.- No da cabida al natural desarrollo de la actividad clínica directa con pacientes con enfermedades de base inmunológica por especialistas inmunólogos médicos, no existiendo actualmente una vía de formación adecuada para este profesional médico.
2.- La adscripción del laboratorio de Inmunología en el Tronco de Laboratorio y Diagnóstico Clínico, tal como consta en el actual borrador de RD, no asegura que la formación para la competencia y realización de pruebas diagnósticas inmunológicas se pueda hacer con las necesarias garantías técnico-científicas que exige este laboratorio altamente especializado.
En la primera parte de este documento hemos aportado soluciones al aspecto de formación de especialistas inmunólogos médicos (Apartado A), dentro del ordenamiento actual, y respetando sustancialmente el RD.
Con respecto al segundo aspecto que afecta a la formación de los inmunólogos de otras licenciaturas (Biólogos, Bioquímicos y Farmacéuticos) la Sociedad Española de Inmunología (SEI) ha transmitido a esta Comisión Nacional la gran preocupación de este colectivo profesional en relación con este tema, la cual hacemos nuestra por el
6
presente escrito. A los efectos de buscar soluciones en relación con la formación del especialista de Inmunología en el ámbito del Laboratorio se quiere significar:
1.- La Especialidad de Inmunología debe contar con especialistas capaces de afrontar con adecuadas garantías científico-técnicas el conjunto de pruebas de laboratorio que posibilitan el establecimiento del diagnóstico, pronóstico y evaluación terapéutica de las enfermedades de base inmunológica.
2.- El anteproyecto del RD propone la creación de un tronco común denominado de Laboratorio y Diagnóstico Clínico en el que se formarían los especialistas que han de realizar las pruebas diagnósticas bioquímicas, microbiológicas, hematológicas, genéticas e inmunológicas. El RD regula la formación polivalente inicial (primeros dos años de tronco común) de los especialistas que se generen, pero dada las características de las especialidades actualmente adscritas al tronco (ninguna de las especialidades adscritas al tronco, Bioquímica y Análisis Clínicos, es una especialidad afín a la Inmunología) se siembran dudas importantes sobre la utilidad de este periodo común, para adquirir, además de las competencias genéricas, las competencias transversales especificas necesarias para que aporten una suficiente formación científico-técnica, relevante y competente para los especialistas inmunólogos.
En el RD los criterios de troncalidad requieren que las especialidades que formen tronco deben de tener competencias transversales (conocimientos, habilidades y actitudes) comunes, deben beneficiarse de estancias formativas comunes y deben compartir áreas en las que el trabajo conjunto mejora la efectividad y eficiencia del sistema. Las especialidades anteriormente mencionadas no comparten competencias transversales con la Inmunología. Además, esta situación ocurre en un contexto de relativa indefinición de las competencias exigibles a los profesionales que asumen actualmente las tareas propias de las especialidades de laboratorio mencionadas anteriormente. En alguna medida esta situación podría paliarse en el caso de profesionales ya incluidos en los laboratorios hospitalarios, cuya actividad no está suficientemente acreditada, gracias a las medidas de Reespecialización Troncal propuestas en el borrador del RD.
3.- Por otra parte, el RD establece que el profesional se forme inicialmente en el tronco de Laboratorio y Diagnóstico Clínico (primeros dos años), para adquirir las competencias polivalentes propias de dicho tronco (competencias troncales) y, posteriormente, desarrollar la formación específica en Inmunología (siguientes 2 años). Sin embargo, este diseño formativo no sería adecuado para profesionales que tras el periodo formativo troncal continúen el desarrollo de formación polivalente durante la fase formativa específica. Es decir, que las fases específicas de formación sólo se desarrollarían para las especialidades de Bioquímica e Inmunología.
El análisis del tronco de laboratorio y Diagnóstico Clínico evidencia que la especialidad de Inmunología carece de una integración adecuada dentro del sistema de distribución troncal de especialidades propuesto en el RD.
C) CONCLUSIONES
Por todo lo dicho anteriormente, la Especialidad de Inmunología se Configuraría en el Anteproyecto de Troncalidad con un doble itinerario:
a) Uno para especialistas médicos, con formación esencial dentro del tronco Médico, para afrontar los crecientes retos clínicos de la especialidad; y b) Otro para especialistas de origen multi-disciplinar (BIR, FIR y BQIR), que afrontarían la actividad de laboratorio de Inmunología, vinculados a un tronco de Laboratorio y Diagnóstico Clínico en el que todos sus profesionales compartan competencias transversales comunes y desarrollen un equivalente y adecuado nivel de formación polivalente y que en el caso del inmunólogo adquiera las competencias especializadas del laboratorio de Inmunología con la suficiente profundidad y especificidad.
ANEXO I. GUÍA DE FORMACIÓN DE ESPECIALISTAS DE INMUNOLOGÍA ACTUALMENTE VIGENTE (BOE Núm 252, 21 Octubre 2006, Orden SCO/3255/2006). Ver ANEXO Programa Oficial de la Especialidad de Inmunología apartados: 4.2.2; 5.1; 5.3; 6.1; 6.2; 6.3; 6.6.2 y 8 (Inmunología Clínica)
36894 Sábado 21 octubre 2006 BOE núm. 252
Conocer los aspectos relativos al Banco de Sangre en el trasplante de progenitores hematopoyéticos y de otros órganos, así como la autotrans-fusión.
Conocer el funcionamiento y manejo de los programas de aféresis (plasma, plaquetas, y células progenitoras) y plasmaféresis.
Conocer el funcionamiento y manejo de los programas de criopreser-vación.
Conocer las indicaciones y la metodología de la exanguinotrans-fusión.
Conocer las técnicas de extracción, aféresis, cultivos, procesamientos y criopreservación de progenitores hematopoyéticos.
Después de cada rotación, el responsable de cada Sección que ha tute-lado la formación y el trabajo realizado por el MIR realizará una valora-ción en las hojas que se adjuntan, estas hojas, una vez cumplimentadas serán entregadas al Tutor.
8.2.2 Actividades científicas:
Realizará diversas presentaciones en sesión clínica en relación con los pacientes hospitalizados.
Participará activamente en las sesiones bibliográficas del Servicio.Participará activamente en sesiones conjuntas programadas con otros
Servicios, en relación con la especialidad (p.e. Radiodiagnóstico, Anato-mía Patológica).
Presentará algunas de las sesiones monográficas programadas en el Servicio.
Presentará un mínimo de 3 comunicaciones a congresos.Habrá participado directamente en la publicación de, al menos, 2 tra-
bajos en revistas que se incluyan en el «Journal of Citation Reports».Colaborará en la docencia de los estudiantes que roten por el
Servicio.Participará en Cursos o Seminarios de Gestión Clínica, Bioética y
Metodología de la investigación clínica-básica.Participará en el desarrollo de ensayos clínicos.
8.2.3 Conocimiento de idiomas:
El conocimiento del inglés científico es una adquisición altamente recomendable en el transcurso de la residencia, por lo que se realizarán escalonadamente las siguientes actividades:
Lectura del inglés científico.Escritura de comunicaciones y trabajos en inglés.Presentaciones orales en inglés en reuniones científicas.
18430 ORDEN SCO/3255/2006, de octubre, por la que se aprueba y publica el programa formativo de la especialidad de Inmunología.
El artículo 21 de la Ley 44/2003, de 21 de noviembre, de ordenación de las profesiones sanitarias, establece el procedimiento para aprobar los programas formativos de las especialidades sanitarias en ciencias de la salud, previendo su publicación en el Boletín Oficial del Estado para general conocimiento.
La Comisión Nacional de la Especialidad de Inmunología ha elaborado el programa formativo de dicha especialidad que ha sido verificado por el Consejo Nacional de Especialidades Médicas, órgano asesor en materia de formación sanitaria especializada al que, de conformidad con lo pre-visto en la disposición transitoria sexta de la Ley 44/2003 antes citada, corresponde ejercer las competencias del todavía no constituido Consejo Nacional de Especialidades en Ciencias de la Salud.
Asimismo, dicho programa formativo ha sido estudiado, analizado e informado por la Comisión de Recursos Humanos del Sistema Nacional de Salud al que se refiere el Real Decreto 182/2004, de 30 de enero, por el que se creó dicho órgano colegiado del que forman parte, entre otros, los consejeros de sanidad de las diversas comunidades autónomas y el Direc-tor General de Universidades del Ministerio de Educación y Ciencia.
En su virtud, de conformidad con lo previsto en el artículo 21 de la Ley 44/2003, previos informes favorables de la Comisión de Recursos Humanos del Sistema Nacional de Salud y del Ministerio de Educación y Ciencia, dispongo:
Primero.–Aprobar el programa formativo de la Especialidad de Inmu-nología, cuyo contenido se publica como anexo a esta Orden.
Segundo.–Dicho programa formativo será de aplicación a los residen-tes de la Especialidad de Inmunología que obtengan plaza en formación en Unidades Docentes de dicha especialidad, a partir de la Orden del Ministerio de Sanidad y Consumo por la que se apruebe la convocatoria nacional de pruebas selectivas 2006 para el acceso en el año 2007 a plazas de formación sanitaria especializada.
Disposición transitoria única.
A los residentes que hubieran iniciado su formación en la Especialidad de Inmunología por haber obtenido plaza en formación en convocatorias anteriores a la que se cita en el apartado segundo de esta Orden les será de aplicación el programa anterior de dicha especialidad, aprobado por Resolución de 25 de abril de 1996, de la Secretaria de Estado de Universi-dades e Investigación del Ministerio de Educación y Ciencia.
No obstante lo anterior, la Comisión de Docencia de la Unidad Docente en la que se haya obtenido plaza podrá adaptar, a propuesta del responsable de la Unidad y con la conformidad del residente, los planes individuales de formación previstos en el Apartado segundo 2.c de la Orden de 22 de junio de 1995, al nuevo programa formativo en la medida en que, a juicio de dicha Comisión, sea compatible con la organización general de la Unidad y con la situación específica de cada residente.
Disposición final.
Esta Orden entrará en vigor el día siguiente al de su publicación en el «Boletín Oficial del Estado».
Madrid, 2 de octubre de 2006.–La Ministra de Sanidad y Consumo, Elena Salgado Méndez.
ANEXO
Programa oficial de la Especialidad de Inmunología
1. Denominación oficial de la especialidad y requisitos de titulación
Inmunología.Duración: 4 años.Licenciaturas previas: Medicina, Biología, Bioquímica y Farmacia.
2. Introducción
2.1 Origen y desarrollo de la especialidad.–El rápido desarrollo de la Inmunología durante el pasado y presente siglo ha hecho que cada vez sea más necesaria su aplicación en la práctica clínica, tanto en la prevención, como en el diagnóstico y tratamiento de un gran número de enfermeda-des. Por lo tanto, es de gran importancia definir los contenidos y la orga-nización de la Inmunología y agrupar los criterios que se deben utilizar para la educación postgraduada y la titulación correspondiente. La Orga-nización Mundial de la Salud (OMS) y la Unión Internacional de Socieda-des de Inmunología (IUIS) publicaron sendos informes en 1972 y 1976, respectivamente, que versaban sobre el contenido y la organización de la especialidad médica de Inmunología. En similares términos se pronuncia-ron la IUIS, y la Sociedad Inglesa de Inmunología. Con posterioridad, un Comité conjunto de Inmunología Clínica de la IUIS, de la OMS y de la Aso-ciación de Alergología y de Inmunología Clínica (IAACI) compararon los distintos programas de enseñanza para postgraduados en diferentes paí-ses e hicieron unas recomendaciones que sirvieran de guía para su integra-ción en los diversos sistemas de salud y para la obtención del título de especialista para aquéllos que deseen dedicarse a esta disciplina. Reciente-mente, el Grupo de Inmunología Clínica (CIG) de la European Federation of Immunological Societies (EFIS-CIG) y el Grupo de Inmunología Clínica de la IUIS (IUIS-CIC) han publicado revisiones sobre la situación de los Programas de Inmunología en diversos países Europeos y EEUU y donde se definen los diferentes componentes de diagnóstico de laboratorio, clí-nico-asistencial y de investigación de la Inmunología. Es igualmente de gran interés considerar el desarrollo de la investigación básica y aplicada en el contexto de la formación de los especialistas en Inmunología en línea con las recomendaciones publicadas al respecto.
El presente programa se basa en los documentos actualizados elabora-dos por las Sociedades Internacionales de Inmunología, en la experiencia adquirida durante el desarrollo de la especialidad y en la situación del sistema sanitario de nuestro país.
Dado que los R. D. 1663/2002, de 8 de noviembre y 365/2004, de 5 de marzo, posibilitan que además de los licenciados en medicina, accedan a la especialidad los licenciados en Biología, Bioquímica y Farmacia, se ha estimado necesario elaborar un programa que incluya las actividades y responsabilidades que corresponden a dichos licenciados en función de su formación previa, definiendo un conjunto común para todos los licen-ciados centrado en el contexto de la actividad de laboratorio, especifi-cando asimismo las actividades reservadas a los licenciados en Medicina en el área clínica.
2.2 Contribuciones de la Inmunología a la Medicina.–Las primeras contribuciones de la Inmunología a la Medicina partieron del reconoci-miento de que era posible inducir inmunidad frente a los agentes patóge-nos y prevenir así la aparición de enfermedades infecciosas; es decir, el fundamento de las vacunas representa el nacimiento histórico de la Inmu-nología. Este conocimiento empírico fue de gran utilidad, permitió estu-
BOE núm. 252 Sábado 21 octubre 2006 36895
diar los mecanismos que conferían esta resistencia y condujo al descubri-miento de los anticuerpos. Hasta los años sesenta del pasado siglo, el mayor progreso de la Inmunología se produjo en la elucidación de la natu-raleza de los anticuerpos, del complemento y de la reacción antígeno-anti-cuerpo. Estos avances hicieron posible el perfeccionamiento de los métodos de diagnóstico serológico y su aplicación a otros campos, con la aparición subsiguiente del radioinmunoanálisis y el enzimoinmunoanáli-sis. En las últimas décadas del siglo se produjo la gran eclosión de los estudios referentes al papel fundamental de la inmunidad celular en las reacciones inmunes, que completaban el conocimiento de los mecanis-mos de la inmunidad adquirida. Más recientemente la inmunidad innata, sus células y moléculas participantes, han ocupado asimismo un impor-tante lugar en el estudio de los mecanismos defensivos.
Cada día aumenta el número de enfermedades en las que se reconoce que la participación del sistema inmunitario es la causa o contribuye de forma importante al proceso patológico. Estas enfermedades podrían clasificarse en cuatro grandes grupos: inmunodeficiencias, enfermedades autoinmunes, enfermedades aloinmunes (rechazo de injertos) y enferme-dades por hipersensibilidad. Es igualmente importante el sistema inmuni-tario en el control y tratamiento de tumores. La implicación del sistema inmunitario en la patogenia de estas enfermedades hace necesario un mayor grado de conocimiento de los mecanismos reguladores de la res-puesta inmunitaria del que ahora poseemos. Sin embargo, aun sin com-prender detalladamente los mecanismos de muchas de estas enfermeda-des inmunológicas, ya existen tecnologías de laboratorio que permiten confirmar su diagnóstico clínico. Una mención especial merece la contri-bución de la Inmunología al conocimiento de los mecanismos de rechazo de trasplantes de órganos y tejidos, así como a su prevención y trata-miento inmunosupresor. Sin duda, el papel de los inmunólogos en los estudios de histocompatibilidad y, concretamente en el estudio de recep-tores y donantes de trasplantes de órganos y tejidos ha sido fundamental para el desarrollo de la inmunología en la medicina española.
Actualmente, las pruebas de laboratorio, además de incluir la determi-nación de parámetros de inmunidad humoral, incorporan parámetros celulares y moleculares. La caracterización bioquímica y funcional de las citocinas, quimiocinas y moléculas de adhesión está abriendo nuevas vías de valoración de la situación del sistema inmunitario y de aplicación inmunoterapéutica.
Por último, se cuenta actualmente con la existencia de protocolos inmunoterapéuticos para el tratamiento de las diversas patologías con componente inmunológico, tales como terapias con agentes inmunomo-duladores (gammaglobulina intravenosa, citocinas recombinantes, anti-cuerpos monoclonales, terapias inmunorestauradoras o preventivas (vacunas terapéuticas y profilácticas)), nuevos inmunosupresores para el control del rechazo de injertos, vacunas antitumorales y terapia celular y génica.
3. Definición de la especialidad y sus competencias
3.1 Definición.–La palabra inmunología deriva del latín immunis que significa «sin carga», entendiéndose por carga un impuesto, ley o enfer-medad. Se dice que aquellos individuos que no sucumben ante la enferme-dad cuando se infectan, se hallan inmunes y este estado de resistencia específica a una enfermedad se denomina Inmunidad.
La OMS definió la Inmunología como una disciplina que trata del estu-dio, diagnóstico y tratamiento de pacientes con enfermedades causadas por alteraciones de los mecanismos inmunológicos y de las situaciones en las que las manipulaciones inmunológicas forman una parte importante del tratamiento y/o de la prevención.
La especialidad de Inmunología incluye el estudio de las enfermeda-des en las que los mecanismos inmunitarios no actúan adecuadamente, bien sea por razones genéticas o adquiridas (inmunodeficiencias, inclu-yendo el SIDA), o debido a otras causas intrínsecas al sistema como pue-den ser la transformación neoplásica de células del sistema inmunitario (tumores linfoides), la actuación anómala de anticuerpos específicos y/o linfocitos sensibilizados, u otros sistemas efectores asociados, todo lo cual produce como resultado lesiones tisulares en el hospedador (hiper-sensibilidad inmediata, infecciones y autoinmunidad).
También se ocupa la Inmunología de las situaciones en las que las lesiones pueden ser el resultado de la acción del sistema inmunitario en la defensa contra microorganismos (infección e inmunidad) o durante el rechazo de aloinjertos (transplantes y transfusiones). Por último, la espe-cialidad de Inmunología abarca asimismo el uso de la inmunoterapia o tratamientos de base inmunológica, transplantes y, más recientemente, de protocolos de terapia celular y génica.
El ejercicio de la Inmunología en un Hospital incluye, para todos los licenciados, la práctica en laboratorios especializados, adecuadamente dotados con una tecnología propia, así como la consulta en relación al diagnóstico y procedimientos inmunoterapeúticos. Los médicos especia-listas llevarán a cabo la asistencia a pacientes mediante consultas con
otros especialistas o en una Unidad de Inmunología Clínica especiali-zada.
3.2 Competencias.–La especialidad Inmunología es una actividad profesional que, basándose en la Biología y la Medicina, aplica los conoci-mientos inmunológicos en el ámbito sanitario y competencial que corres-ponda a los distintos titulados que puedan acceder a la misma.
La especialidad de Inmunología conlleva las siguientes competencias:
3.2.1 Comunes a todos los Licenciados:
Capacitación profesional para realizar las técnicas de laboratorio refe-ridas al estudio de patologías de base inmunológica.
Capacidad de interpretación de los datos generados en el laboratorio, poniéndolos en el contexto clínico y, por tanto, contribuyendo a estable-cer el diagnóstico clínico y la toma de decisiones terapéuticas.
Capacidad para diseñar protocolos diagnósticos y emisión de infor-mes inmunológicos.
Capacidad para diseñar y desarrollar proyectos de investigación bási-cas y clínicas, especialmente aquellos dirigidos a profundizar en el cono-cimiento y control de los mecanismos fisiopatogénicos en los que inter-viene el sistema inmunitario.
3.2.2 Específicas de los Licenciados en Medicina:
Capacidad para el diagnóstico y tratamiento de enfermedades de base inmunológica.
4. Objetivos de la formación
4.1 Objetivos generales.–La formación de especialistas con conoci-mientos teóricos y prácticos sobre la fisiopatología de la inmunidad humana, su diagnóstico y su aplicación terapéutica en un entorno hospi-talario, dentro de las competencias que corresponden a su licenciatura de origen, incluyendo conocimientos básicos de gestión, bioética e investi-gación.
4.2 Objetivos específicos:
4.2.1 Comunes a todos los licenciados:
Adquisición de conocimientos teóricos sobre los principios básicos de la inmunología y la patología de base inmunológica.
Adquisición de conocimientos prácticos para la evaluación de la inmu-nidad y su aplicación diagnóstica y terapéutica en el laboratorio.
Formación en gestión, control de calidad, bioética e investigación.
4.2.2 Específicos de los licenciados en Medicina:
Adquisición de experiencia clínica para el diagnóstico y tratamiento de enfermedades de base inmunológica.
4.3 Objetivos relativos a la docencia e investigación.–El residente debe terminar su periodo formativo sabiendo exponer y discutir los con-tenidos teóricos y prácticos de la especialidad, así como los aspectos básicos de la investigación biomédica, mediante la realización de las siguientes actividades formativas:
Preparación y exposición de sesiones clínicas.Seminarios de revisión temática.Preparación y comentario de sesiones bibliográficas.Sesiones clínicas conjuntas con otros servicios donde sea posible.Cooperar en la formación de otros Residentes.Participación activamente en todos los actos docentes, conferencias,
seminarios, sesiones clínicas, etc., que el hospital programe a través de la Comisión de Formación Continuada, y que a juicio del tutor sean de inte-rés para la formación en Inmunología.
En las unidades docentes que asuman formación de pregrado se esti-mulará la participación de los residentes en el desempeño de las mismas.
Asimismo, se considerará como un objetivo importante en la forma-ción del residente de Inmunología la adquisición de conocimientos teó-rico-prácticos relativos a la planificación de la investigación biomédica, participando en las líneas de investigación de la Unidad. A cuyos efectos debe conocer:
Método y procedimiento científico.Planificación, ejecución y verificación científica.Aspectos generales de la medición.Medidas de frecuencia de la enfermedad. Proyectos de investigación: forma y contenido.Rigor metodológico.Presentación de resultados.Conocimientos básicos de estadística descriptiva e inferencial.Desarrollo de un protocolo de investigación.
Se estimulará al residente para que inicie sus Estudios de Doctorado durante el período de formación.
36896 Sábado 21 octubre 2006 BOE núm. 252
5. Contenidos formativos
5.1 Conocimientos específicos: Enfermedades y terapias de base inmunológica.
Conceptos generales:
5.1.1 Antecedentes y desarrollo histórico de la Inmunología:
Inmunología: Área multidisciplinar en las ciencias de la salud.Inmunología y Medicina clínica: situación actual en el marco de la
Unión Europea.
Inmunología básica:
5.1.2 Anatomía y elementos celulares del sistema inmune:
Órganos linfáticos primarios y secundarios.Ontogenia, fenotipo y función de las células del sistema Inmune.
5.1.3 Respuesta Inmune:
Inmunidad innata y adaptativa: características, significación biológica e interacciones.
Mecanismos de reconocimiento inmunológico:
Receptores de inmunidad innata: receptores tipo TOL, tipo manosa, de las células NK.
De la inmunidad adaptativa: receptores clonotípicos de los linfoci-tos T y B.
El complejo principal de histocompatibilidad: estructura, polimor-fismo, función y regulación.
Otras moléculas presentadoras.
Formas de respuesta inmune adaptativa:
Respuesta inmune humoral y celular.Cooperación celular.Memoria inmunológica.
Regulación de la respuesta inmune y homeostasis inmunológica:
Tolerancia central y periférica.Apoptosis inducida por activación.Anergia e inmunosupresión.Linfocitos T reguladores.Actividades reguladoras de citocinas, quimiocinas e inmunomodula-
dores.
5.1.4 Moléculas efectoras de la inmunidad:
Anticuerpos: estructura y función de los diversos isotipos de inmuno-globulinas.
Sistema complemento: vías de activación, funciones biológicas, regu-lación e interacciones con otros sistemas efectores.
Maquinaria lítica celular: Perforina, granzima, apoptosis vía Fas.Citocinas y quimiocinas: Origen, familias, efectos biológicos, recepto-
res, polimorfismos, regulación y señales de activación.Moléculas que regulan el tráfico y alojamiento de las células inmuno-
lógicas: Integrinas y moléculas de adhesión. Selectinas, adresinas, defen-sinas.
Mediadores bioquímicos de esosinófilos, mastocitos y basófilos.Mediadores inflamatorios: Leucotrienos, prostaglandinas, factor acti-
vador de plaquetas, proteinas de fase aguda, citocinas proinflamatorias, factores quimiotácticos.
5.1.5 Mecanismos de hipersensibilidad:
Mediados por IgE: Reacciones de fase aguda y tardía.Mediados por IgG, IgA e IgM: Opsonización, fijación del complemento,
citotoxicidad dependiente o independiente de anticuerpo, estimulación y bloqueo.
Mediados por complejos inmunes: Mecanismos de aclaramiento y propiedades físico-químicas que condicionan el depósito de los comple-jos inmunes.
Mediados por células: Células participantes, mecanismos efectores y formación de granulomas.
Otros: Células NK, células asesinas activadas por citocinas e hipersen-sibilidad cutánea por basófilos.
5.1.6 Inmunidad e Infección:
Respuesta inmunológica a virus, bacterias intra y extracelulares, pro-tozoos, helmintos y hongos.
Mecanismos de evasión viral.Infecciones en el huésped inmunosuprimido.
5.1.7 Inmunología tumoral:
Oncogenes: translocaciones y puntos de ruptura.
Vigilancia anti tumoral.Principios de inmunoterapia del cáncer.
Inmunología clínica:
5.1.8 Inmunoalergia:
Aspectos generales de las enfermedades atópicas.Urticaria y anafilaxis. Alergias medicamentosas y ocupacionales.Asma y neumonitis por hipersensibilidad.
5.1.9 Inmunodeficiencias:
Inmunodeficiencias primarias.Inmunodeficiencias secundarias.Síndrome de Inmunodeficiencia Adquirida.
5.1.10 Enfermedades Autoinmunes Órgano específicas:
Endocrinológicas (Tiroiditis autoinmune, síndromes poliglandulares autoinmunes, Diabetes mellitus tipo I autoinmune, insuficiencia suprarre-nal primaria).
Cutáneas (Dermatitis y dermatosis de origen inmunológico).Sistema hematológico (neutropenia autoinmune, anemia hemolítica
autoinmune, púrpura trombocitopénica idiopática).Sistema neuromuscular (síndrome de Guillain-Barré, miastenia gravis,
neuropatías autoinmunes periféricas).Sistema Hepatobiliar (hepatitis autoinmune, cirrosis biliar primaria,
colangitis esclerosante autoinmune).Tubo digestivo (enfermedad celiaca, anemia perniciosa, enfermedad
inflamatoria intestinal).Oculares (Enfermedades inflamatorias oculares, trombosis de retina
por anticuerpos antifosfolípidos).Sistema Reproductor (infertilidad de causa inmunológica, abortos de
causa autoinmune).
5.1.11 Enfermedades Autoinmunes No-órgano específicas:
Enfermedades del Tejido conectivo (Lupus eritematoso sistémico, artritis reumatoide, esclerodermia, espondilitis anquilopoyética, dermatomiositis/polimiositis, síndrome de Sjögren, Enfermedad de Behcet).
Síndrome antifosfolípido.Vasculitis (poliarteritis nodosa, granulomatosis de Wegener).
5.1.12 Neoplasias y sistema inmune:
Leucemias y linfomas.Neoplasias asociadas a inmunodeficiencias.Neoplasias asociadas a infecciones virales.Gammapatías monoclonales.
5.1.13 Otras enfermedades inmunológicas con afectación de órganos y sistemas:
Sistema respiratorio: Asma, neumonitis por hipersensibilidad, fibrosis pulmonar y enfermedades relacionadas.
Sistema nervioso: Esclerosis Múltiple.Sistema Renal: Glomerulonefritis, nefropatía IgA.
5.1.14 Trasplante de órganos y de médula ósea.
Histocompatibilidad.Selección de receptores.Rechazos alorreactivos: Mecanismos.Enfermedades del injerto contra el huésped: MecanismosInmunosupresión.
5.1.15 Inmunotoxicología:
Mecanismos de reacciones nocivas.Evaluación de componentes citotóxicos in vivo e in vitro.Alteraciones inmunitarias inducidas por fármacos o sustancias quí-
micas.
5.1.16 Protocolos terapéuticos de base inmunológica:
Agentes inmunosupresores: corticosteroides, citostáticos, ciclospo-rina, tacrolimus, globulina anti linfocito y anti timocito, anticuerpos monoclonales de uso clínico (anti TNF-alfa, anti CD20, etc.). Fundamen-tos de su aplicación, efectos biológicos y principios farmacológicos.
Terapias de sustitución, inmunorestauradoras: Ganamaglobulinas intravenosas, citocinas, factores de crecimiento, transplante de médula ósea; transplantes de celulas inmunológicas activadas «ex vivo»; vacunas terapéuticas,
Terapias preventivas.Vacunas profilácticas, plasmaféressis.Terapia génica y celular.
BOE núm. 252 Sábado 21 octubre 2006 36897
5.1.17 Principios biotecnológicos:
Propiedades fisicoquímicas de la reacción antígeno-anticuerpos y apli-caciones prácticas: técnicas ELISA, RIA, aglutinación, etc.
Técnicas de cultivo celular y producción de anticuerpos monoclo-nales.
Fundamentos y aplicaciones de la citometría de flujo.Tecnología del ADN recombinante.
5.2 Formación práctica: Metodología de laboratorio.
Las pruebas analíticas que se realizan en los laboratorios de Inmunolo-gía, reflejan los avances producidos en esta disciplina en los últimos años. Estos avances se deben a la investigación básica, a una mejor compren-sión de las bases inmunológicas de las enfermedades y a las observacio-nes empíricas y de investigación clínica efectuadas en los pacientes. Los contenidos prácticos de laboratorio de la especialidad de Inmulogía inclu-yen todos los tests orientados al diagnóstico y seguimiento de todas las enfermedades de base inmunológica, cualquiera que sea el procedimiento a seguir, que puede incluir el estudio de la inmunidad humoral, celular o alteraciones genéticas. También incluye el aislamiento y/o la manipula-ción de tejidos.
Las pruebas analíticas que, entre otras, se deben desarrollar en un laboratorio de inmunología son las siguientes:
5.2.1 Inmunoquímica e inmunoalergia:
Espectro electroforético de suero y orina.Determinación cuantitativa y cualitativa de las inmunoglobulinas en
suero: Cuantificación de Inmunoglobulinas en suero, cuantificación de subclases de IgG e IgA, cuantificación de IgA secretora, determinación de anticuerpos específicos en suero, respuesta específica a vacunas.
Determinación de inmunoglobulinas en otros fluidos biológicos (orina, saliva, LCR, líquido sinovial, líquido pleural, lavado broncoalveo-lar, lágrimas, leche materna).
Determinación funcional e inmunoquímica de los componentes del complemento y sus productos de activación. Determinación de alotipos de factores del complemento.
Determinación en suero de proteínas inflamatorias.Determinación de inmunoglobulinas y bandas oligoclonales en IgG.
Indices LCR/Suero.Identificación y cuantificación de paraproteínas en suero y orina.Caracterización y cuantificación de crioglobulinas en suero.Medidas de citocinas y quimiocinas así como de sus receptores solu-
bles en el plasma y en los fluidos del organismo.Medida de los productos de las reacciones inflamatorias.Cuantificación de proteína unidora de manosa.Determinación otras proteínas y moléculas relevantes (vg. Beta-2
microglobulina).Cuantificación de la adenosindesaminasa y de purín-nucleótido fosfo-
rilasa.Cuantificación de IgE total e IgE específica.Cuantificación de anticuerpos bloqueantes.Estudio de precipitinas.Estudio de la proteína catiónica del eosinófilo.
5.2.2 Inmunidad celular:
Subtipos de linfocitos y marcadores fenotípicos: Estudio celular feno-típico para evaluación de Inmunodeficiencias, de la infección por el VIH, de síndromes linfoproliferativos.
Estudio fenotípico de granulocitos y plaquetas.Estudio fenotípico de células precursoras hematopoyéticas.Técnicas de aislamiento y purificación de poblaciones celulares.Estudio de la expresión de antígenos HLA, (asociación de alelos HLA
con patologías: espondiloartropatías, celiaca, narcolepsia, hemocromato-sis, etc.).
Determinación de la clonalidad de las células linfoides.Función de los linfocitos: respuesta proliferativa y producción de
inmunoglobulinas in vitro en respuesta a setímulos tipo lectinas, ionófo-ros, citocinas; anticuerpos monoclonales y antígeneos específicos.
Cuantificación de citocinas y quimiocinas en fluidos biológicos.Pruebas cutáneas de hipersensibilidad retardada.Citotoxicidad de células linfoides y otras células efectoras.Apoptosis linfocitaria.Actividad funcional de macrófagos, neutrófilos, mastocito-basófilos y
eosinófilos.Movilización de calcio citosólico en linfocitos.Capacidad quimiotáctica de células fagocíticas.
5.2.3 Autoinmunidad:
Anticuerpos no órganos específicos:
Anticuerpos antinucleares (ADN, histonas, Ku, Scl-70, ENA, aparato mitótico, NOR-90, fibrilarina, etc.).
Anticuerpos anticitoplásmicos (mitocondriales, ribosomas, tRNA sin-tetasas).
Anticuerpos específicos de tejido (músculo liso, dérmicos, endomisio, miocardio, cartílago, enterocitos, membrana basal glomerular, etc.).
Anticuerpos órgano específicos (tiroideos, ICA, GAD, ovario, células de Leydig, adrenales, etc.).
Anticuerpos neurológicos (gangliosidos, receptor acetil colina, Hu, Ri, Yo, proteina básica de la mielina)
Otros: Ac antifosfolípidos (cardiolipina), ANCA, transglutaminsa, etc.
5.2.4 Histocompatibilidad y trasplantes:
Tipaje HLA por técnicas serológicas.Determinación génica de alelos HLA de clase I y clase II: PCR-SSO,
PCR-SSP, PCR-dot-blot reverso. Análisis de asociación de HLA y enfermedad.Determinación de antígenos HLA solubles.Determinación de anticuerpos citotóxicos anti-HLA.Estudio de antisueros anti-HLA.Compatibilidad HLA-D. Cultivo mixto linfocitario.Prueba cruzada para transplante de órgano.Niveles sanguíneos de inmunosupresores: ciclosporina A, micofeno-
lato, rapamicina, etc.Anticuerpos anti-CD3 (OKT3).
5.2.5 Inmunogenética e inmunobiología molecular:
Determinación fenotípica y genotípica de alotipos de proteínas séricas.Diagnóstico prenatal y herencia de enfermedades inmunitarias de ori-
gen genético (Inmunodeficiencias).Estudio de mutaciones del locus HEF (hemocromatosis familiar).Estudio genético del reordenamiento de las cadenas pesadas de inmu-
noglobulinas y del receptor de célula T.Prueba de confirmación de la infección por VIH-1 y VH-2 por técnicas
de inmunotransferencia o Western Blot.Detección y cuantificación de carga viral en pacientes VIH positivos.Amplificación proviral del VIH y cuantificación DNA proviral.Prueba de detección del correceptor CCR5.Diagnóstico molecular de inmunodeficiencias:
Determinación de la expresión y actividad de proteínas alteradas (Btk).
Estudio de portadores: Inactivación del cromosoma X.Mutaciones génicas: Cadena CD3-epsilon, PNP, ADA, Rag, receptores
de interleuquinas, factor de transcripción CIITA, etc.).
5.2.6 Biotecnología: Dependiendo de las posibilidades de cada cen-tro, el residente deberá conocer y aplicar en el laboratorio alguna de las tecnologías que a continuación se citan:
Tecnología de producción de anticuerpos monoclonales.Producción de otras moléculas de interés inmobiológico.
5.3 Formación práctica en inmunología clínica.
En la actualidad, en algunos hospitales se han desarrollado Unidades de Inmunología Clínica Especializada, a través de las cuales se presta una atención directa al paciente, ejercida exclusivamente por el inmunólogo clínico o en colaboración con otros especialistas. Los contenidos de este punto del programa afectan exclusivamente a los licenciados en Medi-cina. Las actividades que pueden desarrollar estas unidades son las siguientes:
5.3.1 Diagnóstico y tratamiento de las patologías de base inmunoló-gica:
Evaluación y tratamiento de inmunodeficiencias primarias, inmunode-ficiencias secundarias, enfermedades autoinmunes (coordinadamente con especialistas relacionados con la patología de base inmunológica), reacciones de hipersensibilidad y de otras patologías que pueden deberse a alteraciones de base inmunológica.
Evaluación y monitorización inmunológica de infecciones crónicas.Evaluación y monitorización inmunológica de terapias de base inmu-
nológica y transplantes.Evaluación y monitorización de crioglobulinemias y paraproteine-
mias.
5.3.2 Administración de terapias de base inmunológica:
Terapia sustitutiva con gammaglobulina intravenosa (GGIV).Terapia inmunosupresora: Corticoides, Azatioprina, Ciclofosfamida,
Ciclosporina, Tacrolimus, Sirolimus, Rapamicina, Micofenolato Mofetil entre otros; GGIV a altas dosis; anticuerpos monoclonales (p.e. anti-CD3, anti-CD52, anti-TNF, anti-rIL2).
36898 Sábado 21 octubre 2006 BOE núm. 252
Terapia inmunomoduladora [anticuerpos monoclonales, citocinas (IL-2, Interferon-gamma) y otros agentes biológicos utilizados para la inmunomodulación (anticuerpos anti-TNF)].
5.3.3 Inmunoterapia de enfermedades prevenibles:
Indicaciones y contraindicaciones de la administración de vacunas.Prevención y tratamiento de reacciones adversas.Inmunización de pacientes con inmunodeficiencia.
En los cuadros que figuran como anexo en el apartado 7 de este pro-grama se resumen los conocimientos prácticos y las habilidades que deben desarrollar los residentes en cada sección funcional de la especia-lidad de Inmunología, que asimismo coinciden con las secciones de rota-ción obligatoria para los residentes.
5.4 Formación en técnicas de gestión.
El programa de formación de residentes de Inmunología incluye el conocimiento de técnicas y herramientas de gestión, necesarias para la organización eficiente de las unidades de Inmunología y el mejor aprove-chamiento de los recursos.
5.4.1 Organización Sanitaria: El modelo de organización sanita-ria se corresponde con el regulado, fundamentalmente por la Ley General 14/1986, de 25 de abril, General de Sanidad, por la Ley 16/2003, de 28 de mayo, de cohesión y calidad del Sistema Nacional de Salud y por las disposiciones que dicten las comunidades autónomas en el ámbito de sus competencias como consecuencia de haber concluido el proceso de transferencias sanitarias a las mismas.
Asimismo, el desarrollo en los próximos años de la Ley 44/2003, de 21 de noviembre de ordenación de las profesiones sanitarias, tendrá un papel destacado en la configuración de las profesiones sanitarias al pre-ver en su artículo 9, la formación de unidades clínicas integradas por equipos de carácter multiprofesional y multidisciplinar.
En este marco, la Inmunología encaja como especialidad mixta (labora-torio-clínica) para la atención especializada de la patología que le es propia en hospitales de la red sanitaria, mayoritariamente públicos y por lo tanto sujetos a las condiciones legales que regulan el funcionamiento de estas instituciones, en lo referente a la contratación de personal, adquisición de material y equipos, condiciones laborales, ámbito de actuación, etc.
Los residentes deberán conocer las características básicas de la orga-nización sanitaria y el marco de actuación en el que van a a desarrollar su actividad profesional.
5.4.2 Herramientas de gestión: Los residentes deberán conocer los instrumentos básicos de negociación y gestión que habrán de aplicar en su futura actividad profesional.
5.4.3 Sistemas de información: En la sociedad de información, donde cualquier actividad laboral o profesional esta condicionada por el manejo de datos informatizados, el programa de formación de residentes deberá cubrir los siguientes aspectos:
Programas de ofimática en entorno windows e internet.Programas de estadística básica.Sistemas de clasificación de enfermedades.Sistemas de gestión de datos de laboratorio.Garantías de confidencialidad de datos.
5.4.4 Sistemas de aseguramiento de la calidad: Uno de los requisitos que se va imponiendo en las actividades laborales y profesionales es la necesidad de someterse a programas de aseguramiento de la calidad. Esta necesidad afecta a los procedimientos del laboratorio, a la calidad de los equipos y reactivos, a la calidad ambiental y a la formación del personal, que deben ser garantizadas por organismos evaluadores (agencia ENAC) con sujeción a las normas de aseguramiento de calidad reconocidas inter-nacionalmente, como son las normas ISO.
En el caso de los laboratorios de inmunología existen asimismo nor-mas de acreditación específicas para determinados procesos como la histocompatibilidad, objeto de acreditación por la EFI (European Foun-dation of Immunogenetics), o para determinados modelos de calidad total como el Baldridge o el EFQM, que en estos momentos están siendo consi-derados.
Los residentes de inmunología deben participar en estos programas de aseguramiento de calidad, tanto en lo que se refiere a los aplicados a la calidad de los ensayos, como a los procedimientos generales del labora-torio.
5.4.5 Optimización de recursos: El sistema de información de costos (contabilidad analítica) aplicado en la gestión económica de numerosos centros permite conocer los resultados por producto y centro de costo (servicio, unidad de gestión clínica), imputar los gastos y establecer pre-visiones para ejercicios anuales en contratos programa o mediante cual-quiera otra forma de gestión económica programada.
La actividad de los laboratorios tiende a medirse en URV (unidades relativas de valor), concepto que asigna un valor relativo a cada prueba analítica, en función de los costos reales.
Los residentes de inmunología deberán conocer los instrumentos de control de gasto que son aplicados en sus unidades.
5.4.6 Análisis y evaluación: El sistema de gestión por procesos obliga a revisiones periódicas conforme a matrices de evaluación, PDCA, REDER, ampliamente utilizados en gestión de empresas. Esta metodolo-gía esta siendo aplicadas en centros sanitarios y debería ser conocida por los Residentes en formación.
5.5 Formación en aspectos bioéticos.
Los residentes de Inmunología deben conocer y recibir formación adecuada en las diferentes normativas vigentes en nuestro País sobre los aspectos bioéticos de la práctica médica y de la actividad investigadora. Esta formación se realizará siempre en estrecho contacto y, principal-mente, a través de los Comités de Bioética de cada hospital.
Los residentes deberán adquirir una formación específica sobre los siguientes aspectos:
Derechos de los pacientes y su marco legal.Confidencialidad y seguridad en la intimidad y privacidad.Criterios acerca del derecho a la información.Aplicación práctica y cumplimiento del consentimiento informado.Medidas de seguridad en el manejo de ficheros automatizados de
pacientes, que incluirá:
Cumplimiento de la normativa de acceso a los datos informatizados.Funciones y obligaciones del personal en el manejo de los ficheros.Procedimiento de acceso que garantice la confidencialidad.Control de salida de datos informáticos de carácter personal.Gestión de incidencias.
Aspectos bioéticos de la experimentación animal.
6. Articulación del periodo formativo: rotaciones y actividades
6.1 Rotaciones internas en áreas fundamentales de la Inmunología:
Para los residentes licenciados en Medicina: las rotaciones internas comportarán un período de tres años por las siguientes unidades:
Inmunoquímica (Inmunoproteínas y Alergia), mínimo 6 meses.Autoinmunidad, mínimo 6 meses.Inmunidad celular e Inmunodeficiencias, mínimo 6 meses.Inmunogenética e Histocompatibilidad, mínimo 6 meses.Unidad de Inmunología Clínica, mínimo 6 meses.
Para los residentes licenciados en Biología, Bioquímica y Farmacia: las rota-ciones internas de formación básica en laboratoio comportarán los dos primeros años de residencia en cada una de las unidades ciadas anteriormente para los licenciados en medicina (excepto la de Inmunología Clínica).
Durante el resto del programa formativo estos residentes se adscribi-rán a una de las Unidades existentes en el Servicio a fin de profundizar en un aspecto particular de la especialidad. Periódicamente y a criterio del Tutor correspondiente, el residente deberá acometer períodos menores de rotación interna por las otras Unidades a fin de renovar los conoci-mientos adquiridos y acceder a las novedades técnicas introducidas, así como familiarizarse con los procedimientos de Gestión de Laboratorio.
El objetivo general de estas rotaciones internas es que el residente adquiera el conocimiento teórico y la habilidad práctica necesaria para realizar cada una de las técnicas diagnósticas de las enfermedades con componente inmunológico, que le permitan una interpretación de los resultados, con especial referencia al significado patológico y valor pro-batorio de las determinaciones realizadas, así como la emisión de infor-mes inmunológicos, con la supervisión del tutor o el responsable del área. Simultáneamente, el residente colaborará en la ejecución de los controles de calidad y la introducción de nuevas tecnologías, siempre bajo la super-visión de un miembro de la plantilla y/o el tutor.
Toda esta labor de aprendizaje debe ser compatible con la formación investigadora del residente, al que se le facilitará la integración en los progra-mas de investigación de la Unidad Docente y en la medida de lo posible la iniciación de los estudios del doctorado sin perjuicio del cumplimiento de sus obligaciones laborales y de su formación como especialista.
Nota: Los contenidos teóricos, prácticos y actividades a realizar son los que se citan en los cuadros que figuran como anexo en el apartado 9 de este programa.
6.2 Rotaciones internas en otros servicios/unidades asistenciales del hospital:
Los residentes médicos (MIR) realizarán rotaciones por Unidades Docentes Clínicas por un periodo mínimo de 6 meses. Estas rotaciones
BOE núm. 252 Sábado 21 octubre 2006 36899
serán, igualmente, diseñadas por el tutor de acuerdo con las peculiarida-des de cada Hospital y pueden incluir:
Medicina Interna.Nefrología/trasplantes renales.Reumatología.Alergia.Neumología.Hematología/trasplantes de médula ósea.Pediatría.
El objetivo de estas rotaciones es que el MIR adquiera conocimientos clínico-prácticos de las enfermedades de base inmunológica.
Se recomienda que los MIR se integren en el programa de Guardias Médicas del Hospital realizando entre 4 y 6 guardias mensuales en Servi-cios de Urgencia por un periodo de un año.
Los residentes licenciados en Biología, Bioquímica y Farmacia realiza-rán rotaciones externas por un periodo total no superior a 6 meses por otras Unidades Docentes que pueden variar dependiendo de connotacio-nes locales hospitalarias. Serán diseñadas por los respectivos tutores y tratarán de suplir carencias formativas de la Unidad Docente de Inmuno-logía como:
Genética Molecular.Microbiología.Hematología.Anatomía Patológica.
El objetivo de estas rotaciones será el de suplir carencias formativas de la unidad docente de Inmunología.
Se aconseja que las rotaciones externas se realicen después de haber adquirido los conocimientos básicos de la especialidad, esto es, durante los periodos de R3 y/o R4. No obstante, y, según las peculiaridades de cada Unidad, el tutor podrá establecer el calendario de rotaciones exter-nas intercaladas con las rotaciones internas, siempre que el residente haya cumplido una rotación en el Servicio de Inmunología no inferior a 6 meses.
6.3 Rotaciones externas por otros hospitales: Los residentes podrán rotar por un tiempo no superior a 6 meses por Unidades Docentes de Inmunología para completar su formación en áreas carentes en el propio hospital.
Para los MIR se aconseja la rotación por Unidades Clínicas de Inmuno-deficiencias, Unidades Clínicas de Conectivopatías y Unidades de Inmu-nología Clínica Especializada.
Para los licenciados en Biología, Bioquímica y Farmacia, se aconseja rotación por Servicios de Inmunología de otros Hospitales que dispongan de formación en un área concreta de la que carezca el Servicio de origen.
6.4 Rotaciones para la formación en protección radiológica: Los resi-dentes deberán adquirir de conformidad con lo establecido en la legisla-ción vigente conocimientos básicos en protección radiológica ajustados a lo previsto en la Guía Europea «Protección Radiológica 116», en las siguientes materias.
a) Estructura atómica, producción e interacción de la radiación.b) Estructura nuclear y radiactividad.c) Magnitudes y unidades radiológicas.d) Características físicas de los equipos de Rayos X o fuentes radiac-
tivas.e) Fundamentos de la detección de la radiación.f) Fundamentos de la radiobiología. Efectos biológicos de la radia-
ción.g) Protección radiológica. Principios generales.h) Control de calidad y garantía de calidad.i) Legislación nacional y normativa europea aplicable al uso de las
radiaciones ionizantes.j) Protección radiológica operacional.k) Aspectos de protección radiológica específicos de los pacientes.l) Aspectos de protección radiológica específicos de los trabajado-
res expuestos.
La enseñanza de los epígrafes anteriores se enfocará teniendo en cuenta los riesgos reales de la exposición a las radiaciones ionizantes y sus efectos biológicos y clínicos.
Duración de la rotación: Los contenidos formativos de las anteriores letras a), b), c), d), e), f), g), h), i), se impartirán durante el primer año de especialización. Su duración será, entre seis y diez horas, fraccionables en módulos, que se impartirán según el plan formativo que se determine.
Los contenidos formativos de las letras j), k) y l): Se impartirán progre-sivamente en cada uno de los sucesivos años de formación y su duración será entre una y dos horas destacando los aspectos prácticos.
Lugar de realización: Los contenidos formativos de las letras a), b), c), d), e), f) g), h), i), se impartirán por lo integrantes de un Servicio de Radiofísica Hospitalaria/ Protección Radiológica/ Física Médica. Los contenidos formativos de las letras j), k) y l): Se impartirán en una Ins-titución Sanitaria con Servicio de Radiofísica Hospitalaria/Protección Radiológica/Física Medica, en coordinación con las unidades asistencia-les de dicha institución específicamente relacionadas con las radiaciones ionizantes.
Organización de la formación: Cuando así lo aconseje el número de residentes, especialidades y Servicios de Radiofísica/Protección Radiológica/Física Médica implicados, los órganos competentes en mate-ria de formación sanitaria especializada de las diversas comunidades autónomas podrán adoptar, en conexión con las Comisiones de Docencia afectadas, las medidas necesarias para coordinar su realización con vistas al aprovechamiento racional de los recursos formativos.
6.5 Actividades clasificadas según niveles de responsabilidad:
Nivel 1: Actividades realizadas directamente por el residente sin nece-sidad de una tutorización directa.
Nivel 2: Actividades realizadas directamente por el residente bajo supervisión del tutor.
Nivel 3: Actividades realizadas por el personal sanitario y observadas/asistidas en su ejecución por el residente.
R1 R2 R3 R4
Técnicas de Laboratorio
Conocimiento teórico de todo el contenido de la especialidad …………………………………… 1 1 1 1Cuantificación de inmunoproteínas ………………………………………………………………… 2 1 1 1Cuantificaciones de IgE total y específica ………………………………………………………… 2 1 1 1Degranulación de basófilos ………………………………………………………………………… 3 3 2 1Estudio de crioglobulinas y paraproteínas ………………………………………………………… 2 2 1 1Purificación de proteínas séricas (cromatografía, isolelectroenfoque) ………………………… 3 3 3 2Ensayos funcionales de la actividad del complemento …………………………………………… 3 3 2 1Análisis de precipitinas ……………………………………………………………………………… 3 2 2 1Técnicas de inmunofluorescencia …………………………………………………………………… 2 1 1 1Patrones de fluorescencia: identificación e interpretación ……………………………………… 3 2 2 1Contraelectroforesis ………………………………………………………………………………… 2 1 1 1Técnicas de ELISA …………………………………………………………………………………… 2 1 1 1Extractos antigénicos e inmunoblotting …………………………………………………………… 3 2 2 1Inmunoprecipitación ………………………………………………………………………………… 3 3 2 2Citofluorometría: poblaciones linfocitarias ………………………………………………………… 3 2 2 1Inmunofenotipaje de leucemias y linfomas ………………………………………………………… 3 3 2 1Separaciones celulares ……………………………………………………………………………… 3 2 2 1Cultivos celulares y ensayos de proliferación ……………………………………………………… 3 2 2 1Cuantificación de citocinas ………………………………………………………………………… 3 2 2 1Citotoxicidad y apoptosis …………………………………………………………………………… 3 3 2 1Ensayo de fagocitosis y estress oxidativo ………………………………………………………… 3 3 2 1Tipaje HLA serólogico y genómico ………………………………………………………………… 3 2 2 1Anticuerpos citotóxicos anti-HLA ………………………………………………………………… 2 2 2 1
36900 Sábado 21 octubre 2006 BOE núm. 252
Análisis mutaciones génicas ………………………………………………………………………… 3 3 2 2Polimorfismos genéticos ……………………………………………………………………………… 3 3 2 1
Actividad clínica
Emisión de informes clínicos ………………………………………………………………………… 3 3 2 1Elaboración de protocolos …………………………………………………………………………… 3 3 2 1Consulta especializada ……………………………………………………………………………… 3 3 3 2
Actividad científica
Elaboración de proyectos de investigación ………………………………………………………… 3 3 2 1Confección de comunicaciones científicas ………………………………………………………… 3 3 2 1Elaboración de artículos científicos ………………………………………………………………… 3 3 2 1
Actividad docente
Seminarios revisión temática ………………………………………………………………………… 2 2 1 1Seminarios bibliográficos …………………………………………………………………………… 3 2 1 1Sesiones clínicas ……………………………………………………………………………………… 3 2 2 1Seminarios de investigación………………………………………………………………………… 3 3 2 2
Otras actividades
Conocimientos básicos de gestión clínica ………………………………………………………… 3 3 2 1Aspectos bioéticos………………………………………………………………… 1 1 1 1Conocimiento informático: Bases de datos, seroteca, gráficos, etc. ……………………………… 2 1 1 1Controles de calidad internos y externos …………………………………………………………… 3 2 2 1Normativa sobre acreditaciones …………………………………………………………………… 3 2 2 1Idiomas: inglés ………………………………………………………………………………………… 2 1 1 1
R1 R2 R3 R4
6.6 Actividades segun objetivos específicos operativos:
6.6.1 Para todos los Residentes:
Aprendizaje tutelado por especialistas en inmunología y de otras espe-cialidades relacionadas que comprenda la observación, ejecución y discu-sión, de las diferentes actividades y procedimientos incluidos en el apar-tado 6 y su consiguiente evaluación.
Realización de un mínimo anual de 2000 informes inmunológicos de laboratorio diagnóstico.
Asistencia y participación en las actividades docentes programadas en el Servicio de Inmunología y el hospital. El Servicio de Inmunología deberá organizar periódicamente sesiones bibliográficas, teóricas y de investigación básica y clínica.
Asistencia a cursos de tercer ciclo y otros cursos de post-grado orga-nizados por entidades avaladas científicamente (Colegios Profesionales, Sociedades Nacionales e Internacionales) así como a congresos naciona-les e internacionales relacionados con la especialidad.
Participación en equipos multidisciplinarios para la evaluación del trabajo de laboratorio y clínico. Elaboración de protocolos de diagnóstico propios del laboratorio de Inmunología.
Utilización de recursos de aprendizaje a través de internet. Búsquedas bibliográficas.
Estudio personal orientado por los tutores. Reuniones periódicas de tutoría.
Participación en grupos de trabajo internos y externos (p.e. Grupos de trabajo hospitalarios, Registro Español de Inmunodeficiencias).
Participación en la realización de talleres de histocompatibilidad, inmunidad celular e inmunoproteínas organizados por la Sociedad Espa-ñola de Inmunología (SEI) y en aquellos organizados por otras Socieda-des Internacionales [European Federation of Immunological Societies (EFIS) y European Confederation of Laboratory Medicine (ECLM), etc.].
Participación en programas de Control de calidad externos e internos.Participación en actividades de gestión del Laboratorio Diagnóstico
de Inmunología.Participación en programas de formación biomédica continuada.Participación en la elaboración y ejecución de proyectos de investiga-
ción. Presentación de trabajos de investigación en congresos y publica-ción de los mismos en revistas nacionales e internacionales.
6.6.2 Para los Residentes Licenciados en Medicina que roten por Unidades Clínicas Especializadas:
Realización de un mínimo de 100 informes clínicos inmunológicosParticipación en las actividades de las Unidades Clínicas Especiali-
zadas.
7. Referencias bibliográficas
1. WHO. Clinical Immunology. WHO Technical Report Series n.º 496, 1972.
2. IUIS. Report of the Clinical Immunology Committee. Lancet 1976;1:196.
3. IUIS/WHO. Report. Use and abuse of laboratory tests in clinical immunology. WHO Bull 1981; 59,717-728.
4. IUIS/WHO. Report. Appropriate uses of human immunoglobulin in clinical practice. Clin. Exp Immunol 1983;52:417.
5. IUIS/WHO. Report on AIDS. Ann Internal Med 1987.6. IUIS/WHO Report. Laboratory investigations in clinical immuno-
logy Clin Exp Immunol 1988;74:494-503./WHO. Current status of allergen immunotherapy. Lancet 1989;1:259.
7. Report of the British Society for Immunology working party on clinical immunology:1981-1982: Functions and training of the Clinical Immunologist. Clin. Exp.Immunol 1983; 52:702-705.
8. Report of the British Society for Immunology working party on clinical immunology: 1984.Guidelines for training the physician immuno-logist. Clin. Exp. Immunol. 1985; 61:216-218.
9. The physician immunologist: future role and manpower needs. Report by the Royal College of Physicians committee on clinical immuno-logy. Clin. Exp. Immunol. 1987; 70: 664-675.
10. Waldmann T.A. 1988 Presidential adress of the Clinical Immuno-logy Society: Clinical Immunology is everywhere and nowhere-strength or weakness? Clin. Immunol.Immunopathol.1989;51:2-12.
11. Barnes R, Chapel H. Current practice and future directions in clinical immunology. J Royal Soc Med 1995; 88: 395-97.
12. WHO/IUIS/IAACI Report. Clinical Immunology. Guidelines for its organization, training and certification. The Immunologist 1993; 1,57-63.
13. Bene MC by the EFIS group for Clinical Immunology (Fernández-Cruz, E, Peña J). State-of-the-art of clinical immunology in Europe. Immu-nology Letters 2000; 71: 191-201.
14. Fontan G., Fernández-Cruz E., Carbone J., Matamoros N., Brieva J.A, Vives J. State-of-the-art of clinical immunology in Europe. Immunol Lett 2000, 1;71 (3):191-201.
15. Fahey J. Clinical immunology: a distinct area of immunology. Immunologist 1995; 3: 104-7.
16. Revillard JP, Celada F. Guidelines for the PhD degree in immuno-logy, International Union of Immunological Societies Education Comit-tee. Immunol Today 1992; 13: 367-73.
17. Cabrera T. Oferta docente, asistencial y científica para Residen-tes de Inmunología en España. Inmunología. 1995; 14: 19-27.
18. Manual de toma de muestras para el laboratorio clínico. Volu-men II. Inmunología. Editado por el INSALUD en coordinación con la Sociedad Española de Inmunología. Madrid, 1996.
BOE núm. 252 Sábado 21 octubre 2006 36901
INMUNOQUIMICA
Objetivos básicos de la rotación: Conocimiento de las técnicas inmunoquímicas de aplicación clínica; de su utilidad diagnóstica y de su
correcta interpretación y valoración. De los procesos de organización y gestión del laboratorio con especial hincapié en la automatización e
informatización.
Contenidos
Teóricos Prácticos
Acciones
• De las moléculas implicadas en las
funciones de la inmunidad natural y
adaptativa
• De la valoración de estas moléculas en
patología
• De los fundamentos técnicos para su
valoración cuantitativa y su actividad
funcional
• Cuantificación de Igs de las diferentes clases
y subclases
• Análisis de paraproteinas en suero y orina
• Caracterización y cuantificación de
crioglobulinas
• Cuantificaciones de IgE total y específica
• Purificación y análisis de proteinas del suero
y otros líquidos orgánicos (cromatografía
líquida, electroforesis, isoelectroenfoque)
• Realización de técnicas de elisa y “blotting”
• Cuantificación de proteinas del complemento
y otros sistemas efectores de la inmunidad
• Ensayos funcionales de la actividad del
complemento
• Cuantificaciones de IgE total y específica
• Análisis de precipitinas
• Control informatizado de seroteca
• Manejo de equipos automáticos para el
análisis de proteinas
• Utilización de recursos informáticos para
el manejo de datos (demográficos,
control de peticiones, resultados e
informes)
• Conocer los circuitos pre y post analítico
de las pruebas del laboratorio
• Aplicación de los controles de calidad
indicados para los distintos procesos y las
diferentes pruebas
• Revisión de resultados e informes bajo la
supervisión del tutor
• Presentación de seminarios sobre los
temas teóricos y las técnicas que se
incluyen en la rotación
Al final de la rotación se pretende que el residente este en condiciones de controlar la realización de las técnicas arriba indicadas, de valorar su
significación clínica y supervisar los resultados e informes de dichas pruebas.
8. ANEXO RELATIVO A LOS CONTENIDOS EN ÁREAS FUNDAMENTALES DE LA ESPECIALIDAD DE INMUNOLOGÍA
(ROTACIONES APARTADO 6.1)
AUTOINMUNIDAD
Objetivos básicos de la rotación: Conocimiento de las base teóricas de la tolerancia y autoinmunidad; de la patogenia y características clínicas
de las enfermedades autoinmunes, de la significación de los diversos autoanticuerpos, de las técnicas empleadas para su detección, y de su
correcta interpretación y valoración.
Contenidos
Teóricos Prácticos
Acciones
• Conocimiento de los mecanismos
etiopatogénicos de la autoinmunidad
• Predisposición genética a la
autoinmunidad
• Regulación inmunológica de la
autoinmunidad
• Espectro clínico y serológico de las
conectivopatías autoinmunes
• Espectro clínico y serológico de los
síndromes poliglandulares
• Diabetes tipo I
• Autinmunidad gastrointesinal
• Autoinmunidad hepato biliar
• Autoinmunidad neurológica
• Dermatopatías ampollosas
• Autoanticuerpos en patología vascular y
renal
• Otras patologías de carácter autoinmune
• Realización de técnicas de
inmunofluorescencia
• Interpretación de patrones de fluoresecencia
en celulas y tejidos
• Preparación de extractos antigénicos de
tejidos
• Preparación de cortes histológicos de tejidos
para fluorescencia
• Técnicas de elisa e inmunoblot
• Técnicas de inmunoprecipitación
• Técnicas de contraelectroforesis
• Valoración de los resultados obtenidos con
otras técnicas de detección de autoanticuerpos
• presentación de seminarios relacionados
con el programa teórico
• participación activa en programas de
control de calidad
• revisión de resultados obtenidos en
patologías concretas
• interpretación de resultados con
asesoramiento del tutor
• colaboración en el desarrollo de pruebas
de detección de autoanticuerpos
• Comunicación fluida y normalizada con
los clínicos que habitualmente atienden
estas patologías
Al final de la rotación se pretende que el residente este en condiciones de deternminar y evaluar los autoanticuerpos habitualmente utilizados en
la clínica, y poder asesorar acerca de su significado e interés clínico a los médicos que lo soliciten
36902 Sábado 21 octubre 2006 BOE núm. 252
INMUNIDAD CELULAR
Objetivos básicos de la rotación: Adquirir los conocimientos y destreza necesarios para la purificación y cultivo de células, realización de
ensayos funcionales y pruebas cutáneas; conocer los principios, tecnologia básica y principales aplicaciones de la citometría de flujo (CF).
Contenidos
Teóricos Prácticos
Acciones
• Conocer las propiedades fenotípicas y
funcionales de las subpoblaciones de
linfocitos y demás componentes
celulares de la respuesta inmune
• Conocer los órganos linfáticos, su
maduración, función, técnicas de
estudio
• Conocer la patología básica de las
celulas del sistema inmune (leucemias,
linfomas e inmunodeficiencias)
• Principios básicos de la CF
• Instrumentación, técnicas de marcaje,
fluorocromos, programas de aplicaciones
• Diferenciación y maduración celular de
la médula ósea normal
• Características inmunofenotípicas de los
neoplasias hematológicas
• Analísis fenotípico y funcional de los
leucocitos polinucleares
• Técnicas de separación y purificación de
celulas
• Técnicas de cultivo
• Técnicas de marcaje (incorporación de
isótopos, inmunoenzimas y trazadores
fluorescentes
• Métodos de análisis, parámetros, controles de
calidad
• Ensayos de proliferación en respuesta a
antígenos y mitógenos
• Técnicas de citotoxicidad
• Análisis de poblaciones linfocitarias en sangre
periférica de pacientes con infección VIH y
otras patologías
• Inmunofenotipaje de leucemias y linfomas
• Tipaje HLA-B27
• Cuantificación de citocinas
• Ensayo de fagocitosis y estress oxidativo
intracelular
• Ensayos de proliferación celular y apoptosis
• Ensayo de degranulación de basófilos
• Presentación de seminarios relacionados
con el programa teórico
• Revisiónes bibliográficas
• participación activa en programas de
control de calidad
• revisión de resultados obtenidos en
patologías concretas
• interpretación de resultados con
asesoramiento del tutor
• Comunicación fluida y normalizada con
los clínicos solicitan estudios de
inmunidad celular
Al final de la rotación se pretende que el residente este en condiciones de trabajar eficazmente en técnicas de cultivo celular, utilizar el citómetro
de flujo para las aplicaciones clínicas mas comunes, y de interpretar resultados de las pruebas de inmunidad celular arriba inicadas.
INMUNOGENETICA E HISTOCOMPATIBILIDAD
Objetivos básicos de la rotación: Conocer el polimorfismo genético y estructural, significado, funcionalidad y métodos de análisis del
complejo principal de histocompatibilidad (CPH), particularmente en el contexto de los transplantes de órganos y tejidos, y con la
susceptibilidad a las enfermedades autoinmunes. Conocer el significado y métodos de estudio del polimorfismo de otros genes importantes en la
fisiología del sistema inmune (receptor T, Igs, citocinas y sus receptores..)
Contenidos
Teóricos Prácticos
Acciones
• Inmunobiología del CPH
• Técnicas de análisis del polimorfismo
del sistema HLA
• Inmunología del Transplante de médula
ósea
• Inmunología del transplante de órganos
(riñón, hígado, corazón y pulmón)
• Asociación HLA y enfermedades
autoinmunes
• Genética de la hemocromatosis
• Defectos genético- moleculares de las
inmunodeficiencias primarias
• Genes de citocinas, quimiocinas y sus
receptores; implicaciones en patología
• Tipaje HLA serológico
• Tipaje HLA genómico
• Detreminación de anticuerpos citotóxicos anti
HLA
• Cultivo linfocitario mixto
• Prueba cruzada para transplante de órgano
• Análisis de mutaciones del gen HFE
• Determinación fenotípica y genotípica de
alotipos de proteinas séricas
• Estudio genético de reordenamiento de
cadenas pesadas de Igs y del receptor de la
célula T
• Análisis del polimorfismo de genss de
citocinas, quimiocinas y sus receptores
• Marcadores genéticos de leucemia y linfomas
• Presentación de seminarios relacionados
con los temas de la rotación
• Analizar estudios familiares con objeto
de identificar donantes compatibles y
segregación de caracteres. Establecer
genotipos y haplotipos familiares
• Aplicar los adecuados tests estadísticos a
los resultados de laboratorio referentes a
asociacion de polimorfismos genéticos a
patologías cocretas
• Participar activamente en talleres y
controles de calidad externos
• Elaborar informes bajo la supervisión del
tutor
• Colaborrar con el personal del laboratorio
en estudios de investigación en ésta área
Al final de la rotación se pretende que el residente este capacitado para tomar responsabilidades en la selección de donantes de transplante
renal alogénico y otras actuaciones en materia de transplante, de interpretar y valorar polimorfismos genéticos en el sistema HLA y otros
sistemas genéticos que afectan al funcionamiento del sistema inmune, y de su aplicación a estudios familiares y al análisis de riesgo de
enfermedad.
BOE núm. 252 Sábado 21 octubre 2006 36903
INMUNOLOGIA CLINICA
Objetivos básicos de la rotación: Los residentes médicos que opten por una formación médica en Inmunología Clínica deben recibir los
conocimientos, habilidades y actitudes requeridas para el diagnóstico y tratamiento de patologías de base inmunológica incluyendo
inmunodeficiencias, enfermedades autoinmunes y reacciones de hipersensibilidad
Contenidos
Teóricos Prácticos
Acciones
• El Sistema Sanitario Español.
• Gestión clínica y financiación
hospitalaria.
• Medicina basada en la evidencia.
• Habilidades con el paciente.
• Capacitación en aspectos relacionados
con la ética clínica y con la
responsabilidad civil y penal del acto
médico.
• Protocolos de atención del paciente
urgente.
• Protocolos y guías de actuación clínica
para la prevención, diagnóstico y
tratamiento de las patologías de base
inmunológica.
• Evaluación y tratamiento de:
Inmunodeficiencias primarias y secundarias,
enfermedades autoinmunes, reacciones de
hipersensibilidad y de otras patologías de base
inmunológica.
• Admistración de terapias de base
inmunológica.
• Asesoramiento en el campo de la
inmunoprofilaxis de enfermedades
prevenibles.
• Organización y mantenimiento de serotecas
para la monitorización de la seguridad
biológica de los tratamientos con
hemoderivados (GGIV).
• Utilización de registros nacionales e
internacionales de enfermedades de base
inmunológica.
• Presentación de seminarios relacionados
con los temas de la rotación.
• Asistencia a unidades clínicas de consulta
externa, hospitalización y de hospital de
día relacionadas con la especialidad.
• Realización de guardias de medicina
(mínimo 1 año).
• Participación en actividades de gestión de
las Unidad Clínica de Inmunología.
• Participar activamente en grupos de
trabajo clínico hospitalarios e inter-
hospitalarios.
• Elaborar informes clínicos bajo la
supervisión del tutor.
• Colaborrar con el personal de las
Unidades Clínicas en estudios de
investigación en éstas áreas.
Al final de las rotaciones clínicas se pretende que el residente este capacitado para tomar responsabilidades en la aplicación de los diferentes
protocolos de diagnóstico y tratamiento de patologías de base inmunológica.
ANEXO II.- DEFINICION DE LAS COMPETENCIAS TRANSVERSALES DEL INMUNÓLOGO MÉDICO.
Se propone la formación de un profesional Médico (MIR) especialista en Inmunología que pueda adquirir las competencias transversales médicas, compatibles con el conjunto de especialidades afines adscritas en el tronco Médico, así como las competencias específicas relativas al tronco de Laboratorio y Diagnóstico Clínico- Inmunología. Ver ANEXOS II.1, II.2, y II.3.
ANEXO II.- COMPETENCIAS TRANSVERSALES DEL INMUNÓLOGO MÉDICO II.1 DEFINICIÓN DE LAS COMPETENCIAS TRANSVERSALES DEL INMUNOLOGO
MEDICO
Descripción de las competencias transversales a adquirir por el inmunólogo médico para su formación y capacitación en la actividad clínica y en el manejo terapéutico de los enfermos con patologías inmunológicas. Se agrupan en los siguientes apartados: 1. Conocimientos, habilidades y actitudes en el manejo de patologías con problemas infecciosos recurrentes de base inmunológica y su atención en el laboratorio de diagnóstico clínico inmunológico 2. Conocimientos, habilidades y actitudes en el manejo de patologías con problemas linfoproliferativos (asociados a hipogammaglobulinemia, a expansiones LGK/NK y clonales linfocitarias) y hematológicos de base inmunológica y su atención en el laboratorio de diagnóstico clínico inmunológico. 3. Conocimientos, habilidades y actitudes en el manejo de problemas de base inmunológica en los transplantes de órganos y terapia celular y su atención en el laboratorio de diagnóstico clínico inmunológico. 4. Conocimientos, habilidades y actitudes en el manejo de patologías con problemas de reacciones de hipersensibilidad y angioedema y su atención en el laboratorio de diagnóstico clínico inmunológico. 5. Conocimientos, habilidades y actitudes en el manejo de patologías con problemas del tracto respiratorio de base inmunológica y su atención en el laboratorio de diagnóstico clínico inmunológico. 6. Conocimientos, habilidades y actitudes en el manejo de patologías con problemas del tracto digestivo y del hígado de base inmunológica y su atención en el laboratorio de diagnóstico clínico. 7. Conocimientos, habilidades y actitudes en el manejo de patologías con problemas inflamatorios de los vasos y músculo-esqueléticos y cutáneos de base inmunológica y su atención en el laboratorio de diagnóstico clínico inmunológico. 8. Conocimientos, habilidades y actitudes en el manejo de patologías con problemas del sistema endocrino de base inmunológica y su atención en el laboratorio de diagnóstico clínico inmunológico. 9. Conocimientos, habilidades y actitudes en el manejo de patologías con problemas del sistema nervioso y aparato ocular de base inmunológica y su atención en el laboratorio de diagnóstico clínico inmunológico. 10. Conocimientos, habilidades y actitudes en el manejo de patologías con problemas del sistema reproductivo (abortos recurrentes/fallos de fertilización in vitro) de base inmunológica y su atención en el laboratorio de diagnóstico clínico inmunológico. 11. Conocimientos, habilidades y actitudes en el manejo y prevención de patologías con tratamientos de base inmunológica (terapias biológicas con anticuerpos monoclonales e inmunoglobulinas, inmunosupresores, e inmunoterapia con vacunas profilácticas y terapéuticas) y su atención en el laboratorio de diagnóstico clínico inmunológico.
II.2 COMPATIBILIDAD DE LAS COMPETENCIAS TRANSVERSALES DEL INMUNOLOGO
MEDICO CON EL TRONCO MEDICO
Las once competencias descritas en el Anexo II.1 son compatibles con las siguientes once competencias del tronco médico (B, D, E, F, G, I, J, K, L, M y Q) que se transcriben más abajo y que aparecen en el documento del Ministerio de Sanidad de Marzo del 2011 “Competencias tronco médico, instrumentos y sistemas de evaluación”. En dicho documento las competencias se agrupan por apartados: A. Enfermedades cardiovasculares B. Enfermedades endocrinas, nutricionales y metabólicas C. Enfermedades renales y de las vías urinarias D. Enfermedades del aparato digestivo E. Enfermedades infecciosas F. Enfermedades del aparato locomotor y autoinmune sistémicas G. Enfermedades del sistema nervioso H. Enfermedades otorrinolaringológicas I. Enfermedades oculares J. Patología neoplásica K. Enfermedades de la piel L. Enfermedades de la sangre y de los órganos hematopoyéticos M. Enfermedades respiratorias N. Salud mental O. Geriatría P. Cuidados paliativos Q. Enfermedades alérgicas R. Atención al paciente crítico y situaciones de urgencia S. Signos y síntomas mal definidos No hacemos mención a los instrumentos de evaluación que serían los mismos que los propuestos en el tronco médico, aunque restringidos a los problemas de base inmunológica.
II.3 COMPATIBILIDAD DE LAS COMPETENCIAS TRANSVERSALES DEL INMUNOLOGO
MEDICO CON EL TRONCO DE LABORATORIO
Las once competencias descritas en el Anexo II.1 para el Inmunólogo médico implican además un conocimiento de las competencias específicas del tronco de laboratorio-Inmunología listadas más abajo en este Anexo II.3. Dichas competencias no se encuentran descritas como tales en el documento del anteproyecto de Troncalidad del Ministerio de Sanidad de Marzo del 2011 “Competencias del tronco de laboratorio y diagnóstico clínico, instrumentos y sistemas de evaluación”. A continuación se describen las competencias transversales específicas del Laboratorio Diagnóstico de Inmunología y que se agrupan en los siguientes apartados: 1. Conocimientos, habilidades y actitudes para los estudios celulares básicos, que incluyan la separación celular, citometría de flujo, los cultivos y la criopreservación. 2. Conocimientos, habilidades y actitudes en la utilización de las tecnologías básicas, automatizadas y de grandes instrumentos necesaria para la validación de otras pruebas diagnósticas, que incluyan la inmunofluorescencia y la secuenciación. 3. Conocimientos, habilidades y actitudes para los estudios de proteómica que incluyan la inmunoquímica, los inmunoenzimoensayos y las técnicas de separación analítica. 4. Conocimientos, habilidades y actitudes para los estudios de los principales alergenos y para la indicación e interpretación de las pruebas diagnósticas relacionadas con las enfermedades por hipersensibilidad y alergia. 5. Conocimientos, habilidades y actitudes para los estudios de biología molecular, que incluyan al menos las técnicas de extracción y amplificación de ácidos nucleicos. 6. Conocimientos, habilidades y actitudes para los estudios de inmunogenética molecular e histocompatibilidad. 7. Conocimientos, habilidades y actitudes en Sistemas de Información y Comunicación del Laboratorio, que incluyan la Bioestadística. 8. Competencias, habilidades, y actitudes en bioseguridad y otras competencias obligatorias determinadas por directiva: protección radiológica.
ANEXO III. ACTIVIDAD ASISTENCIAL MÉDICA Y DE LABORATORIO DE LA ESPECIALIDAD DE INMUNOLOGÍA EN LAS UNIDADES DOCENTES ACREDITADAS EN ESPAÑA.
ANEXO III.1: ACTIVIDAD ASISTENCIAL EN INMUNOLOGÍA CLÍNICA DE LAS UNIDADES DOCENTES ACREDITADAS DE LA ESPECIALIDAD DE INMUNOLOGÍA EN LOS HOSPITALES DEL SNS DEL ESTADO ESPAÑOL.
Comunidad autónoma AndalucíaCiudad Hospital Responsable Actividad Clínica Patologías
InmunológicasCádiz H. Universitario Puerta del Mar José Antonio Brieva Consulta / Interconsulta /
Hospital de díaID / AI / IV
Córdoba H. Universitario Reina Sofía José Peña Consulta / Interconsulta IDComunidad autónoma BalearesCiudad Hospital Responsable Actividad Clínica Patologías
InmunológicasPalma de Mallorca
H. Universitario Son Espases (Son Dureta)
Nuria Matamoros Consulta / Interconsulta ID / EHA
Comunidad autónoma CantabriaCiudad Hospital Responsable Actividad Clínica Patologías
InmunológicasSantander H. Universitario Marqués de Valdecilla Francisco Leyva Covián Consulta / Interconsulta ID / AI
Comunidad autónoma Castilla LeónCiudad Hospital Responsable Actividad Clínica Patologías
InmunológicasLeón Complejo Asistencial de León José María García Ruiz de MoConsulta / Interconsulta ID / UVComunidad autónoma CataluñaCiudad Hospital Responsable Actividad Clínica Patologías
InmunológicasBarcelona H. Universitario Vall d'`Hebron Ricardo Pujol Borrell Consulta / Interconsulta ID / AI / MTC
H. Santa Creu i Sant Pau Cándido Juárez Rubio Consulta / Interconsulta ID
Comunidad autónoma ExtremaduraCiudad Hospital Responsable Actividad Clínica Patologías
InmunológicasBadajoz Complejo Hospitalario Universitario de
Badajoz (H Infanta Cristina)Emilio Doblare Castellano Consulta / Interconsulta /
Hospital de díaID
Cáceres H. San Pedro de Alcántara Luis Miguel Fernández PereiraConsulta / Interconsulta / Hospital de día
ID / UV / AI
Comunidad autónoma MadridCiudad Hospital Responsable Actividad Clínica Patologías
InmunológicasMadrid H. Universitario La Paz Eduardo López Granados Consulta / Interconsulta ID / AI / IC / Tx
H. Universitario Ramón y Cajal Javier Coll Martí Consulta / Interconsulta IDH. General Universitario Gregorio Marañón
Eduardo Fernández-Cruz Consulta / Interconsulta / Hospitalización / Hospital de día
ID / UV / AI / IC / EHA / IR /T x / TB / IV
Fundación Jiménez Díaz Rosa García Delgado Interconsulta IF / AIComunidad autónoma MurciaCiudad Hospital Responsable Actividad Clínica Patologías
InmunológicasMurcia H. Universitario Virgen de la Arreixaca Rocío Álvarez Consulta / Interconsulta /
Hospital de díaID / AI / EHA
Abreviaturas de las Patologías Inmunológicas:AI = Enfermedades autoinmunesEHA = Enfermedades por Hipersensibilidad y AlergiaIC = Enfermedades Inflamatorias CrónicasID= InmunodeficienciasIF = InfecciosasIR = Enfermedades Inmunología ReproductivaIV = Inmunización con VacunasMTC = Monitorización Terapia CelularTB = Terapias BiológicasTx = Tratamientos en TrasplantesUV = Uveítis
Anexo III.1: Actividad Asistencial en Inmunología Clínica de las Unidades Docentes Acreditadas de la Especialidad de Inmunología en los Hospitales del SNS del Estado Español.
ANEXO III.2: CARTERA DE SERVICIOS DE LABORATORIO DIAGNÓSTICO CONSENSUADA POR LAS UNIDADES DOCENTES DE INMUNOLOGÍA ACREDITADAS EN LA COMUNIDAD DE MADRID.
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
1/10
Marañón
La Paz
12-oct
RyC
H. Clínico
P. Hierro
Princesa
Carlos III
GR
UP
O D
E P
ATO
LOG
ÍAS
GR
UP
O D
E T
ÉC
NIC
AS
AU
TOA
NTI
CU
ERPO
SD
EEN
FER
MED
AD
ESA
UTO
INM
UN
ESSI
STEM
ICA
S(L
upus
Erite
mat
oso
Sist
émic
o,A
rtrit
isR
eum
atoi
de,
Polim
iosi
tis,
Enfe
rmed
ades
Sist
émic
asde
lTe
jido
Con
ectiv
o,Es
cler
oder
mia
y S
indr
ome
de C
RES
T)E
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
PÉ
PTI
DO
CÍC
LIC
O C
ITR
ULI
NA
DO
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIN
UC
LEA
RE
SS
IS
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
dsD
NA
SI
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIC
EN
TRO
ME
RO
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIN
UC
LEA
RE
SE
SP
EC
IFIC
OS
SC
RE
EN
ING
(EN
A)
SI
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TI J
o-1
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TI L
a/S
SB
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TI P
M-S
clS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
RN
PS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
Ro/
SS
AS
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
Scl
70
(Top
oiso
mer
asa
I)S
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
Sm
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIH
ISTO
NA
SS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
Mi2
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIR
IBO
SO
MA
LES
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TI K
uS
IS
IS
IA
UTO
AN
TIC
UER
POS
DE
ENFE
RM
EDA
DC
ELIA
CA
YO
TRA
SPA
TOLO
GIA
SA
UTO
INM
UN
ESD
ELA
PAR
ATO
DIG
ESTI
VOY
DEL
HIG
AD
O(H
epat
itis
Aut
oinm
une,
Ane
mia
Pern
icio
saco
nD
éfic
itde
B12
, Cirr
osis
Bili
ar P
rimar
ia, E
nfer
med
ad In
flam
ator
ia in
test
inal
)E
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
MU
SC
ULO
LIS
OS
IS
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
MIT
OC
ON
DR
IALE
SS
IS
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
LK
MS
IS
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
TRA
NS
GLU
TAM
INA
SA
IGA
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
NTI
CU
ER
PO
S A
NTI
GLI
AD
INA
IgA
/ Ig
GS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
TRA
NS
GLU
TAM
INA
SA
IGG
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIE
ND
OM
ISIO
SI
SI
SI
SI
CE
NTR
OC
ATÁ
LOG
O G
RU
PO D
E TR
AB
AJO
: IN
MU
NO
LOG
IA
PRU
EBA
S ES
PEC
IFIC
AS
AU
TOIN
MU
NID
AD
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
2/10
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIR
ETI
CU
LIN
AS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
-LC
1S
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
-SLA
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIC
ELU
LAS
PA
RIE
TALE
S G
AS
TRIC
AS
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIFA
CTO
R IN
TRIN
SE
CO
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIE
NTE
RO
CIT
OS
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
NTI
CU
ER
PO
S A
NTI
SA
CA
RO
MIC
ES
CE
RE
VIS
IAE
SI
AU
TOA
NTI
CU
ERPO
SD
ED
IAB
ETES
YO
TRA
SEN
DO
CR
INO
PATÍ
AS
AU
TOIN
MU
NES
(D
iabe
tes
Insu
linor
esis
tent
e,Ti
roid
itis
Aut
oinm
une,
Hip
otiro
idis
mo
Aut
oinm
une,
Add
ison
, Sin
drom
e Po
ligla
ndul
ar)
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TITI
RO
GLO
BU
LIN
AS
IS
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
MIC
RO
SO
MA
LES
TIR
OID
EO
S (T
PO
)S
IS
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
-GA
DS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
IA2
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIIN
SU
LIN
AS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
CE
LULA
S B
ETA
PA
NC
RE
ATI
CA
S (I
CA
)S
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
SP
OLI
GLA
ND
ULA
RE
S:
AN
TIA
DR
EN
ALE
S;
AN
TIR
EC
EP
TOR
DE
LAH
OR
MO
NA
TSH
(TS
I-LA
TS);
AN
TIH
IPO
FIS
IS;
AN
TIO
VA
RIO
; AN
TITE
STI
CU
LO; A
NTI
PA
RA
TIR
OID
ES
SI
SI
SI
SI
SI
SI
SI
AU
TOA
NTI
CU
ERPO
SD
EVA
SCU
LITI
SY
SIN
DR
OM
ESR
ENO
-PU
LMO
NA
RES
(Vas
culit
issi
stém
icas
,Va
scul
itis
asoc
iada
sa
Sínd
rom
esA
utoi
nmun
es,
Sínd
rom
ede
Weg
ener
,En
ferm
edad
deG
oodp
astu
re)
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIC
ITO
PLA
SM
A D
E N
EU
TRO
FILO
S (A
NC
AS
) S
IS
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
MIE
LOP
ER
OXI
DA
SA
(MP
O)
SI
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIP
RO
TEIN
AS
A 3
(PR
3)S
IS
IS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
ME
MB
RA
NA
BA
SA
L G
LOM
ER
ULA
RS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AN
CA
SO
TRA
SE
SP
EC
IFIC
IDA
DE
S(A
NTI
AZU
RO
CID
INA
,A
NTI
CA
TEP
SIN
AG
,A
NTI
ELA
STA
SA
,A
NTI
LAC
TOFE
RR
INA
,A
NTI
LIS
OZI
MA
, AN
TI-B
PI)
SI
SI
SI
AU
TOA
NTI
CU
ERPO
SA
NTI
FOSF
OLÍ
PID
O(S
índr
ome
Ant
ifosf
olíp
ido,
Trom
bosi
sva
scul
ares
,Abo
rtos
dere
petic
ión
yU
veíti
sde
repe
tició
nde
cau
sa in
mun
ológ
ica)
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIC
AR
DIO
LIP
INA
IgG
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIC
AR
DIO
LIP
INA
IgM
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TI-B
ETA
2 G
LIC
OP
RO
TEÍN
A Ig
GS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
-BE
TA 2
GLI
CO
PR
OTE
ÍNA
IgM
SI
SI
SI
SI
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
3/10
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIP
RO
TRO
MB
INA
SI
AU
TOA
NTI
CU
ERPO
SD
ED
ERM
OPA
TÍA
SA
UTO
INM
UN
ES(D
erm
opat
ías
ampo
llosa
s, P
énfig
o vu
lgar
is)
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIM
EM
BR
AN
A B
AS
AL
DE
RM
OE
PID
ER
MIC
AS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
SU
STA
NC
IA IN
TER
CE
LULA
R E
PID
ER
MIC
AS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
DE
SM
OG
LEIN
A 1
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TI B
P18
0S
IA
UTO
AN
TIC
UER
POS
AN
TIN
EUR
ON
ALE
SY
DE
PLA
CA
MO
TOR
A(S
índr
omes
par
aneo
plás
icos
. Mia
sten
ia g
ravi
s)E
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
MU
SC
ULO
ES
TRIA
DO
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TIR
EC
EP
TOR
DE
AC
ETI
LCO
LIN
AS
IS
IS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AN
TIC
UE
RP
OS
AN
TIQ
UIN
AS
A E
SP
EC
IFIC
A (a
nti-M
usk)
SI
NE
OP
LAS
IA (S
dme.
Par
aneo
pAU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S:
AN
TI-H
u; A
NTI
-Ri;
AN
TI-Y
oS
I
OTR
OS
AU
TOA
NTI
CU
ERPO
SE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
C1q
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TI C
1 IN
HIB
IDO
RS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
FA
CTO
R H
SI
EN
F. A
UTO
INM
UN
EA
UTO
INM
UN
IDA
DA
UTO
AN
TIC
UE
RP
OS
AN
TI Ig
AS
IE
NF.
AU
TOIN
MU
NE
AU
TOIN
MU
NID
AD
AU
TOA
NTI
CU
ER
PO
S A
NTI
NE
UTR
ÓFI
LOS
SI
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
4/10
PRU
EBA
S ES
PEC
IFIC
AS
DE
INM
UN
OLO
GIA
CEL
ULA
R
Marañón
La Paz
12-oct
RyC
H. Clínico
P. Hierro
Princesa
Carlos III
(Dia
gnós
tico
deIn
mun
odef
icie
ncia
sPr
imar
ias,
Inm
unod
efic
ienc
ias
Secu
ndar
ias,
Sínd
rom
ede
Inm
unod
efic
ienc
iaA
dqui
rida,
Inm
unod
efic
ienc
iaSe
cund
aria
aTr
aspl
ante
,Tr
atam
ient
osin
mun
osup
reso
res
yTe
rapi
aB
ioló
gica
con
Ant
icue
rpos
Mon
oclo
nale
s)G
RU
PO
DE
PA
TOLO
GÍA
SG
RU
PO
DE
TÉ
CN
ICA
SC
UA
NTI
FIC
AC
IÓN
DE
SUB
POB
LAC
ION
ES L
INFO
CIT
AR
IAS
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LLI
NFO
CIT
OS
T C
D4
(VA
LOR
AB
S Y
/O P
OR
CE
NTU
AL)
SI
SI
SI
SI
SI
SI
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LLI
NFO
CIT
OS
T C
D8
(VA
LOR
AB
S Y
/O P
OR
CE
NTU
AL)
SI
SI
SI
SI
SI
SI
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LLI
NFO
CIT
OS
T C
D3
(VA
LOR
AB
S Y
/O P
OR
CE
NTU
AL)
SI
SI
SI
SI
SI
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LLI
NFO
CIT
OS
NK
CD
56 (V
ALO
R A
BS
Y/O
PO
RC
EN
TUA
L)S
IS
IS
IS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
LIN
FOC
ITO
S B
CD
19 (V
ALO
R A
BS
Y/O
PO
RC
EN
TUA
L)S
IS
IS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
LIN
FOC
ITO
S T
AC
TIV
AD
OS
(CD
25+/
DR
+)S
IS
IE
NF.
AU
TOIN
MU
NE
CIT
OM
ETR
ÍA /
CE
LFE
NO
TIP
O D
E L
INFO
CIT
OS
INTE
STI
NA
LES
INTR
AE
PIT
ELI
ALE
SS
IS
IC
ITO
ME
TRÍA
/ C
EL
DIA
GN
OS
TIC
O IN
MU
NO
FEN
OTI
PIC
O D
E L
EU
CE
MIA
S Y
LIN
FOM
AS
:S
IS
IFU
NC
ION
DE
LIN
FOC
ITO
S IN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
PR
OLI
FER
AC
ION
LIN
FOC
ITA
RIA
EN
RE
SP
UE
STA
AM
ITÓ
GE
NO
S(A
NTI
GE
NO
S,
AN
TIC
UE
RP
OS
MO
NO
CLO
NA
LES
,C
ITO
CIN
AS
,IO
NÓ
FOR
OS
, LE
CTI
NA
S)
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
RE
SP
UE
STA
ES
PE
CIF
ICA
AV
AC
UN
AS
(HA
EM
OP
HIL
US
,N
EU
MO
CO
CO
,TO
XOID
E D
IFTÉ
RIC
O, T
OXO
IDE
TE
TÁN
ICO
)S
IS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AA
GLU
TIN
INA
S A
CA
ND
IDA
ALB
ICA
NS
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
PR
OD
UC
CIO
N IN
VIT
RO
DE
INM
UN
OG
LOB
ULI
NA
S G
, A Y
MS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
CIT
OTO
XIC
IDA
D N
KS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
AP
OP
TOS
IS L
INFO
CIT
AR
IAS
IEX
PRES
IÓN
DE
REC
EPTO
RES
Y M
EDIA
DO
RES
INM
UN
OLÓ
GIC
OS
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LE
XPR
ES
IÓN
INTR
AC
ELU
LAR
DE
PE
RFO
RIN
AS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
EXP
RE
SIÓ
N IN
TRA
CE
LULA
R D
E S
AP
SI
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LE
XPR
ES
ION
DE
MO
LEC
ULA
S D
E A
DH
ES
IÓN
SI
FUN
CIO
N D
E G
RA
NU
LOC
ITO
SIN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
BIO
LUM
INIS
CE
NC
IA;
SI
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LFA
GO
CIT
OS
IS;
SI
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LE
XPLO
SIO
N M
ETA
BO
LIC
A E
N N
EU
TRO
FILO
S (B
UR
ST
TES
T);
SI
SI
CE
NTR
OC
ATÁ
LOG
O G
RU
PO D
E TR
AB
AJO
: IN
MU
NO
LOG
IA
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
5/10
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LO
TRA
SP
RU
EB
AS
(NB
T,O
PS
ON
IZA
CIÓ
N,
QU
IMIO
TAXI
S,
AD
HE
RE
NC
IA)
SI
DIA
GN
OST
ICO
DE
INM
UN
OD
EFIC
IEN
CIA
S PR
IMA
RIA
SIN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
DIA
GN
OS
TIC
OIN
MU
NO
LOG
ICO
DE
INM
UN
OD
EFI
CIE
NC
IAS
PR
IMA
RIA
SS
IS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
DIA
GN
OS
TIC
O D
E E
NFE
RM
ED
AD
GR
AN
ULO
MA
TOS
A C
RO
NIC
AS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SC
ITO
ME
TRÍA
/ C
EL
DIA
GN
ÓS
TIC
O D
E L
INFO
HIS
TIO
CIT
OS
IS H
EM
OFA
GO
CIT
ICA
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LD
IAG
NO
STI
CO
DE
SÍN
DR
OM
E L
INFO
PR
OLI
FER
ATI
VO
AU
TOIN
MU
NE
SI
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LD
IAG
NÓ
STI
CO
DE
SIN
DR
OM
E D
E P
AP
ILLO
N L
EFE
VR
ES
I
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LD
EFI
CIE
NC
IA D
E A
DH
ES
ION
LE
UC
OC
ITA
RIA
FE
NO
TIP
O C
D11
/CD
18
SI
INM
UN
OD
EFI
CIE
NC
IAS
CIT
OM
ETR
ÍA /
CE
LD
IAG
NO
STI
CO
DE
SIN
DR
OM
E H
IPE
R-Ig
M
SI
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
6/10
Marañón
La Paz
12-oct
RyC
H. Clínico
P. Hierro
Princesa
Carlos III
GR
UP
O D
E P
ATO
LOG
ÍAS
GR
UP
O D
E T
ÉC
NIC
AS
INM
UN
IDA
DH
UM
OR
AL
(Inm
unod
efic
ienc
ias
Prim
aria
s,In
mun
odef
icie
ncia
sSe
cund
aria
s,G
amm
apat
ías
mon
oy
olig
oclo
nale
s, N
eopl
asia
s Li
nfoi
des)
MÚ
LTIP
LES
PA
TOLO
GÍA
SIN
MU
NO
QU
IMIC
AIN
MU
NO
GLO
BU
LIN
A G
SÉ
RIC
AS
IS
IS
IS
IS
IS
IS
IM
ÚLT
IPLE
S P
ATO
LOG
ÍAS
INM
UN
OQ
UIM
ICA
INM
UN
OG
LOB
ULI
NA
A S
ÉR
ICA
SI
SI
SI
SI
SI
SI
SI
MÚ
LTIP
LES
PA
TOLO
GÍA
SIN
MU
NO
QU
IMIC
AIN
MU
NO
GLO
BU
LIN
A M
SÉ
RIC
AS
IS
IS
IS
IS
IS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AIN
MU
NO
GLO
BU
LIN
A D
SÉ
RIC
AS
IS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AIN
MU
NO
GLO
BU
LIN
A G
SU
BC
LAS
ES
(IG
G1,
IGG
2, IG
G3,
IGG
4)S
IS
IS
IN
EO
PLA
SIA
S (L
euc/
Linf
oma)
INM
UN
OQ
UIM
ICA
CA
DE
NA
S L
IGE
RA
S K
AP
PA
TO
TALE
S E
N S
UE
RO
SI
SI
NE
OP
LAS
IAS
(Leu
c/Li
nfom
a)IN
MU
NO
QU
IMIC
AC
AD
EN
AS
LIG
ER
AS
LA
MB
DA
TO
TALE
S E
N S
UE
RO
SI
SI
NE
OP
LAS
IAS
(Leu
c/Li
nfom
a)IN
MU
NO
QU
IMIC
AC
AD
EN
AS
LIG
ER
AS
KA
PP
A E
N O
RIN
AS
IS
IN
EO
PLA
SIA
S (L
euc/
Linf
oma)
INM
UN
OQ
UIM
ICA
CA
DE
NA
S L
IGE
RA
S L
AM
BD
A E
N O
RIN
AS
IS
IN
EO
PLA
SIA
S (L
euc/
Linf
oma)
INM
UN
OQ
UIM
ICA
INM
UN
OG
LOB
ULI
NA
G E
N O
RIN
AS
IN
EO
PLA
SIA
S (L
euc/
Linf
oma)
INM
UN
OQ
UIM
ICA
INM
UN
OG
LOB
ULI
NA
A E
N O
RIN
AS
IN
EO
PLA
SIA
S (L
euc/
Linf
oma)
INM
UN
OQ
UIM
ICA
INM
UN
OG
LOB
ULI
NA
M E
N O
RIN
AS
IM
ÚLT
IPLE
S P
ATO
LOG
ÍAS
INM
UN
OQ
UIM
ICA
INM
UN
OG
LOB
ULI
NA
G E
N L
CR
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EIN
MU
NO
QU
IMIC
AIN
MU
NO
GLO
BU
LIN
A A
EN
LC
RS
IE
NF.
AU
TOIN
MU
NE
INM
UN
OQ
UIM
ICA
INM
UN
OG
LOB
ULI
NA
M E
N L
CR
SI
NE
OP
LAS
IAS
(Leu
c/Li
nfom
a)IN
MU
NO
QU
IMIC
AC
AD
EN
AS
LIG
ER
AS
KA
PP
A L
IBR
ES
EN
SU
ER
OS
IS
IN
EO
PLA
SIA
S (L
euc/
Linf
oma)
INM
UN
OQ
UIM
ICA
CA
DE
NA
S L
IGE
RA
S L
AM
BD
A L
IBR
ES
EN
SU
ER
OS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AIN
MU
NO
GLO
BU
LIN
A A
SE
CR
ETO
RA
EN
FLU
IDO
SS
IS
IA
NA
LISI
SEL
ECTR
OFO
RÉT
ICO
SD
EIN
MU
NO
GLO
BU
LIN
AS
(Gam
map
atía
sm
ono
yol
igoc
lona
les.
Neo
plas
ias
linfo
ides
.Esc
lero
sis
Múl
tiple
)E
NF.
AU
TOIN
MU
NE
, NE
OP
LA
INM
UN
OQ
UIM
ICA
INM
UN
OE
LEC
TRO
FOR
ES
IS E
N S
UE
RO
SI
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
E, N
EO
PLA
IN
MU
NO
QU
IMIC
AIN
MU
NO
ELE
CTR
OFO
RE
SIS
EN
OR
INA
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
E, N
EO
PLA
IN
MU
NO
QU
IMIC
AE
SP
EC
TRO
ELE
CTR
OFO
RE
TIC
O E
N S
UE
RO
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
E, N
EO
PLA
IN
MU
NO
QU
IMIC
AE
SP
EC
TRO
ELE
CTR
OFO
RE
TIC
O E
N O
RIN
AS
IS
IS
IE
NF.
AU
TOIN
MU
NE
, NE
OP
LA
INM
UN
OQ
UIM
ICA
ES
PE
CTR
O E
LEC
TRO
FOR
ETI
CO
EN
LC
RS
IE
NF.
AU
TOIN
MU
NE
, NE
OP
LA
INM
UN
OQ
UIM
ICA
BA
ND
AS
OLI
GO
CLO
NA
LES
EN
LC
RS
IS
IS
IE
NF.
AU
TOIN
MU
NE
, NE
OP
LA
INM
UN
OQ
UIM
ICA
INM
UN
OE
LEC
TRO
FOR
ES
IS E
N C
RIO
PR
EC
IPIT
AD
OS
IS
IS
IS
I
CE
NTR
OC
ATÁ
LOG
O G
RU
PO D
E TR
AB
AJO
: IN
MU
NO
LOG
IA
PRU
EBA
S ES
PEC
IFIC
AS
INM
UN
OQ
UÍM
ICA
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
7/10
MA
RC
AD
OR
ESSÉ
RIC
OS
DE
RES
PUES
TAIN
FLA
MA
TOR
IAEN
PATO
LOG
IAS
CR
ÓN
ICA
S SI
STÉM
ICA
S D
E B
ASE
INM
UN
OLÓ
GIC
AE
NF.
AU
TOIN
MU
NE
INM
UN
OQ
UIM
ICA
FAC
TOR
RE
UM
ATO
IDE
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EIN
MU
NO
QU
IMIC
AP
RO
TEIN
A C
RE
AC
TIV
AS
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
INM
UN
OQ
UIM
ICA
AS
LO (A
NTI
CU
ER
PO
S A
NTI
ES
TRE
PTO
LIS
INA
O)
SI
SI
SI
SI
NE
OP
LAS
IAS
(Leu
c/Li
nfom
a)IN
MU
NO
QU
IMIC
AB
ETA
-2-M
ICR
OG
LOB
ULI
NA
(SU
ER
O)
SI
SI
EN
F. A
UTO
INM
UN
E, N
EO
PLA
IN
MU
NO
QU
IMIC
AC
RIO
GLO
BU
LIN
AS
S
IS
IS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
INM
UN
OQ
UIM
ICA
INM
UN
OC
OM
PLE
JOS
CIR
CU
LAN
TES
SI
SI
SI
ESTU
DIO
DEL
SIST
EMA
DEL
CO
MPL
EMEN
TO(E
nfer
med
ades
med
iada
spo
rco
mpl
ejos
inm
unes
,M
icro
angi
opat
ías
Trom
bótic
as,
Glo
mer
ulop
atía
s. I
nmun
odef
icie
ncia
s Pr
imar
ias)
EN
F. A
UTO
INM
UN
EIN
MU
NO
QU
IMIC
AC
OM
PLE
ME
NTO
C3
SI
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
EIN
MU
NO
QU
IMIC
AC
OM
PLE
ME
NTO
C4
SI
SI
SI
SI
SI
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
Y E
N
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO E
NS
AYO
FU
NC
ION
AL
VÍA
CLA
SIC
A (C
H50
/CH
100)
SI
SI
SI
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO C
1 IN
HIB
IDO
R C
UA
NTI
FIC
AC
ION
SI
SI
SI
SI
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO P
RO
PE
RD
INA
/ FA
CTO
R B
SI
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO F
AC
TOR
HS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AC
OM
PLE
ME
NTO
FA
CTO
R I
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO C
1 IN
HIB
IDO
R F
UN
CIO
NA
LID
AD
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO C
1qS
IS
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AC
OM
PLE
ME
NTO
C1r
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO C
1sS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AC
OM
PLE
ME
NTO
C2
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO C
5S
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AC
OM
PLE
ME
NTO
C6
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO C
7S
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AC
OM
PLE
ME
NTO
C8
SI
INM
UN
OD
EFI
CIE
NC
IAS
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO C
9S
IE
NF.
AU
TOIN
MU
NE
INM
UN
OQ
UIM
ICA
FAC
TOR
NE
FRIT
ICO
SI
INM
UN
OD
EFI
CIE
NC
IAS
Y E
N
INM
UN
OQ
UIM
ICA
CO
MP
LEM
EN
TO E
NS
AYO
FU
NC
ION
AL
VÍA
ALT
ER
NA
TIV
A (A
P50
)S
IC
ITO
QU
INA
SIN
MU
NO
DE
FIC
IEN
CIA
S, E
NF
INM
UN
OQ
UIM
ICA
INTE
RFE
RO
N G
AM
MA
SI
SI
NE
OP
LAS
IAS
(Leu
c/Li
nfom
a)
INM
UN
OQ
UIM
ICA
FAC
TOR
DE
NE
CR
OS
IS T
UM
OR
AL
(TN
F)S
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SIN
MU
NO
QU
IMIC
AO
TRA
S(IN
TER
LEU
QU
INA
1B
ETA
,IL
10,
IL5,
IL6,
IL8,
RE
CE
PTO
RS
OLU
BLE
DE
IL2)
SI
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
8/10
Marañón
La Paz
12-oct
RyC
H. Clínico
P. Hierro
Princesa
Carlos III
GR
UP
O D
E P
ATO
LOG
ÍAS
GR
UP
O D
E T
ÉC
NIC
AS
NE
OP
LAS
IAS
(Leu
c/Li
nfom
a)G
EN
ETI
CA
MO
LEC
ULA
RR
EO
RD
EN
AM
IEN
TO D
E G
EN
ES
DE
INM
UN
OG
LOB
ULI
NA
SS
IS
IN
EO
PLA
SIA
S (L
euc/
Linf
oma)
GE
NE
TIC
A M
OLE
CU
LAR
RE
OR
DE
NA
MIE
NTO
DE
GE
NE
S D
EL
TCR
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
AG
AM
MA
GLO
BU
LIN
EM
IAA
UTO
SO
MIC
AR
EC
ES
IVA
(Mut
acio
nes
enm
u/la
mbd
a 5)
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
AG
AM
MA
GLO
BU
LIN
EM
IA D
E B
RU
TON
(Mut
acio
nes
en B
tk)
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
NE
UTR
OP
EN
IA C
ON
GE
NIT
A (M
utac
ione
s en
gen
de
la e
last
asa)
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
ATA
XIA
TE
LAN
GIE
CTA
SIA
(Mut
acio
nes
en g
en A
TM)
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
DE
FEC
TO D
E A
RTE
MIS
(SC
ID)
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
DE
FEC
TO D
E C
AD
EN
A A
LFA
RE
CE
PTO
R IL
7 (S
CID
)S
IIN
MU
NO
DE
FIC
IEN
CIA
SG
EN
ETI
CA
MO
LEC
ULA
RD
EF.
DE
CA
DE
NA
GA
MM
AC
OM
ÚN
DE
LR
EC
EP
TOR
DE
INTE
RLE
UQ
UIN
AS
(SC
ID)
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
DE
FIC
IT D
E A
DE
NO
SIN
DE
AM
INA
SA
(Mut
acio
nes
en A
DA
)S
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SG
EN
ETI
CA
MO
LEC
ULA
RD
EFI
CIT
DE
AN
TIC
UE
RP
OS
(Mut
acio
nes
en IC
OS
, A
ID, U
NG
)S
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SG
EN
ETI
CA
MO
LEC
ULA
RD
EFI
CIT
DE
CO
MP
LEM
EN
TO (M
utac
ione
s en
un
fact
or)
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
DIS
PLA
SIA
EC
TOD
ÉR
MIC
AA
NH
IDR
ÓTI
CA
CO
NID
(Mut
acio
nes
enge
nN
EM
O)
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
EN
F.G
RA
NU
LOM
ATO
SA
CR
ON
ICA
LIG
AD
AA
LX
(mut
acio
nes
engp
91ph
ox)
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
FIE
BR
E M
ED
ITE
RR
AN
EA
FA
MIL
IAR
(Mut
acio
nes
en M
EFV
)S
IIN
MU
NO
DE
FIC
IEN
CIA
SG
EN
ETI
CA
MO
LEC
ULA
RS
IND
RO
ME
DE
OM
EN
N(M
utac
ione
sen
gene
sde
reco
mbi
nasa
sR
AG
-1y
2)S
IIN
MU
NO
DE
FIC
IEN
CIA
SG
EN
ETI
CA
MO
LEC
ULA
RS
IND
RO
ME
HE
MO
FAG
OC
ITIC
O (M
utac
ione
s en
el g
en d
e la
per
forin
a)S
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SG
EN
ETI
CA
MO
LEC
ULA
RS
IND
RO
ME
HIP
ER
-IgM
(MU
TAC
ION
ES
EN
CD
40, C
D40
L)S
IIN
MU
NO
DE
FIC
IEN
CIA
SG
EN
ETI
CA
MO
LEC
ULA
RS
ÍND
RO
ME
LIN
FOP
RO
LIFE
RA
TIV
OA
UTO
INM
UN
ETI
PO
2b(M
utac
ione
s en
cas
pasa
8)
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
SIN
DR
OM
ELI
NFO
PR
OLI
FER
ATI
VO
AU
TOIN
MU
NE
TIP
O1a
(Mut
acio
nes
en F
as, C
D95
)S
IS
IIN
MU
NO
DE
FIC
IEN
CIA
SG
EN
ETI
CA
MO
LEC
ULA
RS
DM
E.
LIN
FOP
RO
LIFV
O.
LIG
AD
OA
LC
RO
MO
SO
MA
X(X
LP,
Mut
s.en
SA
P, S
H2D
1A)
SI
SI
INM
UN
OD
EFI
CIE
NC
IAS
GE
NE
TIC
A M
OLE
CU
LAR
SIN
DR
OM
E P
AP
ILLO
N-L
EFE
VR
E (M
utac
ione
s en
gen
cat
epsi
na C
)S
IIN
MU
NO
DE
FIC
IEN
CIA
SG
EN
ETI
CA
MO
LEC
ULA
RD
EFE
CTO
DE
L JA
K3
(SC
ID)
SI
CE
NTR
O
PRU
EBA
S G
ENÉT
ICA
S PA
RA
INM
UN
OD
EFIC
IEN
CIA
S PR
IMA
RIA
S
CA
TÁLO
GO
GR
UPO
DE
TRA
BA
JO: I
NM
UN
OLO
GIA
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
9/10
Marañón
La Paz
12-oct
RyC
H. Clínico
P. Hierro
Princesa
Carlos III
GR
UP
O D
E P
ATO
LOG
ÍAS
GR
UP
O D
E T
ÉC
NIC
AS
Tras
plan
tede
órga
nos
sólid
os,T
rasp
lant
ede
méd
ula
ósea
yde
otro
spr
ecur
sore
s he
mat
opoy
étic
os. A
soci
ació
n a
enfe
rmed
ad. )
EN
F. A
UTO
INM
UN
EH
ISTO
CO
MP
ATI
BIL
IDA
DH
LA B
-27
SI
SI
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
E/T
RA
SP
LAH
ISTO
CO
MP
ATI
BIL
IDA
DH
LA A
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
E/T
RA
SP
LAH
ISTO
CO
MP
ATI
BIL
IDA
DH
LA B
SI
SI
SI
SI
EN
F. A
UTO
INM
UN
E/T
RA
SP
LAH
ISTO
CO
MP
ATI
BIL
IDA
DH
LA C
SI
SI
SI
EN
F. A
UTO
INM
UN
E/T
RA
SP
LAH
ISTO
CO
MP
ATI
BIL
IDA
DH
LA D
RS
IS
IS
IS
IE
NF.
AU
TOIN
MU
NE
/TR
AS
PLA
HIS
TOC
OM
PA
TIB
ILID
AD
HLA
DQ
SI
SI
SI
SI
TRA
SP
LAN
TE
HIS
TOC
OM
PA
TIB
ILID
AD
AN
TIC
UE
RP
OS
AN
TI-H
LA
SI
SI
SI
SI
TRA
SP
LAN
TE
HIS
TOC
OM
PA
TIB
ILID
AD
PR
UE
BA
CR
UZA
DA
SI
SI
SI
TRA
SP
LAN
TE
HIS
TOC
OM
PA
TIB
ILID
AD
HLA
DP
B
SI
TRA
SP
LAN
TE
HIS
TOC
OM
PA
TIB
ILID
AD
DIA
GN
ÓS
TIC
O D
E R
EC
HA
ZO H
UM
OR
AL
PO
STR
AS
PLA
NTE
SI
CE
NTR
O
PRU
EBA
S H
ISTO
CO
MPA
TIB
ILID
AD
CA
TÁLO
GO
GR
UPO
DE
TRA
BA
JO: I
NM
UN
OLO
GIA
CAR
TER
A SE
RVI
CIO
S C
ON
SEN
SUAD
ASE
RVI
CIO
S D
E IN
MU
NO
LOG
IAC
OM
UN
IDAD
DE
MAD
RID
Pag
10/1
0
Marañón
La Paz
12-oct
RyC
H. Clínico
P. Hierro
Princesa
Carlos III
GR
UP
O D
E P
ATO
LOG
ÍAS
GR
UP
O D
E T
ÉC
NIC
AS
ALE
RG
IAIN
MU
NO
ALE
RG
IAIN
MU
NO
GLO
BU
LIN
A E
ES
PÉ
CIF
ICA
A M
ÚLT
IPLE
S A
LER
GE
NO
SS
IS
IS
IS
IS
IS
IA
LER
GIA
INM
UN
OA
LER
GIA
INM
UN
OG
LOB
ULI
NA
E T
OTA
LS
IS
IS
IS
IS
IS
IA
LER
GIA
INM
UN
OA
LER
GIA
INM
UN
OG
LOB
ULI
NA
G E
SP
EC
IFIC
A F
RE
NTE
A A
LER
GE
NO
S
SI
SI
ALE
RG
IAIN
MU
NO
ALE
RG
IAO
TRA
SP
RU
EB
AS
(PR
EC
IPIT
INA
S,
PR
OFI
LIN
AS
,TR
IPTA
SA
SÉ
RIC
A,
IGG
4 E
SP
EC
ÍFIC
A)
SI
SI
CE
NTR
OC
ATÁ
LOG
O G
RU
PO D
E TR
AB
AJO
: IN
MU
NO
LOG
IA
PRU
EBA
S ES
PEC
IFIC
AS
DE
INM
UN
OA
LER
GIA
ANEXO III.3: CARTERA DE SERVICIOS CLÍNICA DE INMUNOLOGÍA DEL HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN (HGUGM). Esta Cartera de Servicios está incluida en la base de datos SICAR 2010 (Sistema de Información sobre el Catálogo o Cartera de Servicios de Asistencia Especializada), gestionada por la Dirección General de Sistemas de Información sanitaria de la Comunidad de Madrid. A través de este organismo, o de las Gerencias y/o Departamentos de Admisión de los distintos Hospitales se puede acceder a las Carteras de Servicios específicas de cada Servicio de Inmunología de la Comunidad de Madrid y de otras Comunidades Autónomas.
ANEXO III.4: WEBSITE DEL REGISTRO DE INMUNODEFICIENCIAS PRIMARIAS DE ESPAÑA (REDIP): web.hsd.es/redip/
Esta WEBSITE está gestionada por Inmunólogos en colaboración con la Sociedad Española de Inmunología, y está vinculada al Servicio de Inmunología del Hospital Universitario de Son Espases (Son Dureta) de Palma de Mallorca, bajo la supervisión de la Dra. Nuria Matamoros. El Registro REDIP incluye todos los casos españoles de Inmunodeficiencias Primarias acreditados de acuerdo a los criterios internacionales vigentes, y son aportados, en su mayoría, por Inmunólogos Clínicos integrados en Unidades Clínicas de Inmunología que son responsables directos del diagnóstico y manejo de estos procesos patológicos.
ANEXO IV.- CARTAS DE EXPERTOS EUROPEOS DE INGLATERRA, ALEMANIA E ITALIA APOYANDO LA IMPLANTACIÓN EN ESPAÑA DE UN PROGRAMA FORMATIVO DE INMUNOLOGÍA CLÍNICA.
La actividad Médica y de Laboratorio de la especialidad de Inmunología está implantada en la gran mayoría de Hospitales europeos e internacionales de tercer nivel desde hace más de una década. La utilidad demostrada de la actividad clínica en los centros médicos se basa en la implantación, desde hace años, en esos países de programas formativos específicos como el que solicitamos se debiera implantar en España. Adjuntamos las cartas recibidas de líderes Europeos de la Inmunología Clínica de Inglaterra, Alemania e Italia, del Presidente de la Unión internacional de las Sociedades Inmunológicas y de los Presidentes de las Sociedades de Inmunología de Alemania e Italia (estamos pendientes de la recepción de los documentos de varios líderes profesionales de Francia).
ANEXO IV.1.-Professor Helen Chapel Oxford Centre for Clinical Immunology A FOCIS designated centre of excellence PiA UK Centre of Excellence Clinical Immunology Unit Nuffield Department of Medicine John Radcliffe Hospital Campus University of Oxford
Oxford Centre for Clinical Immunology A FOCIS designated centre of excellence PiA UK Centre of Excellence Professor Helen Chapel
email: [email protected]
Clinical Immunology Unit Nuffield Department of Medicine
Level 7 John Radcliffe Hospital Campus
Headley Way Oxford
OX3 9DU Tel: 01865 740361
Professor Eduardo Fernandez-Cruz President of National Committee of Immunology Head of Division Clinical Immunology Hospital General Universitario Gregorio Marañón Department Microbiology e Immunology Universidad Complutense de Madrid Dear Prof. Fernandez-Cruz, I would like to express my strong support for the developing of a specific Training Programme in “Clinical Immunology” in Spain, along the lines of those in other European countries. In the UK, following the establishment of such a programme in the 1980s, it has been mandatory for the training of medical residents to become consultants in Clinical Immunology in the future. Clinical Immunology has evolved over the past three decades from a predominant laboratory based specialty to a clinical section of medicine. The clinical work of Immunologists is largely but not exclusively out-patient based and involves chronic disease. Such practice involves primary immunodeficiencies, allergy, autoimmune rheumatic diseases and systemic vasculitis (jointly with Rheumatologists), joint paediatric clinics for children with immune deficiencies or allergy as well as immunoglobulin infusion clinics for patients with all types of antibody deficiencies or autoimmune diseases. In addition, Consultant Immunologists remain responsible for directing diagnostic immunology services in terms of clinical usefulness. The variety of clinical problems encountered by an Immunologist gives an opportunity to solve difficult diagnostic problems in patients with complex immune deficiencies or multi-system diseases and is closely linked to new immunomodulatory therapies that require understanding of basic immunological principles as well as clinical knowledge. As you know, Clinical Immunology is widely established in different European countries and we often have European trainees on secondment for clinical training, which
UNIVERSITY OF OXFORD
enhances our training programmes and provides cross European links and collaborations. I understand that the UK training programme has been accepted as a model for Europe by UEMS. We are always pleased to welcome those from Spain in Oxford but it is highly desirable that Spain rapidly develops a similar programme, not least so that the new medical interventions in immunology (including monoclonal antibodies and cytokine therapies) can be used appropriately for relevant patients with immunological disease in a cost-effective manner. Should you need any help, do not hesitate to contact the chairman of the JRCPTB Board for Immunology – Professor Chris Corrigan or the UEMS representative – Dr Siraj Misbah. Best wishes Yours sincerely
Professor Helen Chapel
ANEXO IV.2 Professor Dieter Kabelitz President, German Society for Immunology Institute of Immunology UKS-H Campus Kiel D-Kiel. Germany
ANEXO IV.3.- Gianpietro Semenzato President. Italian Society of Immunology, Clinical Immunology and Allergy (SIICA) Clinica e Sperimentale “G. Patrassi” Università degli Studi di Padova Padova. Italy
1
CF: 94088680486
www.siica.it
EXECUTIVE COMMITTEE
President Gianpietro Semenzato
Vice-President Vincenzo Barnaba
Secretary-Treasurer Massimo Locati
Members Andrea Cossarizza Piergiuseppe De Berardinis Armando Gabrielli Giampiero Girolomoni Paola Parronchi Carlo Pucillo Angelo Vacca
Office of the President Dipartimento di Medicina Clinica e Sperimentale “G. Patrassi” Università degli Studi di Padova Via Giustiniani 2 - 35128 Padova Tel 049-8212298 FAX 049-8211970 [email protected] Office of the Secretary Dipartimento di Medicina Traslazionale Università degli Studi di Milano Istituto Clinico Humanitas Via Manzoni, 56 – 20089 Rozzano (MI) Tel 02-82245116 FAX 02-82245101 [email protected]
Padova, July 13, 2011
Professor Eduardo Fernandez-Cruz President of National Committee of Immunology
Head of Division Clinical Immunology Hospital General Universitario Gregorio Marañón Department Microbiology e Immunology Universidad Complutense de Madrid
Dear Prof. Fernandez-Cruz,
As the President of the Italian Society of Immunology, Clinical Immunology and
Allergy, I would like to express our strong support for the developing in Spain of a
specific Training Program in “Clinical Immunology”. The establishment of this is
mandatory for the training of medical residents that will eventually become consultants
in Clinical Immunology.
Immunological mechanisms are involved in the pathogenesis of almost all human
several diseases and Clinical immunology is a new branch of medicine which is
trasverse to all sciences and involves diseases of different systems, including the skin,
the lung, gastrointestinal and cardiovascular systems, etc. etc.
The possibility to develop a specific Training Program in “Clinical Immunology” in Spain
will certainly let young people to face this interesting area of medicine. This speciality
is widely represented in different European countries and it is highly desirable that
Spain falls into line.
Should you need any help, do not hesitate to contact us.
Sincerely,
Gianpietro Semenzato, M.D.
SIICA President
ANEXO IV.4.- Prof. Dr. med. R.E. Schmidt
Chairman of the Clinical Immunology Committee of International Union Immunological Societies (IUIS).
Head of Department of Clinical Immunology and Rheumatology Medizinische Hochschule Hannover Hannover. Germany
Zentrum Innere Medizin
Klinik für Immunologie und Rheumatologie Prof. Dr. med. R. E. Schmidt, Direktor Telefon: 0511 532- 6656 Fax: 0511 532- 9067 [email protected] www.mh-hannover.de/kir.html Carl-Neuberg-Straße 1 30625 Hannover Telefon: 0511 532-0 www.mh-hannover.de
MHH, Klinik für Immunologie und Rheumatologie, OE 6830
Carl-Neuberg-Str. 1, 30625 Hannover
Professor Eduardo Fernandez-Cruz President of National Committee of Immunology Head of Division Clinical Immunology Hospital General Universitario Gregorio Marañón Department Microbiology e Immunology Universidad Complutense de Madrid
20. Juli 2011 Ihr Zeichen Ihre Nachricht vom Mein Zeichen
Dear Prof. Fernandez-Cruz, As chairman of the Clinical Immunology Committee of the International Union of Immunologi-cal Societies (IUIS) and Head of Clinical Immunology and Rheumatology at the Medical Uni-versity of Hannover I would like to express our strong support for your interest in developing in Spain a Training Program in Clinical Immunology. There is a real need to establish a specific program for understanding pathogenesis of almost all human diseases and modern treatment modalities particularly in immunodeficiencies, rheumatology, infectious diseases, transplanta-tion and tumor immunology as well as allergy. The German Society for Immunology has therefore already established such a program during the past six years and is providing specialists with the respective certificate. We also have established training centres for clinical immunology. The establishment of a clinical immunology program should be mandatory for medical resi-dence that will eventually become consultants in clinical immunology. Yours sincerely,
Prof. Dr. med. R.E. Schmidt Head of Department of Clinical Immunology and Rheumatology Chairman of the Clinical Immunology Committee of IUIS
Zentrale der MHH: Immunol. Rheumatol. Ambulanz Station 32 Tel.: 0511/532-0 Tel.: 0511/532-3014 Rheumatologie/Immunologie Tel.: 0511/532-2321/2 Immunol. Infektiol. Ambulanz Station 78 a Tel.: 0511/532-3637 Infektionsstation Tel.: 0511/532-3269
ANEXO IV.5 Dr.G.P.Spickett Head of Regional Immunology Services Regional Department of Medicine, Royal Victoria Infirmary
Consultant & Senior Lecturer in Clinical Immunology
Newcastle upon Tyne. United Kingdom.
Dr.G.P.Spickett Dip CBT MA LLM DPhil FRCPath FRCP FRCPE Consultant in Clinical Immunology, Allergy and General Medicine
Regional Department of Medicine, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP Tel: 0191 2824281; email: [email protected]
Private Secretary: Miss Anne Bell; Tel: 0191 28225750; Fax 0191 2825070; email: [email protected] 28 July 2011
Professor Eduardo Fernández-Cruz Head Division of Clinical Immunology Hospital General Universitario Gregorio Marañón de Madrid Universidad Complutense de Madrid. Spain Dear Professor Fernandez-Cruz, In response to your email I am writing to express my strong support for the development of a specific postgraduate training programme in Clinical Immunology, to enable junior doctors to train in the speciality and become consultants in Clinical Immunology. Clinical Immunology encompasses both clinical and laboratory dimensions and it is essential that consultant immunologists have in-depth training in both aspects. The immune system is involved in disease of all organ systems and the Immunology Laboratory has a fundamental role in the diagnosis and management of these diseases. Organ-based specialists require guidance on appropriate test selection and results interpretation and this is best carried out by physicians with an understanding of immunological disease. Clinical Immunologists will undertake the diagnosis and clinical management of patients with primary immunodeficiencies, a highly specialised area of medicine, and in the UK will also undertake the diagnosis and management of patients with severe allergic disease. They will be involved, with other organ-based specialists, in the increasing use of biological immunotherapeutic agents in the management of immune-based disease. Clinical Immunology is a well-established discipline in the UK and has had a training programme which spans both clinical and laboratory aspects for the last 20 years. This is supervised by the Royal Colleges of Physicians and Pathologists, and there is an exit examination in the form of the Fellowship examination of the Royal College of Pathologists. In order to ensure harmonisation of postgraduate medical in the European Union, it is essential that Spain has an equivalent training programme. I am happy to provide any further information that may be required. Yours sincerely,
Dr.G.P.Spickett Consultant & Senior Lecturer in Clinical Immunology Head of Regional Immunology Services
ANEXO IV.6 Professor. Bodo Grimbacher Past Secretary of the European Society for Immunodeficiencies Dept of Immunology and Molecular, Royal Free Hospital, University College Division of infection & immunity London. United Kingdom
Dr. Bodo Grimbacher Professor and Consultant, Head of EU Marie-Curie Research Group Dept of Immunology, Royal Free Hospital, University College London Pond Street, London NW3-2QG, United Kingdom Tel: +44 (0)207 794 0500 ext 33321, Fax: +44 (0)207 433 1943 E-mail: [email protected]
DIVISION OF INFECTION & IMMUNITY DEPARTMENT OF IMMUNOLOGY AND MOLECULAR PATHOLOGY ROYAL FREE HOSPITAL London, June 27th, 2011 RE: Letter of support Dear Prof. Fernandez-Cruz, As the Past Secretary of the European Society for Immunodeficiencies (ESID, www.esid.org), and consultant of one of the largest adult primary immune deficiency centres in Europe, I would like to express my strong support for developing a specific training program in Clinical Immunology in Spain. I have established a patient registry for primary immunodeficient patients across Europe, which now contains clinical and laboratory data on more than 12.000 patients with primary immune deficiencies. Doing this, I have noticed that the care for these patients varies considerably in between European countries. One reason for this is the different training physicians receive, but also the different affiliations and “homes” Clinical Immunology has in the different countries. I therefore strongly support Prof. Fernandez-Cruz’ initiative to overhaul the training program for Clinical Immunology in Spain moving it to a Clinical- and Laboratory-based speciality. Should you need any more information, please do not hesitate to contact me. Best regards,
Bodo Grimbacher B. Grimbacher, MD Professor and Consultant Dept. of Immunology and Molecular Pathology (2nd floor) Royal Free Hospital & University College Medical School Pond Street, London NW3 2QG, UK Tel: +44-(0)20-7794-0500 ext.34399 Fax: +44-(0)20-7433-1943
To whom it may concern
ANEXO V.- PROGRAMAS FORMATIVOS EUROPEOS EN INMUNOLOGÍA CLÍNICA Y
DE LABORATORIO DIAGNÓSTICO
ANEXO V.1.- PROGRAMAS FORMATIVOS EN INMUNOLOGÍA CLÍNICA Y DE
LABORATORIO DIAGNÓSTICO VIGENTES EN EL REINO UNIDO.
Immunology Curriculum August 2010 Page 1 of 94
SPECIALTY TRAINING CURRICULUM
FOR
IMMUNOLOGY
AUGUST 2010
Joint Royal Colleges of Physicians Training Board
5 St Andrews Place Regent’s Park
London NW1 4LB
Telephone: (020) 79351174 Facsimile: (020)7486 4160 Email: [email protected]
Website: www.jrcptb.org.uk
Immunology Curriculum August 2010 Page 2 of 94
Table of Contents 1 Introduction........................................................................................................3 2 Rationale ............................................................................................................3
2.1 Purpose of the Curriculum 3
2.2 Development 3
2.3 Training Pathway 4
2.4 Enrolment with JRCPTB 5
2.5 Duration of Training 5
2.6 Less Than Full Time Training (LTFT) 5
3 Content of Learning...........................................................................................6 3.1 Programme Content and Objectives 6
3.2 Good Medical Practice 6
3.3 Syllabus 7
4 Learning and Teaching......................................................................................45 4.1 The Training Programme 45
4.2 Teaching and Learning Methods 45
4.3 Research 47
4.4 Academic Training 48
5 Assessment .......................................................................................................49 5.1 The Assessment System 49
5.2 Assessment Blueprint 49
5.3 Assessment Methods 49
5.4 Decisions on Progress (ARCP) 51
5.5 ARCP Decision Aid - Minimal Standards Determining Satisfactory Progress 53
5.6 Penultimate Year Assessment (PYA) 54
5.7 Complaints and Appeals 54
6 Supervision and Feedback ...............................................................................55 6.1 Supervision 55
6.2 Appraisal 56
7 Managing Curriculum Implementation.............................................................57 7.1 Intended Use of Curriculum by Trainers and Trainees 57
7.2 Recording progress 57
8 Curriculum Review and Updating.....................................................................57 9 Equality and Diversity .......................................................................................58 10 Appendix A.........................................................................................................59
Immunology Curriculum August 2010 Page 3 of 94
1 Introduction Immunology as a medical specialty deals with the clinical and laboratory care of patients with diseases due to disordered immunity. Immune-mediated disease covers a wide spectrum of disorders, ranging from failure of the immune system (immunodeficiency) to disorders characterised by heightened immune reactivity (allergy and autoimmunity). In practice, clinical immunologists take a lead role in the investigation and management of patients with immunodeficiency and severe allergy whilst working collaboratively with relevant organ-based specialists to provide optimal care for patients with systemic autoimmune disease and vasculitis. Alongside the provision of a clinical service to the aforementioned group of patients, immunologists direct a comprehensive diagnostic laboratory service which underpins the diagnosis and monitoring of this broad range of immunological diseases.
2 Rationale
2.1 Purpose of the Curriculum
The purpose of this curriculum is to define the process of training and the competencies needed to produce a consultant immunologist capable of independent practice in the United Kingdom. The award of a certificate of completion of training in the specialty will denote that a trainee is equipped with the requisite specialised scientific knowledge, clinical and laboratory skills required to diagnose, treat and where relevant, prevent diseases characterised by immunodeficiency, autoimmunity and allergy coupled with the ability to direct a diagnostic immunology laboratory service. The UK clinical practice of immunology is fully consistent with the World Health Organisation's (WHO) definition of Immunology as a specialty , encompassing clinical and laboratory activity dealing with the study, diagnosis and management of patients with diseases resulting from disordered immunological mechanisms, and conditions in which immunological manipulations form an important part of therapy(Lambert PH et al.Clinical Immunology: -guidelines for its organisation, training and certification: relationships with allergology and other medical disciplines - a WHO/IUIS/IAACI report. Clin Exp Immunol 1993;93:484-91). In practice, this translates in to Immunologists providing combined clinical and laboratory services for patients with immunodeficiency, autoimmune disease, vasculitis and allergy. The curriculum has been designed to build upon the knowledge and core competencies in general internal medicine that trainees will bring with them as they enter immunology training. Throughout specialty training, the curriculum provides a structured framework to enable incremental learning and reflection across the whole breadth of clinical and laboratory immunology.
2.2 Development
This curriculum was developed by the Immunology SAC of JRCPTB for Immunology which includes lay representation and training programme directors, in consultation with all stakeholders including trainees and trainers. It replaces the previous version of the curriculum dated May 2007 with changes to ensure the curriculum meets GMC’s standards for Curricula and Assessment, and to incorporate revisions to the content and delivery of the training programme. Major changes from the previous curriculum include the incorporation of leadership, health inequalities and common competencies. A draft version of the curriculum was circulated to all immunology consultants and trainees. Patient’s views on the curriculum were obtained through the Primary Immunodeficiency Association (PiA), the national patient support organisation for patients with immunodeficiencies .
Immunology Curriculum August 2010 Page 4 of 94
The content of this curriculum was chosen by the SAC to reflect current UK hospital practice in Immunology. Educational supervisors and trainees were involved in its development via their representation on committees such as the Immunology SAC of JRCPTB.
2.3 Training Pathway
Specialty training in Immunology consists of core and higher speciality training. Core training provides physicians with: the ability to investigate, treat and diagnose patients with acute and chronic medical symptoms; and with high quality review skills for managing inpatients and outpatients. Higher speciality training then builds on these core skills to develop the specific competencies required to practise independently as a consultant Immunologist. Core training may be completed in either a Core Medical Training (CMT) or Acute Care Common Stem (ACCS) programme. The full curriculum for specialty training in Immunology therefore consists of the curriculum for either CMT or ACCS plus this specialty training curriculum for Immunology. There are common competencies that should be acquired by all physicians during their training period starting within the undergraduate career and developed throughout the postgraduate career, for example communication, examination and history taking skills. These are initially defined for CMT and then developed further in the specialty. This curriculum supports the spiral nature of learning that underpins a trainee’s continual development. It recognises that for many of the competences outlined there is a maturation process whereby practitioners become more adept and skilled as their career and experience progresses. It is intended that doctors should recognise that the acquisition of basic competences is often followed by an increasing sophistication and complexity of that competence throughout their career. This is reflected by increasing expertise in their chosen career pathway. Completion of CMT or ACCS and acquisition of full MRCP (UK) will be required before entry into Specialty training at ST3 (2011 onwards). The approved curriculum for CMT is a sub-set of the Curriculum for General Internal Medicine (GIM). A “Framework for CMT” has been created for the convenience of trainees, supervisors, tutors and programme directors. The body of the Framework document has been extracted from the approved curriculum but only includes the syllabus requirements for CMT and not the further requirements for acquiring a CCT in GIM.
Immunology Curriculum August 2010 Page 5 of 94
Diagram 1.0 Training Pathway for Immunology
2.4 Enrolment with JRCPTB
Trainees are required to register for specialist training with JRCPTB at the start of their training programmes. Enrolment with JRCPTB, including the complete payment of enrolment fees, is required before JRCPTB will be able to recommend trainees for a CCT in Immunology. Trainees can enrol online at www.jrcptb.org.uk
2.5 Duration of Training
Although this curriculum is competency based, the duration of training must meet the European minimum of 4 (four) years for post registration in full time training adjusted accordingly for flexible training (EU directive 2005/36/EEC) requires that flexible training can be no less than 50% whole time equivalent). The SAC has advised that training from ST1 will usually be completed in 7 (seven) years in full time training.
2.6 Less Than Full Time Training (LTFT)
Trainees who are unable to work full-time are entitled to opt for less than full time training programmes. EC Directive 2005/36/EC requires that:
• LTFT shall meet the same requirements as full-time training, from which it will differ only in the possibility of limiting participation in medical activities.
• The competent authorities shall ensure that the competencies achieved and the quality of part-time training are not less than those of full-time trainees.
The above provisions must be adhered to. LTFT trainees should undertake a pro rata share of the out-of-hours duties (including on-call and other out-of-hours commitments) required of their full-time colleagues in the same programme and at the equivalent stage. EC Directive 2005/36/EC states that there is no longer a minimum time requirement on training for LTFT trainees. In the past, less than full time trainees were required to work a minimum of 50% of full time. With competence-based training, in order to retain competence, in addition to acquiring new skills, less than full time trainees would still normally be expected to work a minimum of 50% of full time. If you are returning or converting to training at less than full time please complete the LTFT application form on the JRCPTB website www.jrcptb.org.uk .
FY2
MRCP (UK) & WPBAs
Immunology Training
Core Medical Training or Acute Care Common Stem
Selection Selection 84 months to completion minimum
FRCPath
Immunology Curriculum August 2010 Page 6 of 94
Funding for LTFT is from deaneries and these posts are not supernumerary. Ideally therefore 2 LTFT trainees should share one post to provide appropriate service cover. Less than full time trainees should assume that their clinical training will be of a duration pro-rata with the time indicated/recommended, but this should be reviewed during annual appraisal by their TPD and chair of STC and Deanery Associate Dean for LTFT training. As long as the statutory European Minimum Training Time (if relevant), has been exceeded, then indicative training times as stated in curricula may be adjusted in line with the achievement of all stated competencies.
3 Content of Learning
3.1 Programme Content and Objectives
The syllabus (subject matter) for the curriculum comprises the following principal areas:
• Acquisition of a core body of knowledge in fundamental immunology and its applications
• Investigation and management of patients with congenital and acquired immunodeficiency disorders
• Investigation and management of patients with autoimmune (including rheumatic) disease and systemic vasculitides in liaison with appropriate organ-based specialist colleagues
• Investigation and management of patients with allergic diseases. As a group, Immunologists comprise the single biggest specialty currently providing specialist allergy services. In recognition of this important service need, trainees must demonstrate competence in the independent diagnosis and management of common allergic disorders of all degrees of severity
• Delivery of a diagnostic immunology laboratory service in accordance with accreditation standards laid down by Clinical Pathology Accreditation (CPA UK) or other recognised accrediting bodies
• In addition, trainees should be able to explain the principles underlying solid organ and stem cell transplantation
• Acquire “Generic Skills” required for immunology, in accordance with Good Medical Practice (see below)
On completion of the immunology training programme, the trainee must have acquired and be able to demonstrate:
• Appropriate attitudes and behaviours in order to be able to work as a consultant
• Good working relationships with colleagues and the appropriate communication skills required for the practice of immunology
• Knowledge, skills, attitudes and behaviours to act in a professional manner at all times
• Knowledge, skills, attitudes and behaviours to provide appropriate teaching and to participate in effective research to underpin immunology practice
• Understanding of the context, meaning and implementation of clinical governance
• Knowledge of the structure and organisation of the NHS
• Acquisition of management skills required for the running of an Immunology laboratory
• Familiarity with health and safety regulations, as applied to the work of an Immunology department
3.2 Good Medical Practice
In preparation for the introduction of licensing and revalidation, the General Medical Council has translated Good Medical Practice into a Framework for Appraisal and Assessment which
Immunology Curriculum August 2010 Page 7 of 94
provides a foundation for the development of the appraisal and assessment system for revalidation. The Framework can be accessed at http://www.gmc-uk.org/Framework_4_3.pdf_25396256.pdf The Framework for Appraisal and Assessment covers the following domains: Domain 1 – Knowledge, Skills and Performance Domain 2 – Safety and Quality Domain 3 – Communication, Partnership and Teamwork Domain 4 – Maintaining Trust The “GMP” column in the syllabus defines which of the 4 domains of the Good Medical Practice Framework for Appraisal and Assessment are addressed by each competency. Most parts of the syllabus relate to “Knowledge, Skills and Performance” but some parts will also relate to other domains.
3.3 Syllabus
In the tables below, the “Assessment Methods” shown are those that are appropriate as possible methods that could be used to assess each competency. It is not expected that all competencies will be assessed and that where they are assessed not every method will be used. See section 5.2 for more details. “GMP” defines which of the 4 domains of the Good Medical Practice Framework for Appraisal and Assessment are addressed by each competency. See section 3.2 for more details. Each section of the curriculum outlines the knowledge, skills and behaviours that must be obtained by the trainee in order to successfully complete training. During their training, it is expected that the trainee will progress through three levels of competence, as outlined below:
Level 1: Introductory - The trainee has comprehensive understanding of principles and practices under direct supervision.
Level 2: Intermediate - The trainee has a good general knowledge and understanding of most principles and practices under indirect supervision. He/she should be able to deal with most of the day-to-day issues in a hospital immunology laboratory and outpatient clinic/ward to an adequate level but will still require consultant input with regard to complex management and clinical issues.
Level 3: Independent - The trainee has an in-depth knowledge and understanding of principles. He/she should be competent to discuss and deal with the subject (or, where appropriate, perform the task/procedure), demonstrating a level of clinical or professional judgement commensurate with independent practice at consultant level. It is anticipated that a trainee at this level should have consultant input readily available at all times where required
Syllabus Contents
1. Common Competencies................................................................................................... 9 1.1 History Taking........................................................................................................... 9
1.2 Clinical Examination ................................................................................................. 10
1.3 Therapeutics and Safe Prescribing ........................................................................... 10
1.4 Time Management and Decision Making .................................................................. 12
1.5 Decision Making and Clinical Reasoning .................................................................. 13
Immunology Curriculum August 2010 Page 8 of 94
1.6 The Patient as Central Focus of Care ....................................................................... 14
1.7 Prioritisation of Patient Safety in Clinical Practice ..................................................... 15
1.8 Team Working and Patient Safety ............................................................................ 16
1.9 Principles of Quality and Safety Improvement........................................................... 17
1.10 Infection Control...................................................................................................... 18
1.11 Managing Long-Term Conditions and Promoting Patient Self-Care ........................ 19
1.12 Relationships with Patients and Communication within a Consultation ................... 20
1.13 Breaking Bad News ................................................................................................ 21
1.14 Complaints and Medical Error................................................................................. 22
1.15 Communication with colleagues and cooperation ................................................... 23
1.16 Health Promotion and Public Health ....................................................................... 24
1.17 Environmental Protection and Emergency Planning................................................ 25
1.18 Principles of Medical Ethics and Confidentiality ...................................................... 26
1.19 Obtaining of Consent .............................................................................................. 27
1.20 Legal Framework for Practice ................................................................................. 28
1.21 Ethical Research..................................................................................................... 29
1.22 Evidence and Guidelines ........................................................................................ 29
1.23 Audit ....................................................................................................................... 30
1.24 Teaching and Training ............................................................................................ 31
1.25 Personal Behaviour ................................................................................................ 33
1.26 Management and NHS Structure ............................................................................ 34
2. Medical Leadership and Management ............................................................................ 36 2.1 Personal Qualities..................................................................................................... 36
2.2 Working with Others ................................................................................................. 36
2.3 Managing Services ................................................................................................... 37
2.4 Improving Services ................................................................................................... 38
2.5 Setting Direction ....................................................................................................... 38
3. Content of learning........................................................................................................... 40 3.1 Fundamental Immunology ........................................................................................ 40
3.2 Primary and Secondary Immunodeficiency Diseases................................................ 41
3.3 Systemic Autoimmune Rheumatic Disease and Systemic Vasculitides..................... 42
3.4 Allergic Diseases ...................................................................................................... 43
3.5 Laboratory Immunology ............................................................................................ 44
Immunology Curriculum August 2010 Page 9 of 94
1. Common Competencies
1.1 History Taking
To elicit a relevant focused history from patients with increasingly complex issues and in increasingly challenging circumstances
To record the history accurately and synthesise this with relevant clinical examination, establish a problem list increasingly based on pattern recognition including differential diagnosis and formulate a management plan that takes account of likely clinical evolution
Knowledge
Assessment
Methods
GMP
Comprehends the importance of different elements of the history mini-CEX 1
Comprehends that patients do not always present their history in a structured fashion
mini-CEX 1,3
Knows the likely causes and risk factors for conditions relevant to mode of presentation
mini-CEX 1
Recognises that the patient’s wishes and beliefs and the history should inform examination, investigation and management
mini-CEX 1
Recognises the importance of social and cultural issues and practices that may have an impact on health
mini-CEX 1
Skills
Identifies and overcomes possible barriers to effective communication mini-CEX 1,3
Communicates effectively with patients from diverse backgrounds and those with special communication needs, such as those who need interpreters
mini-CEX
Manages time and draws consultation to a close appropriately mini-CEX 1,3
Comprehends that effective history taking in non-urgent cases may require several discussions with the patient and other parties, over time
mini-CEX 1,3
Supplements history with standardised instruments or questionnaires when relevant
mini-CEX 1,3
Manages alternative and conflicting views from family, carers, friends and members of the multi-professional team and maintains focus
mini-CEX 1,3
Assimilates history from the available information from patient and other sources including members of the multi-professional team.
mini-CEX 1,3
Where values and perceptions of health and health promotion conflict, facilitates balanced and mutually respectful decision making
mini-CEX
Recognises and interprets appropriately the use of non verbal communication from patients and carers
mini-CEX 1,3
Focuses on relevant aspects of history mini-CEX 1,3
Behaviours
Shows respect and behaves in accordance with Good Medical Practice mini-CEX 3,4
Immunology Curriculum August 2010 Page 10 of 94
1.2 Clinical Examination
To perform focused, relevant and accurate clinical examination in patients with increasingly complex issues and in increasingly challenging circumstances
To relate physical findings to history in order to establish diagnosis and formulate a management plan
Knowledge
Assessment Methods
GMP
Understands the need for a targeted and relevant clinical examination CbD, mini-CEX 1
Understands the basis for clinical signs and the relevance of positive and negative physical signs
CbD, mini-CEX 1
Comprehends constraints (including those that are cultural or social) on performing physical examination and strategies that may be used to overcome them
CbD, mini-CEX 1
Comprehends the limitations of physical examination and the need for adjunctive forms of assessment to confirm diagnosis
CbD, mini-CEX 1
Recognises when the offer/use of a chaperone is appropriate or required CbD, mini-CEX 1
Skills
Performs a valid, targeted and time efficient examination relevant to the presentation and risk factors
CbD, mini-CEX 1
Recognises the possibility of deliberate harm (both self harm and harm by others) in vulnerable patients and reports to appropriate agencies
CbD, mini-CEX 1,2
Actively elicits important clinical findings CbD, mini-CEX 1
Performs relevant adjunctive examinations CbD, mini-CEX 1
Behaviours
Shows respect and behaves in accordance with Good Medical Practice CbD, mini-CEX, MSF 1,4
Considers social, cultural and religious boundaries to clinical examination, appropriately communicates and makes alternative arrangements where necessary
CbD, mini-CEX, MSF 1,4
1.3 Therapeutics and Safe Prescribing
To prescribe, review and monitor appropriate therapeutic interventions relevant to clinical practice including non – medication based therapeutic and preventative indications
Knowledge
Assessment Methods
GMP
States indications, contraindications, side effects, drug interactions and dosage of commonly used drugs
CbD, mini-CEX 1
Recalls range of adverse drug reactions to commonly used drugs, including complementary medicines
CbD, mini-CEX 1
Recalls drugs requiring therapeutic drug monitoring and interprets results CbD, mini-CEX 1
Outlines tools to promote patient safety and prescribing, including electronic clinical record systems and other IT systems
CbD, mini-CEX 1,2
Defines the effects of age, body size, organ dysfunction and concurrent illness on drug distribution and metabolism relevant to the trainees practice
CbD, mini-CEX 1,2
Understands the roles of regulatory agencies involved in drug use, CbD, mini-CEX 1,2
Immunology Curriculum August 2010 Page 11 of 94
monitoring and licensing (e.g. National Institute for Clinical Excellence (NICE), Medical Healthcare Products Regulatory Agency (MHRA) and hospital formulary committees
Understands the importance of non-medication based therapeutic interventions including the legitimate role of placebos
CbD, mini-CEX 1,2
Recalls in detail the propensity of drugs to elicit IgE-mediated and non-IgE mediated systemic anaphylactic reactions in certain individuals and the capacity of structurally related drugs to cross-react
CbD, mini-CEX
Recalls a rational basis for the use of alternative drugs in drug allergic patients
CbD, mini-CEX
Is familiar with the indications, products, modes of delivery and dosage regimens for allergen immunotherapy
CbD, mini-CEX
Skills
Reviews the continuing need for, effect of and adverse effects of long term medications relevant to the trainees clinical practice
CbD, mini-CEX 1, 2
Anticipates and avoid defined drug interactions, including complementary medicines
CbD, mini-CEX 1
Advises patients (and carers) about important interactions and adverse drug effects
CbD, mini-CEX 1,3
Prescribes appropriately in pregnancy, and during breast feeding CbD, mini-CEX 1
Makes appropriate dose adjustments following therapeutic drug monitoring, or physiological change (e.g. deteriorating renal function)
CbD, mini-CEX 1
Uses IT prescribing tools where available to improve safety CbD, mini-CEX 1,2
Employs validated methods to improve patient concordance with prescribed medication
mini-CEX 1,3
Provides comprehensible explanations to the patient, and carers when relevant, for the use of medicines and understands the principles of concordance in ensuring that drug regimes are followed
CbD, mini-CEX 1,3
Ensures safe systems for monitoring, review and authorisation where involved in “repeat prescribing”
CbD, mini-CEX 1
Recognises the importance of resources when prescribing, including the role of a Drug Formulary and electronic prescribing systems
CbD, mini-CEX 1
Is able to provide advice on, and perform relevant skin prick and other challenge tests for drug allergy and interpret the results
CbD, mini-CEX, DOPS
1,2
Behaviours
Minimises the number of medications taken by a patient to a level compatible with best care
CbD, mini-CEX 1
Appreciates the role of non-medical prescribers CbD, mini-CEX 1,3
Remains open to advice from other health professionals on medication issues
CbD, mini-CEX 1,3
Ensures prescribing information is shared promptly and accurately between a patient’s health providers, including between primary and secondary care
CbD 1,3
Participates in adverse drug event reporting mechanisms CbD 1
Takes particular care to disseminate information about drug allergies appropriately and instructs patients to do the same
CbD, mini-CEX 1
Remains up to date with therapeutic alerts, and responds appropriately CbD 1
Immunology Curriculum August 2010 Page 12 of 94
1.4 Time Management and Decision Making
Learn how to prioritise and organise clinical and clerical duties in order to optimise patient care and make appropriate clinical and clerical decisions in order to optimise the effectiveness of the clinical team resource.
Knowledge Assessment Methods
GMP
Understands that effective organisation is key to time management CbD 1
Understands that some tasks are more urgent and/or more important than others
CbD 1
Understands the need to prioritise work according to urgency and importance
CbD 1
Understands that some tasks may have to wait or be delegated to others CbD 1
Understands the roles, competences and capabilities of other professionals and support workers
CbD 1
Outlines techniques for improving time management CbD 1
Understands the importance of prompt investigation, diagnosis and treatment in disease and illness management
CbD, mini-CEX 1,2
Skills
Maintains focus on individual patient needs whilst balancing multiple competing pressures
CbD 1
Identifies clinical and clerical tasks requiring attention or predicted to arise CbD, mini-CEX 1,2
Estimates the time likely to be required for essential tasks and plans accordingly
CbD, mini-CEX 1
Groups together tasks when this will be the most effective way of working CbD, mini-CEX 1
Recognises the most urgent / important tasks and ensures that they managed expediently
CbD, mini-CEX 1
Regularly reviews and re-prioritises personal and team work load CbD, mini-CEX 1
Organises and manages workload effectively and flexibly CbD, mini-CEX 1
Makes appropriate use of other professionals and support workers CbD, mini-CEX 1
Behaviours
Works flexibly and deals with tasks in an effective and efficient fashion CbD, MSF 3
Recognises when self or others are falling behind and takes steps to rectify the situation
CbD, MSF 3
Communicates changes in priority to others MSF 1
Remains calm in stressful or high pressure situations and adopts a timely, rational approach
MSF 1
Appropriately recognises and handles uncertainty within the consultation MSF 1
Immunology Curriculum August 2010 Page 13 of 94
1.5 Decision Making and Clinical Reasoning
Acquire the ability to formulate a diagnostic and therapeutic plan for a patient according to the clinical information available.
Acquire the ability to prioritise the diagnostic and therapeutic plan.
Acquire the ability to communicate a diagnostic and therapeutic plan appropriately.
Knowledge Assessment Methods
GMP
Defines the steps of diagnostic reasoning CbD, mini-CEX 1
Conceptualises clinical problems in a medical and social context CbD, mini-CEX 1
Understands the psychological components of disease and illness presentation
CbD, mini-CEX 1
Recognises how to use expert advice, clinical guidelines and algorithms CbD, mini-CEX 1
Recognises and appropriately responds to sources of information accessed by patients
CbD, mini-CEX 1
Defines the concepts of disease natural history and assessment of risk CbD, mini-CEX 1,2
Outlines methods and associated problems of quantifying risk e.g. cohort studies
CbD, mini-CEX 1
Outlines the concepts and drawbacks of quantitative assessment of risk or benefit e.g. numbers needed to treat
CbD 1
Describes commonly used statistical methodology CbD 1
Knows how relative and absolute risks are derived and the meaning of the terms predictive value, sensitivity and specificity in relation to diagnostic tests
mini-CEX 1
Skills
Interprets clinical features, their reliability and relevance to clinical scenarios including recognition of the breadth of presentation of common disorders
CbD, mini-CEX 1
Incorporates an understanding of the psychological and social elements of clinical scenarios into decision making through a robust process of clinical reasoning
CbD, mini-CEX 1
Interprets history and clinical signs CbD, mini-CEX 1
Generates hypothesis within context of clinical likelihood CbD, mini-CEX 1
Tests, refines and verifies hypotheses CbD, mini-CEX 1
Develops problem list and action plan CbD, mini-CEX 1
Comprehends the need to determine the best value and most effective treatment both for the individual patient and for a patient cohort
CbD, mini-CEX 1
Recognises critical illness and respond with due urgency CbD, mini-CEX 1
Generates plausible hypotheses following patient assessment CbD, mini-CEX 1
Constructs a concise and applicable problem list using available information
CbD, mini-CEX 1
Constructs an appropriate management plan in conjunction with the patient, carers and other members of the clinical team and communicate this effectively to the patient, parents and carers where relevant
CbD, mini-CEX 1,3,4
Applies the relevance of an estimated risk of a future event to an individual patient
CbD, mini-CEX 1
Immunology Curriculum August 2010 Page 14 of 94
Uses risk calculators appropriately CbD, mini-CEX 1
Considers the risks and benefits of screening investigations CbD, mini-CEX 1
Applies quantitative data to assess the risks and benefits of therapeutic intervention in an individual patients
CbD, mini-CEX 1
Searches and comprehends the medical literature to guide reasoning CbD, mini-CEX 1
Behaviours
Recognises the difficulties in predicting occurrence of future events CbD, mini-CEX 1
Shows willingness to discuss intelligibly with a patient the notion and difficulties of prediction of future events, and benefit/risk balance of therapeutic intervention
CbD, mini-CEX 3
Shows willingness to adapt and adjust approaches according to the beliefs and preferences of the patient and/or carers
CbD, mini-CEX 3
Shows willingness to facilitate patient choice CbD, mini-CEX 3
Shows willingness to search for evidence to support clinical decision making
CbD, mini-CEX 1,4
Demonstrates ability to identify one’s own biases and inconsistencies in clinical reasoning
CbD, mini-CEX 1,3
1.6 The Patient as Central Focus of Care
Prioritises the patient’s wishes encompassing their beliefs, concerns, expectations and needs
Knowledge Assessment Methods
GMP
Outlines health needs of particular populations e.g. ethnic minorities and recognise the impact of health beliefs, culture and ethnicity in presentations of physical and psychological conditions
CbD 1
Ensures that all decisions and actions are in the best interests of the patient and the public good
CbD 1
Skills
Gives adequate time for patients and carers to express their beliefs ideas, concerns and expectations
mini-CEX 1,3,4
Encourages the health care team to respect the philosophy of patient focussed care
CbD, mini-CEX, MSF 3
Develops a self-management plan with the patient CbD, mini-CEX 1,3
Supports patients, parents and carers where relevant to comply with management plans
CbD, mini-CEX, PS 3
Encourages patients to voice their preferences and personal choices about their care
mini-CEX, PS 3
Behaviours
Supports patient self-management CbD, mini-CEX, PS 3
Responds to questions honestly and seeks advice if unable to answer CbD, mini-CEX 3
Recognises the duty of the medical professional to act as patient advocate
CbD, mini-CEX, MSF, PS
3,4
Responds to people in an ethical, honest and non-judgmental manner CbD, mini-CEX, MSF, PS
1,3
Adopts assessments and interventions that are inclusive, respectful of CbD, mini-CEX, 1,3
Immunology Curriculum August 2010 Page 15 of 94
diversity and patient-centred MSF, PS
1.7 Prioritisation of Patient Safety in Clinical Practice
To understand that patient safety depends on:
• The effective and efficient organisation of care
• Health care staff working well together
• Safe systems not just individual competency and safe practice
To understand the risks of treatments and to discuss these honestly and openly with patients so that they are able to make decisions about risks and treatment options
To understand that all staff should be made aware of risks and work together to minimise risk
To act always to promote patient safety
Knowledge Assessment Methods
GMP
Outline the features of a safe working environment CbD, mini-CEX 1
Outlines the hazards of medical equipment in common use CbD 1
Recalls unwanted effects and contraindications of medications prescribed CbD, mini-CEX 1
Recalls principles of risk assessment and management CbD 1
Recalls the components of safe working practice in personal, clinical and organisational settings
ACAT, CbD 1
Outlines human factors theory and understands its impact on safety CbD 1
Knows about root cause analysis CbD 1
Knows about significant event analysis CbD 1
Outlines local procedures and protocols for optimal practice e.g. GI bleed protocol, safe prescribing
CbD, mini-CEX 1
Understands the investigation of significant events, serious untoward incidents and near misses
CbD, mini-CEX 1
Is very familiar with the principles of management of systemic anaphylaxis and the governance required to deal with the possibility of anaphylaxis in the allergen challenge clinic
CbD, mini-CEX 1
Skills
Recognises limits of own professional competence and practises only within these
ACAT, CbD, mini-CEX
1
Recognises when a patient is not responding to treatment, reassesses the situation and encourages others to do so
CbD, mini-CEX 1
Ensures the correct and safe use of medical equipment, ensuring faulty equipment is reported appropriately
CbD, mini-CEX 1
Improves patients’ and colleagues’ understanding of the side effects and contraindications of therapeutic intervention
CbD, mini-CEX 1,3
Sensitively counsels a colleague following a significant untoward event, or near incident, to encourage improvement in practice of individual and unit
CbD 3
Recognises and respond to the manifestations of a patient’s deterioration or lack of improvement (symptoms, signs, observations, and laboratory results) and supports other members of the team to act similarly
CbD, mini-CEX, MSF 1
Behaviours
Maintains a high level of safety awareness and consciousness at all times CbD, mini-CEX 2
Immunology Curriculum August 2010 Page 16 of 94
Encourages feedback from all members of the team on safety issues CbD, mini-CEX, MSF 3
Reports serious untoward incidents and near misses and co-operates with the investigation of the same
CbD, mini-CEX, MSF 3
Shows willingness to take action when concerns are raised about performance of members of the healthcare team, and act appropriately when these concerns are voiced to you by others
CbD, mini-CEX, MSF 3
Continues to be aware of own limitations, and operates within them competently
CbD, mini-CEX 1
1.8 Team Working and Patient Safety
To work well in a variety of different teams and team settings and to contribute to discussion on the team’s role in patient safety
To display the leadership skills necessary to lead teams so that they are more effective and better able to deliver safer care
Knowledge Assessment Methods
GMP
Outlines the components of effective collaboration and team working CbD 1
Describes the roles and responsibilities of members of the healthcare team
CbD 1
Outlines factors adversely affecting a doctor’s and team performance and methods to rectify these
CbD 1
Skills
Practises with attention to the important steps of providing good continuity of care
CbD, mini-CEX 1,3,4
Keeps accurate and attributable notes including appropriate use of electronic clinical record systems
CbD, mini-CEX 1,3
Demonstrates leadership and management in education and training of junior colleagues and other members of the healthcare team
CbD, mini-CEX 1,2,3
Recognises deteriorating performance of colleagues (e.g. stress, fatigue) CbD, mini-CEX 1,2,3
Provides high quality care CbD, mini-CEX 1,2,3
Leads and participates in interdisciplinary team meetings CbD, mini-CEX 3
Provides appropriate supervision to less experienced colleagues CbD, MSF 3
Behaviours
Encourages an open environment to foster and explore concerns and issues about the functioning and safety of team working
CbD, MSF 3
Recognises limits of own professional competence and practises within these
CbD, MSF 3
Recognises and respect the request for a second opinion CbD, MSF 3
Recognises the importance of induction for new members of a team CbD, MSF 3
Recognises the importance of prompt and accurate information sharing with Primary Care team following hospital discharge
CbD, mini-CEX, MSF 3
Immunology Curriculum August 2010 Page 17 of 94
1.9 Principles of Quality and Safety Improvement
To recognise the desirability of monitoring performance, learning from mistakes and adopting a no blame culture in order to ensure high standards of care and optimise patient safety
Knowledge Assessment Methods
GMP
Understands the elements of clinical governance CbD, MSF 1
Defines local and national significant event reporting systems relevant to allergy
CbD, mini-CEX 1
Outlines local health and safety protocols (fire, manual handling etc) CbD 1
Understands risks associated with training in allergy including biohazards and mechanisms to reduce risk
CbD 1
Outlines the use of patient early warning systems to detect clinical deterioration
CbD, mini-CEX 1
Keeps abreast of national patient safety initiatives including National Patient Safety Agency , NCEPOD reports, NICE guidelines etc
CbD, mini-CEX 1
Skills
Adopts strategies to reduce risk CbD 1,2
Recognises that governance safeguards high standards of care and facilitates the development of improved clinical services
CbD 1,2
Recognises importance of evidence-based practice in relation to clinical effectiveness
CbD 1
Reflects regularly on personal standards of medical practice in accordance with GMC guidance on licensing and revalidation
AA 1,2,3,
4
Behaviours
Shows willingness to participate in safety improvement strategies such as critical incident reporting
CbD, MSF 3
Develops reflection in order to achieve insight into own professional practice
CbD, MSF 3
Demonstrates personal commitment to improve self performance in the light of feedback and assessment
CbD, MSF 3
Contributes to quality improvement processes such as: CbD, MSF 3
• Audit of personal and departmental/directorate/practice performance
• Errors / discrepancy meetings
• Critical incident and near miss reporting
• Unit morbidity and mortality meetings
• Local and national databases
Maintains a portfolio of information and evidence drawn from personal medical practice
CbD, MSF 3
Engages with an open no blame culture CbD, MSF 3
Responds positively to outcomes of audit and quality improvement CbD, MSF 1,3
Co-operates with changes necessary to improve service quality and safety
CbD, MSF 1,2
Immunology Curriculum August 2010 Page 18 of 94
1.10 Infection Control
To learn how to manage and control infection in patients, including controlling the risk of cross-infection, appropriately managing infection in individual patients, and working appropriately within the wider community to manage the risk posed by communicable diseases.
Knowledge Assessment Methods
GMP
Understands the principles of infection control as defined by the GMC CbD, mini-CEX 1
Understands the principles of preventing infection in high risk groups (eg managing antibiotic use to reduce Clostridium difficile infection) including understanding the local antibiotic prescribing policy
CbD, mini-CEX 1
Understands the role of Notification of diseases within the UK and identify the principle notifiable diseases for UK and international purposes
CbD, mini-CEX 1
Understands the role of the Health Protection Agency and Consultants in Health Protection (previously Consultants in Communicable Disease Control – CCDC)
CbD, mini-CEX 1
Understands the role of the local authority in relation to infection control CbD, mini-CEX 1
Knows how to access and use local health data CbD, mini-CEX 1
Skills
Recognises the potential for infection within patients being cared for CbD 1,2
Counsels patients on matters of infection risk, transmission and control CbD, mini-CEX, PS 2,3
Recognises potential for cross-infection in clinical settings CbD, mini-CEX 1,2
Practices aseptic technique whenever relevant DOPS 1
Behaviours
Actively engages in local infection control procedures CbD 1
Actively engages in local infection control monitoring and reporting processes
CbD 1,2
Prescribes antibiotics according to local antibiotic guidelines and works with microbiological services where this is not possible
CbD 1
Encourages all staff, patients and relatives to observe infection control principles
CbD, MSF 1
Recognises personal ill-health as a risk to patients and colleagues and its effect on performance
CbD, MSF 1,3
Immunology Curriculum August 2010 Page 19 of 94
1.11 Managing Long-Term Conditions and Promoting Patient Self-Care
To learn how to pursue a holistic and long term approach to the planning and implementation of patient care, in particular to identify and facilitate the role of the patient, the family and other carers in the long term management of severe allergic diseases
Knowledge Assessment Methods
GMP
Describes the natural history of allergic diseases that run a chronic course CbD, mini-CEX 1
Defines the role of services and the multi-disciplinary teams to facilitate long-term care of patients with allergic diseases
CbD, mini-CEX 1
Outlines the concept of quality of life and how this can be measured whilst understanding the limitations of such measures for individual patients
CbD, mini-CEX 1
Outlines the concept of patient self-care and the role of the expert patient CbD, mini-CEX 1
Works with an appropriate knowledge of guidance documents on supporting people with long term conditions to self care
CbD, mini-CEX 1
Knows, understands and is able to compare and contrast the medical and social models of disability
CbD, mini-CEX 1
Knows about and practises within the key provisions of disability discrimination and other contemporary legislation
CbD, mini-CEX 1
Understands the relationship between local health, educational and social service provision including the voluntary sector and how they can be accessed
CbD, mini-CEX 1
Is familiar with the range of agencies that can provide care and support in and out of hospital and how they can be accessed
CbD, mini-CEX 1
Skills
Develops and agrees a management plan with the patient (and carers), ensuring awareness of alternatives to maximise self-care within care pathways where relevant
CbD, mini-CEX 1,3
Assesses the patient’s ability to access various services in the health and social system and offer appropriate assistance
CbD, mini-CEX 1,3
Advocates and facilitates appropriate self care CbD, mini-CEX 1,3
Develops and sustains supportive relationships with patients with whom care will be prolonged and potentially life long
CbD, mini-CEX 1,4
Provides relevant evidence-based information and where appropriate effective patient education, with support of the multi-disciplinary team
CbD, mini-CEX 1,3,4
Provides relevant and evidence based information in an appropriate medium to enable sufficient choice, when possible
CbD, PS 1,3
Behaviours
Shows willingness and support for patient in his/her own advocacy, within the constraints of available resources and taking into account the best interests of the wider community
CbD, mini-CEX 1,3
Promotes and encourages involvement of patients in appropriate support networks, both to receive support and to give support to others
CbD, mini-CEX 3,4
Recognises the potential impact of long term conditions on the patient, family and friends
CbD 1
Ensures equipment and devices relevant to the patient’s care are discussed
CbD, mini-CEX 1,2,3,4
Immunology Curriculum August 2010 Page 20 of 94
Puts patients in touch with the relevant agency including the voluntary sector from where they can procure the items as appropriate
CbD, mini-CEX 1,3
Provides the relevant tools and devices when possible CbD, mini-CEX 1,2
Shows willingness to facilitate access to the appropriate training and skills in order to develop the patient's confidence and competence to self care and adapt appropriately as needs change with time
CbD, mini-CEX, PS 1,3,4
Shows willingness to maintain a close working relationship with other members of the multi-disciplinary team, primary and community care
CbD, mini-CEX, MSF 3
Shows willingness to engage with expert patients and representatives of charities or networks that focus on diseases and comprehends their role in supporting patients and their families/carers
CbD, mini-CEX, MSF, PS
1,3
Recognises and respect the role of family, friends and carers in the management of the patient with a long term condition
CbD, mini-CEX, PS 1,3
Puts patients in touch with the relevant agencies including the voluntary sector from where they can procure the items as appropriate
CbD, mini-CEX, MSF, PS
1,3
1.12 Relationships with Patients and Communication within a Consultation
To recognise the need, and develop the abilities, to communicate effectively and sensitively with patients, relatives and carers
Knowledge Assessment Methods
GMP
Demonstrates how to structure a consultation appropriately CbD, mini-CEX, PS 1
States the importance of the patient's background, culture, education and preconceptions (beliefs, ideas, concerns, expectations) to the process
CbD, mini-CEX, PS 1
Skills
Establishes a rapport with the patient and any relevant others
Utilises open and closed questioning appropriately
CbD, mini-CEX, PS 1,3
Listens actively and questions sensitively to guide the patient and to clarify information
mini-CEX, PS 1,3
Identifies and manages communication barriers, tailoring language to the individual patient and others and using interpreters when indicated
CbD, mini-CEX, PS 1,3
Delivers information compassionately, being alert to and managing personal and patients emotional responses
CbD, mini-CEX 1,3,4
Uses, and refers patients to, appropriate written and other evidence based information sources
CbD, mini-CEX 1,3
Checks the patient's/carer's understanding, ensuring that all their concerns/questions have been covered
CbD, mini-CEX 1,3
Indicates when the consultation nearing its end and conclude with a summary and appropriate action plan; ask the patient to summarise back to check his/her understanding
CbD, mini-CEX 1,3
Makes accurate contemporaneous records of the discussion CbD, mini-CEX 1,3
Manages follow-up effectively and safely utilising a variety of methods CbD, mini-CEX 1
Ensures appropriate referral and communications with other healthcare professional resulting from the consultation are made accurately and in a timely manner
CbD, mini-CEX 1
Behaviours
Immunology Curriculum August 2010 Page 21 of 94
Approaches situations with courtesy, empathy, compassion and professionalism, especially by appropriate body language and endeavouring to ensure an appropriate physical environment, acting as an equal not a superior
CbD, mini-CEX, MSF, PS
1,3,4
Ensures appropriate personal language and behaviour CbD, mini-CEX, MSF, PS
1.3
Ensures that the approach is inclusive and patient centred and respects the diversity of values in patients, carers and colleagues.
CbD, mini-CEX, MSF, PS
13
Is willing to provide patients with a second opinion CbD, mini-CEX, MSF, PS
1,3
Uses different methods of ethical reasoning to come to a balanced decision where complex and conflicting issues are involved
CbD, mini-CEX, MSF 1,3
Is confident and positive in personal values CbD, mini-CEX 1,3
1.13 Breaking Bad News
To recognise the fundamental importance of breaking bad news
To use strategies for skilled delivery of bad news according to the needs of individual patients and their relatives and/or carers
Knowledge Assessment Methods
GMP
Understands that how bad news is delivered irretrievably affects the subsequent relationship with the patient
CbD, mini-CEX, MSF, PS
1
Appreciates that every patient may desire different levels of explanation and have different responses to bad news
CbD, mini-CEX, PS 1,4
Knows that although bad news is confidential the patient may wish to be accompanied
CbD, mini-CEX, PS 1
Appreciates that once the news is given, patients are unlikely to take anything subsequent in, so an early further appointment should be made
CbD, mini-CEX, PS
Appreciates that breaking bad news can be extremely stressful for the doctor or professional involved
CbD, mini-CEX 1,3
Is aware that the interview during which bad news is delivered may be an educational opportunity
CbD, mini-CEX 1
States and understands the importance of adequate preparation for breaking of bad news
CbD, mini-CEX 1,3
Knows that “bad news” may be expected or unexpected and cannot always be predicted
CbD, mini-CEX 1
Knows that sensitive communication of bad news is an essential part of professional practice
CbD, mini-CEX 1
Knows that “bad news” has different connotations depending on the context, individual, social and cultural circumstances
CbD, mini-CEX, PS 1
Understands that a post mortem examination may be required and what this involves
CbD, mini-CEX, PS 1
Is familiar with the local organ retrieval process CbD, mini-CEX 1
Skills
Demonstrates to others good practice in breaking bad news CbD, DOPS, MSF 1,3
Involves patients and carers in decisions regarding their future management
CbD, DOPS, MSF 1,3,4
Immunology Curriculum August 2010 Page 22 of 94
Comprehends the impact of the bad news on the patient, carer, supporters, staff members and self
CbD, DOPS, MSF 1,3,4
Encourages questioning and ensures comprehension CbD, DOPS, MSF 1,3
Responds to verbal and visual cues from patients and relatives CbD, DOPS, MSF 1,3
Acts with empathy, honesty and sensitivity avoiding undue optimism or pessimism
CbD, DOPS, MSF 1,3
In preparing to break bad news:
• Sets aside sufficient uninterrupted time
• Chooses an appropriate private environment and ensures that there will be no unplanned disturbances
• Has sufficient information regarding prognosis and treatment
• Ensures the individual has appropriate support if desired
• Structures the interview
• Is honest, factual, realistic and empathic
CbD, DOPS, MSF 1,3
Is aware of relevant guidance documents CbD 1
Structures the interview:
• Sets the scene
• Establishes understanding
• Discusses diagnosis, implications, treatment, prognosis and subsequent care
CbD 1,3
Behaviours
Take leadership in breaking bad news CbD, DOPS, MSF 1
Respects the different ways people react to bad news CbD, DOPS, MSF 1
Ensures appropriate recognition and management of the impact of breaking bad news on the doctor
CbD, DOPS, MSF 1
1.14 Complaints and Medical Error
To recognise causes of error and to learn from them, and to realise the importance of honesty and effective apology and to take a leadership role in the handling of complaints
Knowledge Assessment Methods
GMP
Describes the local complaints procedure CbD, MSF 1
Recognises factors likely to lead to complaints (poor communication, dishonesty, clinical errors, adverse clinical outcomes etc)
CbD, MSF 1
Outlines the principles of an effective apology CbD, MSF 1
Identifies sources of help and support for patients and doctors when a complaint is made about self or a colleague
CbD, MSF 1
Skills
Contributes to processes whereby complaints are reviewed and learned from
CbD, DOPS, MSF 1
Explains comprehensibly to the patient the events leading up to a medical error or serious untoward incident, and sources of support for patients and their relatives
CbD, DOPS, MSF 1,3
Recognises when something has gone wrong and identifies appropriate staff with whom to communicate this
CbD, DOPS, MSF 1
Immunology Curriculum August 2010 Page 23 of 94
Delivers an appropriate apology and explanation CbD, DOPS, MSF 1,3,4
Distinguishes between system and individual errors (personal and organisational)
CbD, DOPS, MSF 1
Shows ability to learn from previous errors CbD, DOPS, MSF 1
Behaviours
Takes leadership over complaint issues CbD, DOPS, MSF 1
Adopts behaviour likely to prevent causes for complaints CbD, DOPS, MSF 1,3
Deals appropriately with concerned or dissatisfied patients or relatives CbD, DOPS, MSF 1
Acts with honesty and sensitivity in a non-confrontational manner CbD, DOPS, MSF 1
Acts with honesty and sensitivity in a non-confrontational manner CbD, DOPS, MSF 1
Recognises the impact of complaints and medical error on staff, patients and the National Health Service
CbD, DOPS, MSF 1
Contributes to a fair and transparent culture around complaints and errors CbD, DOPS, MSF 1
Recognises the rights of patients, family members and carers to make a complaint
CbD, DOPS, MSF 1,4
Recognises the impact of a complaint upon self and seeks appropriate help and support
CbD, DOPS, MSF 1,4
1.15 Communication with colleagues and cooperation
To recognise and accept the responsibilities and role of the doctor in relation to other healthcare professionals
To communicate succinctly and effectively with other professionals as appropriate
Knowledge Assessment Methods
GMP
Understands the section in "Good Medical Practice" on Working with Colleagues, in particular:
CbD, MSF 1
States the roles played by all members of a multi-disciplinary team CbD, MSF 1
States the features of good team dynamics CbD, MSF 1
States the principles of effective inter-professional collaboration to optimise patient, or population, care
CbD, MSF 1
Understands the principles of confidentiality that provide boundaries to communication
CbD, MSF 1
Acts with appropriate knowledge of professional and ethical conduct in challenging situations
Cb 1
Knows techniques to manage anger and aggression in self and colleagues
CbD 1
Knows personal responsibilities when managing physical and/or mental ill health in self and colleagues
CbD 1
Skills
Communicates accurately, clearly, promptly and comprehensively with relevant colleagues by means appropriate to the urgency of a situation (telephone, email, letter etc), especially where responsibility for a patient's care is transferred
CbD, mini-CEX 1,3
Utilises the expertise of the whole multi-disciplinary team as appropriate, ensuring when delegating responsibility that appropriate supervision is
CbD, mini-CEX, MSF 1,3
Immunology Curriculum August 2010 Page 24 of 94
maintained
Communicates effectively with administrative bodies and support organisations
CbD, mini-CEX, MSF 1,3
Employs behavioural management skills with colleagues to prevent and resolve conflict and enhance collaboration
CbD, mini-CEX, MSF 1,3
Behaviours
Shows awareness of the importance of, and takes part in multi-disciplinary teamwork, including adoption of a leadership role when appropriate but also recognising where others are better equipped to lead
CbD, mini-CEX, MSF 3
Fosters a supportive and respectful environment where there is open and transparent communication between all team members
CbD, mini-CEX, MSF 1,3
Ensures appropriate confidentiality is maintained during communication with any member of the team
CbD, mini-CEX, MSF 1,3
Recognises the need for a healthy work/life balance for the entire team, but takes any personal leave only after giving appropriate notice to ensure that cover is in place
CbD, mini-CEX, MSF 1
Accepts additional duties in situations of unavoidable and unpredictable absence of colleagues ensuring that the best interests of the patient are paramount
CbD, MSF 1
1.16 Health Promotion and Public Health
To work with individuals and communities to reduce ill health, remove inequalities in healthcare provision and improve the general health of a community.
Knowledge Assessment Methods
GMP
Understands the factors which influence the incidence and prevalence of common conditions
CbD, mini-CEX 1
Understands the factors which influence health and illness – psychological, biological, social, cultural and economic especially poverty and unemployment
CbD, mini-CEX
1
Understands the influence of lifestyle on health and the factors that influence an individual to change their lifestyle
CbD, mini-CEX 1
Understands the influence of culture and beliefs on patients perceptions of health
CbD, mini-CEX 1
Understands the purpose of screening programmes and knows in outline the common programmes available within the UK
CbD, mini-CEX 1
Understands the positive and negative effects of screening on the individual
CbD, mini-CEX 1
Understands the possible positive and negative implications of health promotion activities (e.g. immunisation)
CbD, mini-CEX 1
Understands the relationship between the health of an individual and that of a community and vice versa
CbD, mini-CEX 1
Knows key local concerns about health of communities such as smoking and obesity and the potential determinants
CbD, mini-CEX 1
Understands the role of other agencies and factors including the impact of globalisation in increasing disease and in protecting and promoting health
CbD, mini-CEX 1
Demonstrates knowledge of the determinants of health worldwide and strategies to influence policy relating to health issues including the impact
CbD, mini-CEX 1
Immunology Curriculum August 2010 Page 25 of 94
of the developed world strategies on the third world
Outlines the major causes of global morbidity and mortality and effective, affordable interventions to reduce these
CbD, mini-CEX 1
Recalls the effect of addictive and self harming behaviours, especially substance misuse and gambling, on personal and community health and poverty
CbD, mini-CEX 1
Skills
Identifies opportunities to prevent ill health and disease in patients CbD, mini-CEX, PS 1,2
Identifies opportunities to promote changes in lifestyle and other actions which will positively improve health and/or disease outcomes.
CbD, mini-CEX 1,2
Identifies the interaction between mental, physical and social wellbeing in relation to health.
CbD, mini-CEX 1
Counsels patients appropriately on the benefits and risks of screening and health promotion activities
CbD, mini-CEX, PS 1,3
Identifies patient’s ideas, concerns and health beliefs regarding screening and health promotions programmes and is capable of responding appropriately
mini-CEX, CbD 1,3
Works collaboratively with other agencies to improve the health of communities
CbD, mini-CEX 1
Behaviours
Engages in effective team-working around the improvement of health CbD, MSF 1,3
Encourages where appropriate screening to facilitate early intervention CbD 1
Seeks out and utilises opportunities for health promotion and disease prevention
CbD 1
1.17 Environmental Protection and Emergency Planning
To understand the relationship of the physical environment to health
To be able to identify situations where environmental exposure may be the cause of ill health and to relate to emergency planning arrangements both in relation to environmental matters and other issues in clinical practice
Knowledge Assessment Methods
GMP
Understands in outline the mechanisms by which environmental chemicals have an impact on human health
CbD 1
Understands in outline the mechanisms by which adverse chemical exposure can be mitigated (decontamination, specific antidotes)
CbD, mini-CEX 1
Knows the potential sources of information and guidance to manage a case of chemical etc exposure. (including local, regional and national sources)
CbD 1
Understands the principles of emergency planning CbD 1
Knows in outline the emergency plan for health care organisation they currently work for and specifically knows their duties and responsibilities within the plan
CbD 1
Skills
Recognises the potential for chemical or other hazardous environmental exposure in relation to an individual patient.
CbD
1,2
Immunology Curriculum August 2010 Page 26 of 94
Manages patients in an appropriate manner according to guidance CbD, mini-CEX 1,2
Appropriately performs duties and tasks when required in accordance with Trust emergency plans
CbD
1,3
Behaviours
Actively engages in emergency planning arrangements including exercises in accordance with Trust plans
CbD, MSF 2,3
Openly considers the possibility of chemical or environmental exposure in clinical work
CbD, MSF 1,2
1.18 Principles of Medical Ethics and Confidentiality
To know, understand and apply appropriately the principles, guidance and laws regarding medical ethics and confidentiality
Knowledge Assessment Methods
GMP
Demonstrates knowledge of the principles of medical ethics CbD, mini-CEX 1
Outlines and follows the guidance given by the GMC on confidentiality CbD, mini-CEX 1
Defines the provisions of the Data Protection Act and Freedom of Information Act
CbD, mini-CEX 1
Defines the principles of Information Governance CbD, mini-CEX 1
Defines the role of the Caldicott Guardian and Information Governance lead within an institution, and outline the process of attaining Caldicott approval for audit or research
CbD, mini-CEX 1,4
Outlines situations where patient consent, while desirable, is not required for disclosure e.g. serious communicable diseases, public interest
CbD, mini-CEX 1,4
Outlines the procedures for seeking a patient’s consent for disclosure of identifiable information
CbD, mini-CEX 1
Recalls the obligations for confidentiality following a patient’s death CbD, mini-CEX 1,4
Defines the standards of practice defined by the GMC when deciding to withhold or withdraw life-prolonging treatment
CbD, mini-CEX 1
Knows the role and legal standing of advance directives CbD, mini-CEX 1
Outlines the principles of the Mental Capacity Act CbD, mini-CEX 1
Skills
Uses and shares information with the highest regard for confidentiality, and encourages such behaviour in other members of the team
CbD, mini-CEX, MSF 1,2,3
Recognises the problems posed by disclosure in the public interest, without the patient’s consent
CbD, mini-CEX, MSF 1,4
Recognises the factors influencing ethical decision making: including religion, personal and moral beliefs, cultural practices
CbD, mini-CEX, MSF 1
Uses and promotes strategies to ensure that confidentiality is maintained, for example anonymisation
CbD 1
Counsels patients on the need for information distribution within members of the immediate healthcare team
CbD, MSF 1,3
Counsels patients, family, carers and advocates tactfully and effectively when making decisions about resuscitation status, and withholding or withdrawing treatment
CbD, mini-CEX, PS 1,3
Immunology Curriculum August 2010 Page 27 of 94
Behaviours
Encourages informed ethical reflection in others CbD, MSF 1
Shows willingness to seek advice of peers, legal bodies, and the GMC in the event of ethical dilemmas over disclosure and confidentiality
CbD, mini-CEX, MSF 1
Respects patient’s requests for information not to be shared, unless this puts the patient, or others, at risk of harm
CbD, mini-CEX, PS 1,4
Shows willingness to share information about care with patients unless they have expressed a wish not to receive such information
CbD, mini-CEX 1,3
Shows willingness to seek the opinion of others when making decisions about resuscitation status, and withholding or withdrawing treatment
CbD, mini-CEX, MSF 1,3
1.19 Obtaining of Consent
To understand the necessity of obtaining valid consent from the patient, and when and how to obtain it
Knowledge Assessment Methods
GMP
Outlines the guidance given by the GMC on consent, in particular: CbD, MSF 1
Understands that consent is a process that may culminate in, but is not limited to, the completion of a consent form
CbD, MSF 1
Understands the particular importance of considering the patient's level of understanding and mental state (and also that of the parents, relatives or carers when appropriate) and how this may impair their capacity for informed consent
CbD, MSF 1
Understands the social and cultural issues that might affect consent CbD, MSF 1
Skills
Presents all information to patients (and carers) in a format they understand, checking understanding and allowing time for reflection on the decision to give consent
CbD, mini-CEX, PS 1,3
Provides a balanced view of all care options CbD, mini-CEX, PS 1,3,4
Behaviours
Respects a patient’s rights of autonomy even in situations where their decision might put them at risk of harm
CbD, mini-CEX, PS 1
Keeps within the scope of authority given by a competent patient CbD, mini-CEX, PS 1
Provides all information relevant to proposed care or treatment in a competent patient
CbD, mini-CEX 1,3,4
Seeks consent for procedures within own capabilities
Shows willingness to seek advance directives
CbD, mini-CEX 1,3
Shows willingness to obtain a second opinion, senior opinion, and legal advice in difficult situations of consent or capacity
CbD, mini-CEX, MSF 1,3
Informs patients and seeks alternative care where personal, moral or religious belief prevents a usual professional action
CbD, mini-CEX, PS 1,3,4
Immunology Curriculum August 2010 Page 28 of 94
1.20 Legal Framework for Practice
To understand the legal framework within which healthcare is provided in the UK and/or devolved administrations in order to ensure that personal clinical practice is always provided in line with this legal framework.
Knowledge Assessment Methods
GMP
Knows that all decisions and actions must be in the best interests of the patient
CbD, mini-CEX 1
Understands the legislative framework within which healthcare is provided in the UK and/or devolved administrations – in particular death certification and the role of the Coroner/Procurator Fiscal; child protection legislation; mental health legislation (including powers to detain a patient and giving emergency treatment against a patient’s will under common law); advanced directives and living Wills; withdrawing and withholding treatment; decisions regarding resuscitation of patients; surrogate decision making; organ donation and retention; communicable disease notification; medical risk and driving; Data Protection and Freedom of Information Acts; provision of continuing care and community nursing care by a local authorities.
CbD, mini-CEX 1,2
Is familiar with disability and other equality legislation CbD, mini-CEX 1,2
Understands the differences between health related legislation in the four countries of the UK
CbD 1
States sources of medical legal information CbD, mini-CEX 1
Understands disciplinary processes in relation to medical malpractice CbD, mini-CEX, MSF 1
Understands the role of the medical practitioner in relation to personal health and substance misuse, including understanding the procedure to be followed when such abuse is suspected
CbD, mini-CEX, MSF 1
Skills
Cooperates with other agencies with regard to legal requirements – including reporting to the Coroner’s/Procurator Officer, the Police or the proper officer of the local authority in relevant circumstances
CbD, mini-CEX 1
Prepares appropriate medical legal statements for submission to the Coroner’s Court, Procurator Fiscal, Fatal Accident Inquiry and other legal proceedings and be prepared to present such material in court
CbD, MSF 1
Incorporates legal principles into day to day practice CbD, mini-CEX 1
Practices and promotes accurate documentation within clinical practice CbD, mini-CEX 1,3
Behaviour
Shows willingness to seek advice from employer, appropriate legal bodies (including defence societies), and the GMC on medico-legal matters
CbD, mini-CEX, MSF 1, 3
Promotes informed reflection on legal issues by members of the team CbD, mini-CEX, MSF 1,3
Demonstrates that all decisions and actions must be in the best interests of the patient
CbD, mini-CEX, MSF 1,3
Immunology Curriculum August 2010 Page 29 of 94
1.21 Ethical Research
To be equipped to ensure that research is undertaken using relevant ethical guidelines.
Knowledge Assessment Methods
GMP
Outlines the GMC guidance on good practice in research CbD 1
Knows about local and national research guidelines CbD 1
Knows the principles of research governance
Outlines the differences between audit and research
AA, CbD, mini-CEX 1
Describes how clinical guidelines are produced CbD 1
Demonstrates a knowledge of research principles CbD, mini-CEX 1
Outlines the principles of formulating a research question and designing a project
CbD, mini-CEX 1
Comprehends the principal qualitative, quantitative, bio-statistical and epidemiological research methods
CbD 1
Outlines sources of research funding CbD 1
Skills
Uses critical appraisal skills and applies these when reading literature CbD 1
Demonstrates the ability to write a scientific paper CbD 1
Applies for appropriate ethical research approval CbD 1
Demonstrates the use of literature databases CbD 1
Demonstrates good verbal and written presentations skills CbD, DOPS 1
Understands the difference between population-based assessment and unit-based studies and be able to evaluate outcomes for epidemiological work
CbD 1
Behaviour
Follows guidelines on ethical conduct in research and consent for research
CbD 1
Shows willingness to encourage and take part in research CbD 1
1.22 Evidence and Guidelines
To learn to make the optimal use of current best evidence in making decisions about the care of patients.
To develop the ability to construct evidence based guidelines and protocols in relation to medical practise
Knowledge Assessment Methods
GMP
Outlines the principles of critical appraisal CbD 1
Knows the advantages and disadvantages of different study methodologies (quantitative and qualitative) for different types of questions
CbD 1
Outlines levels of evidence and quality of evidence CbD 1
Knows how to apply statistics in scientific medical practice CbD 1
Understands the use and differences between the basic measures of risk CbD 1
Immunology Curriculum August 2010 Page 30 of 94
and uncertainty
Describes the role and limitations of evidence in the development of clinical guidelines and protocols
CbD 1
Understands the processes that result in nationally applicable guidelines (eg NICE and SIGN)
CbD 1
Skills
Searches medical literature with relevant tools including PubMed, Medline, Cochrane reviews and the internet
CbD 1
Appraises retrieved evidence to address a clinical question CbD 1
Applies conclusions from critical appraisal into clinical care CbD 1
Contributes to the construction, review and updating of local (and national) guidelines of good practice using the principles of evidence based medicine
CbD 1
Behaviours
Aims for best clinical practice (clinical effectiveness) at all times, as informed by evidence based medicine
CbD, mini-CEX 1
Recognises knowledge gaps and keeps a logbook of clinical questions CbD, mini-CEX 1
Keeps up to date with national reviews, key new relevant research, and guidelines of practice (e.g. NICE and SIGN)
CbD 1
Recognises the common need to practise outside clinical guidelines CbD, mini-CEX 1
Communicates risk information, and risk-benefit trade-offs in ways appropriate for individual patients
CbD, mini-CEX
Encourage discussion amongst colleagues on evidence-based practice CbD, mini-CEX, MSF 1
1.23 Audit
To learn how to audit clinical practice and to apply the findings appropriately to complete the audit cycle.
Knowledge Assessment Methods
GMP
Understands the different methods of obtaining data for audit including patient feedback questionnaires, hospital sources and national reference data
AA, CbD 1
Understands the role of audit (improving patient care and services, risk management etc)
AA, CbD 1
Understands the steps involved in completing the audit cycle AA, CbD 1
Describes the working and uses of national and local databases used for audit such as specialty data collection systems, cancer registries etc. and for reporting and learning from clinical incidents and near misses in the UK
AA, CbD 1
Skills
Designs, implements and completes audit cycles AA, CbD 1,2
Contributes to local and national audit projects as appropriate (e.g. NCEPOD, SASM)
AA, CbD 1,2
Supports audit by junior medical trainees and within the multi-disciplinary team
AA, CbD 1,2
Behaviours
Immunology Curriculum August 2010 Page 31 of 94
Recognises the need for audit in clinical practice to promote standard setting and quality assurance
AA, CbD 1,2
1.24 Teaching and Training
To teach a variety of different audiences in a variety of different ways.
To assess the quality of the teaching.
To plan and deliver a training programme with appropriate assessments.
To supervise, teach and mentor learners (trainees) in a work setting.
Knowledge Assessment Methods
GMP
Describes relevant educational theories and principles
Outlines adult learning principles relevant to medical education:
CbD 1
Demonstrates knowledge of relevant literature relevant to developments and challenges in medical education and other sectors
CbD 1
Outlines the structure of an effective appraisal interview CbD 1
Defines the roles to the various bodies involved in medical education and other sectors
Recalls learning methods and effective learning objectives and outcomes
Describes the differences between learning objectives and outcomes
CbD 1
Differentiates between appraisal and assessment and performance review and aware of the need for both
Differentiates between formative and summative assessment and define their role in medical education
Outlines the structure of the effective appraisal review
CbD 1
Outlines the role of workplace-based assessments, the assessment tools in use, their relationship to course learning outcomes, the factors that influence their selection and the need for monitoring evaluation
CbD 1
Outlines the appropriate local course of action to assist a trainee experiencing difficulty in making progress within their training programme
CbD 1
Skills
Critically evaluates relevant educational literature
Varies teaching formats and stimuli, appropriate to the situation and the audience
CbD 1
Provides effective and appropriate feedback after teaching, and promotes learner reflection
CbD, MSF, TO 1
Conducts developmental conversations as appropriate eg: appraisal, supervision, mentoring
CbD, MSF 1
Demonstrates effective lecture, presentation, small group and bed side teaching sessions
CbD, MSF 1,3
Provides appropriate career support, or refers trainee to an alternative effective source of career information
CbD, MSF, TO 1,3
Participates in strategies aimed at improving patient education e.g. talking at support group meetings
CbD, MSF 1
Leads departmental teaching programmes including journal clubs CbD, TO 1
Recognises the trainee in difficulty and take appropriate action including where relevant referral to other services
CbD, TO 1
Immunology Curriculum August 2010 Page 32 of 94
Is able to identify and plan learning activities in the workplace CbD 1
Contributes to educational research or projects eg: through the development of research ideas of data/information gathering. Is able to manage personal time and resources effectively to the benefit of the educational faculty and the need of the learners
CbD, TO 1
Factors in safeguards to protect the patient when teaching and training is being conducted using patients
CbD 1
Behaviour
Maintains the dignity and safety of patients at all times in discharging educational duties
CbD, MSF 1,4
Recognises the importance of the role of the physician as an educator within the multi-professional healthcare team and uses medical education to enhance the care of patients
CbD, MSF 1
Balances the needs of service delivery with education CbD, MSF 1
Demonstrates willingness to teach trainees and other health and social workers in a variety of settings to maximise effective communication and practical skills and to improve patient care
CbD, MSF 1
Demonstrates consideration for learners including their emotional, physical and psychological well being with their development needs. Acts to endure equality of opportunity for students, trainees, staff and professional colleagues
CbD, MSF 1
Encourages discussions with colleagues in clinical settings to colleagues to share knowledge and understanding
CbD, MSF, TO 1,3
Maintains honesty and objectivity during appraisal and assessment CbD, MSF 1
Shows willingness to participate in workplace-based assessments and demonstrates a clear understanding of their purpose
CbD, MSF 1
Shows willingness to take up formal training as a trainer and respond to feedback obtained after teaching sessions
CbD, MSF, TO 1,3
Demonstrates willingness to become involved in the wider medical education activities and fosters an enthusiasm for medical education activity in others
CbD, MSF, TO 1
Recognises the importance of personal development as a role model to guide trainees in aspects of good professional behaviour
CbD, MSF, TO 1
Demonstrates willingness to advance own educational capability through continuous learning
CbD, MSF 1
Acts to enhance and improve educational provision through evaluation of own practice
CbD, MSF 1
Contributes to educational policy and development at local or national levels
CbD, MSF 1
Immunology Curriculum August 2010 Page 33 of 94
1.25 Personal Behaviour
To acquire and nurture behaviours that will enable the trainee to become a senior leader able to deal with complex situations and difficult behaviours and attitudes
To learn how to work increasingly effectively with many teams to put the quality and safety of patient care as a prime objective
To demonstrate the attributes of someone who is trusted to be able to manage complex human, legal and ethical problems
To strive to be someone who is trusted and known to act fairly in all situations
Knowledge Assessment Methods
GMP
Recalls and build upon the competences defined in the Foundation Programme Curriculum
CbD, mini-CEX 1,2,3,4
Outlines the main methods of ethical reasoning: casuistry, ontology and consequential
CbD, mini-CEX 1,2,3,4
Is familiar with the overall approach of value based practice and how this relates to ethics, law and decision-making
CbD, mini-CEX 1,2,3,4
Defines the concept of modern medical professionalism CbD 1
Outlines the relevance of professional bodies (Royal Colleges, NHSMEE , GMC, Postgraduate Dean, BMA, specialist societies, medical defence societies etc)
CbD 1
Skills
Practises with professionalism including:
• Integrity
• Compassion
• Altruism
• A view to continuous improvement
• Aspiration to excellence
• Respect of cultural and ethnic diversity
• Regard to the principles of equity
CbD, mini-CEX, MSF, PS
1,2,3,4
Works in partnership with patients and members of the wider healthcare team
CbD, mini-CEX, MSF 3
Liaises with colleagues to plan and implement work rotas MSF 3
Promotes awareness of the doctor’s role in utilising healthcare resources optimally and within defined resource constraints
CbD, mini-CEX, MSF 1,3
Recognises and responds appropriately to unprofessional behaviour in others
CbD 1
Provides specialist support to hospital and community based services if appropriate and permitted
CbD, MSF 1
Handles enquiries from the press and other media effectively CbD, DOPS 1,3
Behaviour
Recognises personal beliefs and biases and understands their impact on the delivery of health services
CbD, mini-CEX, MSF 1
Appropriately refers patients where personal beliefs and biases could impact upon professional practice
Uses all healthcare resources prudently and appropriately CbD, mini-CEX 1,2
Immunology Curriculum August 2010 Page 34 of 94
Improves clinical leadership and management skill CbD, mini-CEX 1
Recognises situations when it is appropriate to involve professional and regulatory bodies
CbD, mini-CEX 1
Acts as a leader, mentor, educator and role model CbD, mini-CEX, MSF 1
Reviews competences defined in the Foundation programme:
• Deals with inappropriate patient and family behaviour
• Respects the rights of children, elderly, people with physical, mental, learning or communication difficulties
• Adopts an approach to eliminate discrimination against patients from diverse backgrounds including age, gender, race, culture, disability, spirituality and sexuality
• Places needs of patients above own convenience
• Behaves with honesty and probity
• Acts with honesty and sensitivity in a non-confrontational manner
CbD, mini-CEX 1
Accepts mentoring as a positive contribution to promote personal professional development
Participates in professional regulation and professional development
CbD, mini-CEX, MSF 1
Takes part in 360 degree feedback as part of appraisal CbD, MSF 1,2,4
Promotes the right for equity of access to healthcare CbD, mini-CEX 1
Demonstrates reliability and accessibility throughout the healthcare team CbD, mini-CEX, MSF 1
1.26 Management and NHS Structure
Understand the structure of the NHS and the management of local healthcare systems in order to be able to participate fully in managing healthcare provision
Knowledge Assessment
Methods
GMP
Understands the guidance given on management and doctors by the GMC
CbD 1
Understands the local structure of NHS systems recognising the potential differences between the four countries of the UK
CbD 1
Recalls the range of agencies that can provide care and support in and out of hospital, and how they can be accessed
CbD 1
Understands the structure and function of healthcare systems as they apply to your specialty
CbD 1
Understands the consistent debates and changes that occur in the NHS including the political, social, technical, economic, organisational and professional aspects that can impact on provision of service
CbD 1
Understands the importance of local demographic, socio-economic and health data and the use to improve system performance
CbD 1
Understands the principles of:
• Clinical coding
• European Working Time Regulations including rest provisions
• National Service Frameworks
• Health regulatory agencies (e.g., NICE, Scottish Government)
• NHS Structure and relationships
• NHS finance and budgeting
CbD, mini-CEX 1
Immunology Curriculum August 2010 Page 35 of 94
• Consultant contract and the contracting process
• Resource allocation
• The role of the Independent sector as providers of healthcare
• Patient and public involvement processes and role
Understands the principles of recruitment and appointment procedures CbD 1
Skills
Participates in managerial meetings CbD 1
Works with stakeholders to create and sustain a patient-centred service CbD, mini-CEX 1
Employs new technologies appropriately, including information technology CbD, mini-CEX 1
Conducts an assessment of the community needs for specific health improvement measures
CbD, mini-CEX 1
Behaviour
Recognises the importance of equitable allocation of healthcare resources and of commissioning
CbD 1,2
Recognises the role of doctors as active participants in healthcare systems
CbD, mini-CEX 1,2
Responds appropriately to health service objectives and targets and take part in the development of services
CbD, mini-CEX 1,2
Recognises the role of patients and carers as active participants in healthcare systems and service planning
CbD, mini-CEX, PS 1,2,3
Takes an active role in promoting the best use of healthcare resources CbD 1
Shows willingness to improve leadership and managerial skills (e.g. management courses) and engage in leadership and management of the service
CbD, MSF 1
Immunology Curriculum August 2010 Page 36 of 94
2. Medical Leadership and Management The Medical Leadership Competency Framework, developed by the Academy of Medical Royal Colleges and the NHS Institute for Innovation and Improvement, has informed the inclusion of leadership competencies in this curriculum. The Framework identified possible assessment methods, but in reviewing these we identified a need for more specific methods. JRCPTB and the RCP Education Department has established a working group to develop and evaluate leadership assessment methods. These may include variants of CbD and ACAT, as well as the Case Conference Assessment Tool currently being piloted.
2.1 Personal Qualities
To identify personal strengths, limitations and the impact of personal behaviour and to be able to change this in the light of feedback and reflection
Knowledge
Assessment Methods
GMP
Demonstrates different methods of obtaining feedback CbD, MSF 1
Demonstrates awareness of personal values and principles and how these may differ from those of other individuals and groups
1,3,4
Realises the importance of best practice transparency and consistency 1
Skills
Maintains and routinely practices critical self awareness, including being able to discuss strengths and weaknesses with supervisor and recognising external influences and changing behaviour accordingly
1
Uses assessment, appraisal, complaints and other feedback to discuss and develop an understanding of personal development needs
1.3
Identifies personal strengths and weaknesses MSF 1,3
Organises and manages workload effectively and flexibly CbD, MSF 1,3
Behaviours
Recognising and showing respect for diversity and differences in others 1
Shows commitment to continuing professional development which involves seeking training and self development opportunities, learning from colleagues and accepting criticism
1,3
Demonstrate self management: organising and managing themselves while taking account of the needs and priorities of others.
CbD, PS 3
2.2 Working with Others
To adopt a team approach, acknowledging and appreciating efforts, contributions and compromises. To continue to recognise the common purpose of the team and respect the decisions of its members
Knowledge
Assessment Methods
GMP
Demonstrates a wide range of leadership styles and approaches and the applicability to different situations and people
MSF 1
Skills
Enables individuals, groups and agencies to implement plans and make decisions
1,3
Assesses and appraises of more junior clinical colleagues or students 1,3
Immunology Curriculum August 2010 Page 37 of 94
Builds and maintains relationships by listening, supporting others, gaining trust and showing understanding
MSF 3
Shows willingness to act as a leader, mentor, educator and role model 3
Behaviours
Shows recognition of a team approach, respecting colleagues, including non-medical professionals
1,3
2.3 Managing Services
To support team members to develop their roles and responsibilities and continue to review performance of team members to ensure that planned service outcomes are met
Knowledge
Assessment Methods
GMP
Demonstrates knowledge of relevant legislation and HR policies 1
Shows knowledge of the duties, rights and responsibilities of an employer and co-worker
1
Demonstrates knowledge of individual performance review 1
Comprehends the roles, competences and capabilities of other professionals and support workers
1,3,4
States the role of audit (improving patient care and services, risk management etc).
1
States the steps involved in completing the audit cycle 1
Skills
Continues to contribute towards staff development and training, including mentoring, supervision and appraisal
1,3
Is able to write a job description, including person specification and short listing criteria
1
Contributes to the development of an organisational response to emerging health policy.
1
Behaviours
Commitment to good communication whilst also inspiring confidence and trust
1,3
Managing resources: knowing what resources are available and using influence to ensure that resources are used efficiently and safely
1
Managing people: providing direction, reviewing performance and motivating others
1,3
Managing performance: holding self and others accountable for service outcomes.
1,3
Immunology Curriculum August 2010 Page 38 of 94
2.4 Improving Services
To ensure patient safety at all times, continue to encourage innovation and facilitate transformation
Knowledge
Assessment Methods
GMP
Demonstrates knowledge of risk management issues and risk management tools
1,2
Demonstrates understanding of how healthcare governance influences patient care
1
Demonstrates knowledge of a variety of methodologies for developing creative solutions to improving services
1,2
Recalls principles of risk assessment and management 1,2
Identifies risk management guidance such as safe prescribing, sharps disposal, needle stick injury
1,2
Skills
Reports clinical incidents . 1,2
Assesses and manages risk to patients 2
Monitors the quality of equipment and safety of the environment relevant to the specialty
1,2
Ensures the correct and safe use of medical equipment, ensuring faulty equipment is reported appropriately
2
Questions existing practice in order to improve the services 1,2
Behaviours
Seeks advice and or assistance whenever concerned about patient safety 1,2,3
Supports colleagues to voice new ideas and is open minded to new thoughts
1,3
2.5 Setting Direction
To be able to identify contexts for change and make decisions
Knowledge
Assessment Methods
GMP
Demonstrates knowledge of the functions and responsibilities of national bodies, College and faculties, representatives, regulatory bodies
1
Demonstrates effective communication strategies within organisations 1
Skills
The ability to discuss the local, national and UK health priorities and how they impact on the delivery of health care relevant to the specialty
. 1
Is able to run committee meetings and work collegiately and collaboratively with a wide range of people outside the immediate clinical setting
1,3
Behaviours
Willingness to articulate strategic ideas and use effective influencing skills 1,3
Willingness to participate in decision making processes beyond the immediate clinical care setting
1,3
Immunology Curriculum August 2010 Page 39 of 94
Applies knowledge and evidence to construct an evidence-based challenge to systems and processes in order to identify opportunities for service improvements
1
Makes decisions: integrates values with evidence to inform decisions 1,3
Immunology Curriculum August 2010 Page 40 of 94
3. Content of learning
3.1 Fundamental Immunology
The trainee will acquire a sound knowledge of Fundamental Immunology required to underpin clinical and laboratory practice
Knowledge
Assessment Methods
GMP
Core body of knowledge in fundamental immunology:
• Cells of the immune system
• Cytokines,chemokines and other inflammatory mediators including lipid mediators
• Phagocytic cells and their function
• Antibody mediated immunity
• Complement system
• Cell-mediated immunity
• Innate immunity
• Regulation of the immune system
• Hypersensitivity mechanisms
• Pathogenesis of immunodeficiency
• Pathogenesis of allergic diseases
• Immunological tolerance and the pathogenesis of autoimmunity
• Immunobiology of transplant rejection and its prevention
• Classification and biology of malignancies of the lymphoid system
• Scientific basis of allergen immunotherapy
• Scientific basis of immunoprophylaxis
• Scientific basis of therapy for primary immunodeficiency
• Scientific basis of immunosuppressive and immunomodulatory therapy
• New developments in therapy of immunodeficiency
FRCPath, CbD 1
Skills
Ability to integrate knowledge of fundamental immunology to understand the patho-physiology, including the genetic and molecular basis of (a) immunodeficiency diseases, (b) autoimmune / rheumatic disease and systemic vasculitides, (c) allergic disease
FRCPath, CbD 1
Behaviours
Recognise vital importance of fundamental immunology to practice as a clinical immunologist
FRCPath 1
Immunology Curriculum August 2010 Page 41 of 94
3.2 Primary and Secondary Immunodeficiency Diseases
The trainee will acquire and be able to apply a comprehensive body of knowledge relating to the clinical presentation, investigation and management of patients with primary and secondary immunodeficiency diseases
Knowledge
Assessment Methods
GMP
The skills and knowledge required to:
assess and manage patients with congenital and acquired immunodeficiency – including antibody and cell mediated defects, complement deficiency, C1 inhibitor deficiency and neutrophil defects, at a consultant level.(Use report of IUIS Scientific Committee : Bonilla FA,Geha RS.Update on primary immunodeficiency diseases.J Allergy Clin Immunol 2006;117:S 435-441)
FRCPath, CbD 1,2,3
Skills
Eliciting a relevant focused history in the context of immunodeficiency to guide clinical examination and formulation of differential diagnoses.
Mini-CEX, CbD 1
Physical examination – to perform a targeted and relevant clinical examination and link findings to the history to establish diagnosis(es) and formulate a management plan.
Mini-CEX, CbD 1
Selection of appropriate laboratory and ancillary investigations FRCPath, CbD, Mini-CEX
1,3
Formulating differential diagnoses FRCPath, CbD, Mini-CEX
1
Decision making and Clinical Reasoning – develops the ability to formulate a diagnostic and therapeutic plan based on integration of laboratory results and current guidelines on management of immunodeficiency.
FRCPath, CbD 1
Therapeutic Interventions – to prescribe, review and monitor therapeutic interventions relevant to the management of immunodeficiencies.
FRCPath, CbD, Mini-CEX
1,2
Understand putative mechanisms of action of various immunological therapies including immunoprophylaxis
FRCPath, CbD 1
Have a working knowledge of the evidence base for the use of various immunological therapies including immunoprophylaxis
FRCPath, CbD 1
Be able to explain the indications for the use of these therapies including immunoprophylaxis
FRCPath, CbD 1
Be able to explain adverse effects associated with individual therapies and immunoprophylaxis
FRCPath, CbD 1
Behaviours
Recognise importance of understanding immunopathogenesis to devise therapeutic options in these disorders
FRCPath, CbD 1,2
Recognise importance of understanding genetic basis of immunodeficiencies and the importance of genetic counselling in disease prevention
FRCPath, CbD 1,3
As the primary physician for patients with immunodeficiencies, recognise importance of patient and service advocacy in leading and developing clinical and laboratory services for this group of patients.
FRCPath 1,3
Recognise importance of obtaining valid consent from the patient for treatment with immunoglobulin and therapeutic monoclonal antibodies
CbD, DOPS 1,2,3
Immunology Curriculum August 2010 Page 42 of 94
Recognise importance of making optimal use of current best evidence in making decisions about immunoglobulin replacement and treatment with therapeutic monoclonal antibodies
CbD 1,2
Recognise the need for audit of clinical practice in immunodeficiency to promote standard setting and quality assurance
AA, CbD 1,2
3.3 Systemic Autoimmune Rheumatic Disease and Systemic Vasculitides
The trainee will acquire and be able to apply a comprehensive body of knowledge relating to the clinical presentation, investigation and management of patients with systemic autoimmune rheumatic disease and systemic vasculitides
Knowledge
Assessment Methods
GMP
Core body of knowledge required to recognise, investigate and manage patients (in liaison with rheumatologists or relevant organ-based specialist) with systemic lupus erythematosus, scleroderma, inflammatory myositis, Wegener’s granulomatosis, microscopic polyangiitis, cryoglobulinaemic vasculitis, giant cell arteritis, Takayasu’s arteritis, polyarteritis nodosa and Henoch-Schonlein purpura and auto-inflammatory syndromes
FRCPath, CbD 1,3
Evidence –base for the various therapeutic options (conventional immunosuppressive agents, biologics) available to treat these patients
FRCPath, CbD 1,2
Skills
History taking - eliciting a relevant focused history in the context of suspected systemic autoimmune rheumatic disease and systemic vasculitides to guide clinical examination and formulation of differential diagnoses
FRCPath, CbD, Mini-CEX
1
Physical examination - to perform a targeted and relevant clinical examination and link findings to the history to establish diagnosis(es) and formulate a management plan.
FRCPath, CbD, Mini-CEX
1
Selection of appropriate laboratory and ancillary investigations FRCPath, CbD, Mini-CEX
1,3
Formulating differential diagnoses FRCPath, CbD, Mini-CEX
1
Decision making and Clinical Reasoning – develops the ability to formulate a diagnostic and therapeutic plan based on integration of laboratory results and current guidelines on management of systemic autoimmune rheumatic disease and systemic vasculitides
FRCPath, CbD 1
Ability to apply knowledge of therapeutic options to select the most appropriate treatment for an individual patient
FRCPath, CbD 1
Behaviours
Recognise importance of understanding immunopathogenesis to devise therapeutic options in these disorders
FRCPath, CbD 1
Recognise importance of service leadership in providing a diagnostic immunology laboratory service for patients with autoimmune diseases
FRCPath 1,3
Recognise importance of obtaining valid consent from the patient for treatment with immunosuppressive therapy and therapeutic monoclonal antibodies
CbD, DOPS 1,2,3
Recognise importance of making optimal use of current best evidence in making decisions about immunosuppressive therapy and treatment with therapeutic monoclonal antibodies
CbD 1,2
Immunology Curriculum August 2010 Page 43 of 94
Appreciate need for close monitoring of patients to prevent/minimise adverse effects of therapy
FRCPath, CbD 1,2
Recognise the need for audit of clinical practice in autoimmune rheumatic diseases and systemic vasculitides to promote standard setting and quality assurance
AA, CbD 1,2
3.4 Allergic Diseases
The trainee will acquire and be able to apply a comprehensive body of knowledge relating to the clinical presentation, investigation and management of patients with allergic diseases of all degrees of severity
Knowledge
Assessment Methods
GMP
Core body of knowledge required to recognise, investigate and manage patients with allergic diseases of all degrees of severity including food and aero allergy, insect venom allergy, drug allergy, anaesthetic allergy, latex allergy, anaphylaxis, anaphylactoid reactions, urticaria, non-hereditary angioedema, mastocytosis
FRCPath, CbD 1
Evidence –base for the various therapeutic options to treat these patients, including anti-histamines, steroids and allergen-immunotherapy (desensitization therapy)
FRCPath, CbD 1,2
Skills
History taking - eliciting a relevant focused history in the context of suspected allergic disease to guide clinical examination and formulation of differential diagnoses
FRCPath, CbD, Mini-CEX
1,3
Physical examination - to perform a targeted and relevant clinical examination and link findings to the history to establish diagnosis(es) and formulate a management plan.
FRCPath, CbD, Mini-CEX
1
Selection of appropriate laboratory and ancillary investigations FRCPath, CbD, Mini-CEX
1,3
Skin testing FRCPath, CbD, Mini-CEX
1,3
Allergen immunotherapy FRCPath, CbD, DOPS, Mini-CEX
1,3
Challenge testing FRCPath, CbD, DOPS, Mini-CEX
Self-injectable adrenaline training FRCPath, CbD, DOPS, Mini-CEX
1,3
Formulating differential diagnoses FRCPath, CbD, Mini-CEX
1
Ability to apply knowledge of therapeutic options to select the most appropriate treatment for an individual patient
FRCPath, CbD 1
Decision making and Clinical Reasoning – develops the ability to formulate a diagnostic and therapeutic plan based on integration of laboratory results and current guidelines on management of allergic diseases.
FRCPath, CbD 1
Behaviours
Recognise importance of understanding immunopathogenesis to devise therapeutic options in these disorders
FRCPath, CbD 1
Recognise importance of obtaining valid consent from the patient for CbD, DOPS 1,2,3
Immunology Curriculum August 2010 Page 44 of 94
desensitisation immunotherapy
Appreciate need for close monitoring of patients to prevent/minimise adverse effects of therapy
FRCPath, CbD 1,2
Recognise importance of making optimal use of current best evidence in making decisions about desensitisation immunotherapy,immunosuppressive therapy and treatment with therapeutic monoclonal antibodies
CbD 1,2
Recognise importance of service leadership in providing a diagnostic immunology service for patients with allergic diseases
FRCPath 1
Recognise the need for audit of clinical practice in allergy to promote standard setting and quality assurance
AA, CbD 1,2
3.5 Laboratory Immunology
The trainee will acquire and be able to apply a solid foundation of knowledge required to direct a diagnostic immunology laboratory at Consultant Level
Knowledge
Assessment Methods
GMP
The skills and knowledge essential for directing a diagnostic immunology laboratory at Consultant level
FRCPath 1,3
A sound knowledge of the principles of laboratory testing in diagnostic immunology
FRCPath 1
Be able to perform certain designated laboratory tests without supervision DOPS 1
Be able to select, interpret and provide clinical advice based on laboratory investigations as set out in the Laboratory Training Manual, relevant to the diagnosis, assessment and monitoring of patients with suspected immunodeficiency, allergy or autoimmunity.
FRCPath, CbD 1
Be fully conversant with the diagnostic utility and limitations of laboratory tests e.g. sensitivity, specificity, predictive values
FRCPath, CbD 1,2
Trainees will be able to explain the concept of Quality Assurance and Quality Control and apply these in practice as detailed in the Laboratory Manual and Training Record.
FRCPath 1,2
Skills
These are detailed in the laboratory manual and training record FRCPath, DOPS 1,2,3
Behaviours
Establishes close rapport and understanding with laboratory staff, users of the laboratory service and service managers
MSF 3
Appreciates integral importance of teamwork in running a diagnostic laboratory service
MSF 3
Recognise importance of service leadership in providing a diagnostic immunology laboratory service for patients with autoimmune disease, immunodeficiency and allergy.
FRCPath 2,3
Recognise the need for audit of laboratory practice in immunology to promote standard setting and quality assurance
AA, CbD 1,2
Immunology Curriculum August 2010 Page 45 of 94
4 Learning and Teaching
4.1 The Training Programme
The organisation and delivery of postgraduate training is the statutory responsibility of the General Medical Council (GMC) which devolves responsibility for the local organisation and delivery of training to the deaneries. Each deanery oversees a “School of Medicine” which is comprised of the regional Specialty Training Committees (STCs) in each medical specialty. Responsibility for the organisation and delivery of specialty training in Immunology in each deanery is, therefore, the remit of the regional Immunology STC. Each STC has a Training Programme Director who coordinates the training programme in the specialty. Immunological diseases may have both adult and paediatric presentations. Collaborative training with paediatricians, particularly in relation to immunodeficiency will be undertaken. This will include a dedicated period of secondment to a recognised paediatric immunology centre where in-depth experience in the assessment and management of immunodeficient children will be obtained. The assessment and management of children with suspected severe combined immunodeficiency (SCID) will form an important component of this period of secondment. This will allow the trainee to develop the required skills essential for liaising with paediatric colleagues. The training programme is structured to deliver a solid grounding in fundamental immunology in ST3 and ST4 years whilst simultaneously enabling trainees to acquire Level 1 competencies in clinical and laboratory immunology. As trainees progress through ST5 and ST6, they will broaden their experience and understanding of applied clinical and diagnostic laboratory immunology, culminating with the completion of the FRCPath examination in immunology prior to completion of training at the end of ST7. In addition to paediatric immunology, it is recognised that trainees will require a period of secondment to other regional or national centres (typically 2-3 months) for acquisition of experience in those subject areas which may not be available in the local training programme e.g drug allergy, desensitisation immunotherapy. The sequence of training should ensure appropriate progression in experience and responsibility. The training to be provided at each training site is defined to ensure that, during the programme, the entire curriculum is covered and also that unnecessary duplication and educationally unrewarding experiences are avoided. However, the sequence of training should ideally be flexible enough to allow the trainee to develop a special interest.
4.2 Teaching and Learning Methods
The curriculum will be delivered through a variety of learning experiences. Trainees will learn from practice, clinical skills appropriate to their level of training and to their attachment within the department. Trainees will achieve the competencies described in the curriculum through a variety of learning methods. There will be a balance of different modes of learning from formal teaching programmes to experiential learning ‘on the job’. The proportion of time allocated to different learning methods may vary depending on the nature of the attachment within a rotation.
Immunology Curriculum August 2010 Page 46 of 94
This section identifies the types of situations in which a trainee will learn. Learning with Peers - There are many opportunities for trainees to learn with their peers. Local postgraduate teaching opportunities allow trainees of varied levels of experience to come together for small group sessions. Examination preparation encourages the formation of self-help groups and learning sets. Work-based Experiential Learning - The content of work-based experiential learning is decided by the local faculty for education but includes active participation in:
• Immunology and Allergy clinics, including immunoglobulin infusion and desensitisation immunotherapy. After initial induction, trainees will review patients in outpatient clinics, under direct supervision. The degree of responsibility taken by the trainee will increase as competency increases. As experience and clinical competence increase trainees will assess ‘new’ and ‘review’ patients and present their findings to their clinical supervisor
• Depending on the stage of training, trainees will actively participate in connective tissue disease clinics
• Assessment of in-patients referred for immunological or allergy opinions. Every patient seen, on the ward or in out-patients, provides a learning opportunity, which will be enhanced by following the patient through the course of their illness: the experience of the evolution of patients’ problems over time is a critical part both of the diagnostic process as well as management. Patients seen should provide the basis for critical reading and reflection of clinical problems
• Consultant-led ward rounds. Every time a trainee observes another doctor, consultant or fellow trainee, seeing a patient or their relatives there is an opportunity for learning. Ward rounds should be led by a consultant and include feedback on clinical and decision-making skills
• Multi-disciplinary team meetings. There are many situations where clinical problems are discussed with clinicians in other disciplines. These provide excellent opportunities for observation of clinical reasoning
• Laboratory-based learning – trainees will undertake a range of immunological techniques as required by the curriculum, initially under supervision to be followed by independent performance when fully competent
• Management of common laboratory issues including assessment of new diagnostic tests, audit, troubleshooting and evaluation of data relating to quality assurance
Formal Postgraduate Teaching – The content of these sessions are determined by the local faculty of medical education and will be based on the curriculum. There are many opportunities throughout the year for formal teaching in the local postgraduate teaching sessions and at regional, national and international meetings. Many of these are organised by the Royal Colleges of Physicians, the Royal College of Pathologists, the Association of Clinical Pathologists, the British Society for Immunology and the British Society for Allergy and Clinical Immunology. Suggested activities include:
• A programme of formal bleep-free regular teaching sessions to cohorts of trainees (e.g. a weekly core training hour of teaching within a Trust)
• Case presentations
• Journal clubs
• Research and audit projects
• Lectures and small group teaching
Immunology Curriculum August 2010 Page 47 of 94
• Grand Rounds
• Clinical skills demonstrations and teaching
• Critical appraisal and evidence based medicine and journal clubs
• Joint specialty meetings
• Attendance at national Immunology FRCPath training days (organised by the Association of Clinical Pathologists), which are designed to cover aspects of the training programme outlined in this curriculum.
Independent Self-Directed Learning -Trainees will use this time in a variety of ways depending upon their stage of learning. Suggested activities include:
• Reading, including web-based material
• Maintenance of personal portfolio (self-assessment, reflective learning, personal development plan)
• Audit and research projects
• Reading journals
• Achieving personal learning goals beyond the essential, core curriculum Formal Study Courses - Time to be made available for formal courses is encouraged, subject to local conditions of service. Examples include management courses and communication courses. It is implicit that active participation in the above learning and teaching opportunities will enhance a trainee’s knowledge and skills which eventually translates in to a fully competent immunologist able to meet the needs of patients with a wide range of immune-mediated disease, including immunodeficiency, systemic autoimmune disease and serious allergy.
4.3 Research
Trainees who wish to acquire research competencies, in addition to those specified in their specialty curriculum, may undertake a research project as an ideal way of obtaining those competencies. For those in specialty training, one option to be considered is that of taking time out of programme to complete a specified project or research degree. Applications to research bodies, the deanery (via an OOPR form) and the JRCPTB (via a Research Application Form) are necessary steps, which are the responsibility of the trainee. The JRCPTB Research Application Form can be accessed via the JRCPTB website. It requires an estimate of the competencies that will be achieved and, once completed, it should be returned to JRCPTB together with a job description and an up to date CV. The JRCPTB will submit applications to the relevant SACs for review of the research content including an indicative assessment of the amount of clinical credit (competence acquisition) which might be achieved. This is likely to be influenced by the nature of the research (eg entirely laboratory-based or strong clinical commitment), as well as duration (eg 12 month Masters, 2-year MD, 3-Year PhD). On approval by the SAC, the JRCPTB will advise the trainee and the deanery of the decision. The deanery will make an application to the GMC for approval of the out of programme research. All applications for out of programme research must be prospectively approved. Upon completion of the research period the competencies achieved will be agreed by the OOP Supervisor, Educational Supervisor and communicated to the SAC, accessing the facilities available on the JRCPTB ePortfolio. The competencies achieved will determine the trainee’s position on return to programme; for example if an ST3 trainee obtains all ST4 competencies then 12 months will be recognised towards the minimum training time and the trainee will return to the programme at ST5. This would be corroborated by the subsequent ARCP.
Immunology Curriculum August 2010 Page 48 of 94
This process is shown in the diagram below:
Funding will need to be identified for the duration of the research period. Trainees need not count research experience or its clinical component towards a CCT programme but must decide whether or not they wish it to be counted on application to the deanery and the JRCPTB. A maximum period of 3 years out of programme is allowed and the SACs will recognise up to 12 months towards the minimum training times.
4.4 Academic Training
For those contemplating an academic career path, there are now well-defined posts at all levels in the Integrated Academic Training Pathway (IATP) involving the National Institute for Health Research (NIHR) and the Academy of Medical Sciences (AMS). For full details see http://www.nccrcd.nhs.uk/intetacatrain and http://www.academicmedicine.ac.uk/uploads/A-pocket-guide.pdf. Academic trainees may wish to focus on education or research and are united by the target of a consultant-level post in a university and/or teaching hospital, typically starting as a senior lecturer and aiming to progress to readership and professor. A postgraduate degree will usually be essential (see “out of programme experience”) and academic mentorship is advised (see section 6.1). Academic competencies have been defined by the JRCPTB in association with AMS and the Colleges and modes of assessment have been incorporated in the latest edition of the Gold Guide (section 7, see http://www.jrcptb.org.uk/forms/Documents/GoldGuide2009.pdf). Academic integrated pathways to CCT are a) considered fulltime CCTs as the default position and b) are run through in nature. The academic programmes are CCT programmes and the time set for the CCT is the time set for academic trainees. If a trainee fails to achieve all the required competencies within the notional time period for the programme, this would be considered at the ARCP, and recommendations to allow completion of clinical training would be made (assuming other progress to be satisfactory) see the guidelines for monitoring training and progress http://www.academicmedicine.ac.uk/careersacademicmedicine.aspx. Extension of a
OOPR Applicant seeks approval from Deanery
Deanery grant time to go OOP
OOPR Applicant applies to JRCPTB for OOP approval
SAC decide on research content
OOPR Applicant obtains competencies whilst OOP
SAC decide how many competencies can be counted towards minimum training time
OOP applicant returns to programme at appropriate competency level
Immunology Curriculum August 2010 Page 49 of 94
CCT date will be in proportion depending upon the nature of the research and will ensure full capture of the specialty outcomes set down by the Royal College and approved by GMC. All applications for research must be prospectively approved by the SAC and the regulator, see www.jrcptb.org.uk for details of the process.
5 Assessment
5.1 The Assessment System
The purpose of the assessment system is to:
• Enhance learning by providing formative assessment, enabling trainees to receive immediate feedback, measure their own performance and identify areas for development;
• Drive learning and enhance the training process by making it clear what is required of trainees and motivating them to ensure they receive suitable training and experience;
• Provide robust, summative evidence that trainees are meeting the curriculum standards during the training programme;
• Ensure trainees are acquiring competencies within the domains of Good Medical Practice;
• Assess trainees’ actual performance in the workplace;
• Ensure that trainees possess the essential underlying knowledge required for their specialty;
• Inform the Annual Review of Competence Progression (ARCP), identifying any requirements for targeted or additional training where necessary and facilitating decisions regarding progression through the training programme;
• Identify trainees who should be advised to consider changes of career direction. The integrated assessment system comprises a combination of workplace-based assessments and knowledge – based assessments. Individual assessment methods are described in more detail below. Workplace-based assessments will take place throughout the training programme to allow trainees to continually gather evidence of learning and to provide trainees with formative feedback. They are not individually summative but overall outcomes from a number of such assessments provide evidence for summative decision making. The number and range of these will ensure a reliable assessment of the training relevant to their stage of training and achieve coverage of the curriculum.
5.2 Assessment Blueprint
In the syllabus (3.3) the “Assessment Methods” shown are those that are appropriate as possible methods that could be used to assess each competency. It is not expected that all competencies will be assessed and that where they are assessed not every method will be used.
5.3 Assessment Methods
The following assessment methods are used in the integrated assessment system:
Examinations and Certificates
• The FRCPath examination in Immunology: Part I, Part II
• Advanced Life Support Certificate (ALS)
Immunology Curriculum August 2010 Page 50 of 94
The FRCPath Examination in Immunology comprises two parts. The Part I examination comprises 2 written papers covering fundamental immunology and clinical problem-solving. The part I examination is designed to test a candidate’s grasp of fundamental immunology and ability to integrate knowledge and experience to critically evaluate clinical cases and laboratory results. The Part II examination is composed of a written component, an objective structured practical examination (OSPE), followed by an extended objective structured oral examination (OSOE). Successful completion of the FRCPath part II examination denotes that a candidate has reached the standard required for independent practice as a consultant immunologist. FRCPath examiners are appointed to the Panel of Examiners for a five year period. They will have been in a substantive post for at least five years and be actively involved in training and educational supervision and be undertaking continuous professional development. Examiners are required to undertake training in, and contribute to the ongoing development of, the examinations process. They are expected to examine a minimum number of times during the five year period as defined in the RCPath examination regulations. Their examining work can be in one or all of the examination components, as determined by the Chair of the Panel of Examiners. Information about the FRCPath, including guidance for candidates, is available on the Royal College of Pathologist’s website: http://www.rcpath.org/index.asp?PageID=114&SearchStr=frcpath .
Workplace-Based Assessments
• Multi-Source Feedback (MSF)
• mini-Clinical Evaluation Exercise (mini-CEX)
• Direct Observation of Procedural Skills (DOPS)
• Case-Based Discussion (CbD)
• Patient Survey (PS)
• Audit Assessment (AA)
• Teaching Observation (TO) These methods are described briefly below. More information about these methods including guidance for trainees and assessors is available in the ePortfolio and on the JRCPTB website www.jrcptb.org.uk. Workplace-based assessments should be recorded in the trainee’s ePortfolio. The workplace-based assessment methods include feedback opportunities as an integral part of the assessment process, this is explained in the guidance notes provided for the techniques. Multisource Feedback (MSF) This tool is a method of assessing generic skills such as communication, leadership, team working, reliability etc, across the domains of Good Medical Practice. This provides objective systematic collection and feedback of performance data on a trainee, derived from a number of colleagues. ‘Raters’ are individuals with whom the trainee works, and includes doctors, administration staff, and other allied professionals. The trainee will not see the individual responses by raters, feedback is given to the trainee by the Educational Supervisor. Mini-Clinical Evaluation Exercise (mini-CEX)
Immunology Curriculum August 2010 Page 51 of 94
This tool evaluates a clinical encounter with a patient to provide an indication of competence in skills essential for good clinical care such as history taking, examination and clinical reasoning. The trainee receives immediate feedback to aid learning. The mini-CEX can be used at any time and in any setting when there is a trainee and patient interaction and an assessor is available. Direct Observation of Procedural Skills (DOPS) A DOPS is an assessment tool designed to assess the performance of a trainee in undertaking a practical procedure, against a structured checklist or standard operating procedure. The trainee receives immediate feedback to identify strengths and areas for development. Case based Discussion (CbD) The CbD assesses the performance of a trainee in their management of a patient to provide an indication of competence in areas such as clinical reasoning, decision-making and application of medical knowledge in relation to patient care. It also serves as a method to document conversations about, and presentations of, cases by trainees. The CbD should include discussion about a written record (such as written case notes, out-patient letter, discharge summary). A typical encounter might be when presenting newly referred patients in the out-patient department. Patient Survey (PS) Patient Survey address issues, including behaviour of the doctor and effectiveness of the consultation, which are important to patients. It is intended to assess the trainee’s performance in areas such as interpersonal skills, communication skills and professionalism by concentrating solely on their performance during one consultation. Audit Assessment Tool (AA) The Audit Assessment Tool is designed to assess a trainee’s competence in completing an audit. The Audit Assessment can be based on review of audit documentation OR on a presentation of the audit at a meeting. If possible the trainee should be assessed on the same audit by more than one assessor. Teaching Observation (TO) The Teaching Observation form is designed to provide structured, formative feedback to trainees on their competence at teaching. The Teaching Observation can be based on any instance of formalised teaching by the trainee who has been observed by the assessor. The process should be trainee-led (identifying appropriate teaching sessions and assessors).
5.4 Decisions on Progress (ARCP)
The Annual Review of Competence Progression (ARCP) is the formal method by which a trainee’s progression through her/his training programme is monitored and recorded. ARCP is not an assessment – it is the review of evidence of training and assessment. The ARCP process is described in A Reference Guide for Postgraduate Specialty Training in the UK (the “Gold Guide” – available from www.mmc.nhs.uk). Deaneries are responsible for organising and conducting ARCPs. The evidence to be reviewed by ARCP panels should be collected in the trainee’s ePortfolio. In each year of training, acquisition of knowledge and competencies relating to each of the main subject areas of the curriculum will be assessed by a combination of mini-CEX, DOPS, CbD, AA and TO. These methods of formative assessment will be complemented by summative assessment in the form of the FRCPath examination in
Immunology Curriculum August 2010 Page 52 of 94
Immunology, which will be taken at defined points in the training programme – part I of the FRCPath will generally be taken at the end of ST4 or early in ST5 with part II being taken towards the end of ST6 or early in ST7. Successful completion of the FRCPath examination coupled with satisfactory progress through the ARCP process is essential pre-requisites for the award of a CCT in Immunology. The ARCP Decision Aid is included in section 5.5, giving details of the evidence required of trainees for submission to the ARCP panels. Each section of the syllabus outlines the knowledge, skills and behaviours that must be obtained by the trainee in order to successfully complete training. During their training, it is expected that the trainee will progress through three levels of competence, as outlined below:
Level 1: Introductory - The trainee has comprehensive understanding of principles and practices under direct supervision.
Level 2: Intermediate - The trainee has a good general knowledge and understanding of most principles and practices under indirect supervision. He/she should be able to deal with most of the day-to-day issues in a hospital immunology laboratory and outpatient clinic/ward to an adequate level but will still require consultant input with regard to complex management and clinical issues.
Level 3: Independent - The trainee has an in-depth knowledge and understanding of principles. He/she should be competent to discuss and deal with the subject (or, where appropriate, perform the task/procedure), demonstrating a level of clinical or professional judgement commensurate with independent practice at consultant level. It is anticipated that a trainee at this level should have consultant input readily available at all times where required
.
Immunology Oct 09 Page 53 of 94
5.5 ARCP Decision Aid - Minimal Standards Determining Satisfactory Progress
Immunology Specialist Training Curriculum topic ST3 ST4 ST5 ST6 ST7
Fundamental Immunology Level 1 competent Level 2 competent Level 2 competent Level 3 competent Level 3 competent
Primary immunodeficiency Level 1 competent Level 2 competent Level 2 competent Level 2 competent Level 3 competent
Autoimmune disease and systemic vasculitides
Level 1 competent Level 2 competent Level 2 competent Level 2 competent Level 3 competent
Allergic diseases Level 1 competent Level 2 competent Level 2 competent Level 2 competent Level 3 competent
Laboratory Immunology (see laboratory training manual and record)
Level 3 competent in all core areas of laboratory immunology
Audit assessment (AA) 1 completed project 1 completed project
Teaching observation (TO) episodes
1 1 1 1 1
Acquisition of common competencies (% by end of year) evidenced by above assessments
20% 40% 60% 80% 100%
ALS Valid Valid Valid Valid Valid
Examinations FRCPath part I FRCPath part II
MSF Satisfactory Satisfactory
Patient Survey Satisfactory Satisfactory
Minimum number of work place assessments (comprising a combination of mini-CEX, DOPS, ,CbD, AA and TO) ensuring coverage of the key subject areas of the curriculum
6 6 6 6 6
The above table serves as a guide to ARCP panels in assessing the progress of trainees in Immunology. The rate at which each individual trainee will acquire the necessary knowledge base in the 5 main subject areas of the curriculum (fundamental immunology, immunodeficiency, autoimmune disease, allergy and laboratory immunology) will inevitably vary. The incremental nature of acquisition of competencies (L1 to L3) is mapped against key learning outcomes as defined in the curriculum.It is meant to be interpreted flexibly and designed to ensure that the progress of trainees is measurable. While failure to achieve coverage of the precise proportion of the curriculum at the end of each year should not be seen as an insurmountable barrier to trainee progress, it is necessary for all trainees to achieve Level 3 competence across the curriculum and complete the FRCPath examination by the end of the training programme.
Immunology Oct 09 Page 54 of 94
5.6 Penultimate Year Assessment (PYA)
The penultimate ARCP prior to the anticipated CCT date will include an external assessor from outside the training programme. JRCPTB and the deanery will coordinate the appointment of this assessor. This is known as “PYA”. Whilst the ARCP will be a review of evidence, the PYA will include a face to face component.
5.7 Complaints and Appeals
FRCPath Examinations A trainee who has taken any Royal College of Pathologists examination has the right of appeal if there is evidence of a procedural or administrative irregularity by the College or its contracted examination centres in the conduct or content of the examination that has adversely affected the trainee’s result. The appeals procedure is outlined in the Regulations and Guidelines for Membership Exams and Diplomas on the College website. The regulations and guidelines are reviewed annually, at which time the appeals procedure will automatically be reviewed. Appeals submitted on the grounds that a candidate seeks to challenge the professional or academic judgement of the examiners will not be considered and in no circumstances will the examination be re-marked. The principle underlying this is that the written papers and options are double blind marked and the reliability of the marking decisions in oral and practical assessments is greatest at the time of the initial examiners’ judgement. Subsequent review by different or senior examiners or by independent assessors cannot guarantee increased accuracy or reliability. Moreover, in the case of the oral and some practical assessments there is no residual physical evidence of the candidate’s performance, which could be revisited. Any appeal must be made by the trainee in writing to the Examinations Department within one month of issue of the examination result. The appeal will be considered by the Director of Examinations and Assessment, who will arrange an appropriate investigation of the appeal. This will include checking that no administrative, procedural, numerical, data transcription or computing errors have occurred, and that the declared result accurately reflects the judgement of the examiners. The Director may also ask the Chair of the Panel of Examiners for a report on the examination in question. Where a procedural irregularity is found the Director may authorise a refund of the examination fee or waiver of the fee to re-sit the relevant component of the examination. Only in exceptional circumstances, where it is clear that a paper has been overlooked or marks incorrectly totalled, will a fail mark be converted to a pass. There is a complaints procedure for all activities managed by the Examinations Department not directly linked to an outcome of an examination. The complaints procedure is available on the College website. The Examinations Manager is responsible for the complaints procedure and for maintaining a register of complaints detailing the nature of the complaint and the outcome. The register will be reviewed on a periodic basis by the Director of Examinations and Assessment who will aim to identify trends that indicate a need to review regulations and procedures. The Chair of the Panel of Examiners will also be advised of all complaints relating to the specialty. Candidates dissatisfied by the outcome of the examinations complaints procedure can take the matter further by going through the College’s complaints procedure and
Immunology Oct 09 Page 55 of 94
referring the matter to the Chief Executive. Complaints referred to the Chief Executive are reviewed on a periodic basic by the College’s Executive Committee All workplace-based assessment methods incorporate direct feedback from the assessor to the trainee and the opportunity to discuss the outcome. If a trainee has a complaint about the outcome from a specific assessment this is their first opportunity to raise it. Appeals against decisions concerning in-year assessments will be handled at deanery level and deaneries are responsible for setting up and reviewing suitable processes. If a formal complaint about assessment is to be pursued this should be referred in the first instance to the chair of the Specialty Training Committee who is accountable to the regional deanery. Continuing concerns should be referred to the Associate Dean.
6 Supervision and Feedback
6.1 Supervision
All elements of work in training posts must be supervised with the level of supervision varying depending on the experience of the trainee and the clinical exposure and case mix undertaken. Outpatient and referral supervision must routinely include the opportunity to personally discuss all cases if required. As training progresses the trainee should have the opportunity for increasing autonomy, consistent with safe and effective care for the patient. Trainees will at all times have a named Educational Supervisor and Clinical Supervisor, responsible for overseeing their education. Given the small size of the specialty of Immunology, these roles have been combined into a single role of Educational Supervisor. The responsibilities of supervisors have been defined by GMC in the document “Operational Guide for the PMETB Quality Framework”. These definitions have been agreed with the National Association of Clinical Tutors, the Academy of Medical Royal Colleges and the Gold Guide team at MMC, and are reproduced below: Educational Supervisor A trainer who is selected and appropriately trained to be responsible for the overall supervision and management of a specified trainee’s educational progress during a training placement or series of placements. The Educational Supervisor is responsible for the trainee’s Educational Agreement. Clinical Supervisor A trainer who is selected and appropriately trained to be responsible for overseeing a specified trainee’s clinical work and providing constructive feedback during a training placement. Some training schemes appoint an Educational Supervisor for each placement. The roles of Clinical and Educational Supervisor may then be merged. Trainees will at all times have a named Educational Supervisor and Clinical Supervisor, responsible for overseeing their education. All trainers and educational supervisors will be consultants of at least 1years standing who will have undergone appropriate training to fulfil these roles, as determined by the local postgraduate deanery. The educational supervisor will be responsible for performing an induction appraisal soon after the trainee is appointed followed by 2 to 3 appraisals per year where developmental goals are agreed and previous goals reviewed. In co-ordinating training,the educational
Immunology Oct 09 Page 56 of 94
supervisor will ensure that the curriculum is followed, write the supervisor’s report, provide feedback, communicate with other supervisors as required and support the under-performing trainee. The Educational Supervisor, when meeting with the trainee, should discuss issues of clinical governance, risk management and any report of any untoward clinical incidents involving the trainee. The Educational Supervisor should be part of the clinical specialty team. Thus if the clinical directorate (clinical director) have any concerns about the performance of the trainee, or there were issues of doctor or patient safety, these would be discussed with the Educational Supervisor. These processes, which are integral to trainee development, must not detract from the statutory duty of the trust to deliver effective clinical governance through its management systems. Opportunities for feedback to trainees about their performance will arise through the use of the workplace-based assessments, regular appraisal meetings with supervisors, other meetings and discussions with supervisors and colleagues, and feedback from ARCP. Deaneries will be responsible for ensuring that trainers and assessors are appropriately trained to undertake their educational responsibilities. Trainers and assessors will be expected to be fully conversant with the curriculum and assessment methods and work in conjunction with the SAC to deliver effective training.
6.2 Appraisal
A formal process of appraisals and reviews underpins training. This process ensures adequate supervision during training, provides continuity between posts and different supervisors and is one of the main ways of providing feedback to trainees. All appraisals should be recorded in the ePortfolio.
Induction Appraisal
The trainee and educational supervisor should have an appraisal meeting at the beginning of each post to review the trainee’s progress so far, agree learning objectives for the post ahead and identify the learning opportunities presented by the post. Reviewing progress through the curriculum will help trainees to compile an effective Personal Development Plan (PDP) of objectives for the upcoming post. This PDP should be agreed during the Induction Appraisal. The trainee and supervisor should also both sign the educational agreement in the e-portfolio at this time, recording their commitment to the training process.
Mid-point Review
This meeting between trainee and educational supervisor is mandatory (except when an attachment is shorter than 6 months), but is encouraged particularly if either the trainee or educational or clinical supervisor has training concerns or the trainee has been set specific targeted training objectives at their ARCP. At this meeting trainees should review their PDP with their supervisor using evidence from the e-portfolio. Workplace-based assessments and progress through the curriculum can be reviewed to ensure trainees are progressing satisfactorily, and attendance at educational events should also be reviewed. The PDP can be amended at this review.
End of Attachment Appraisal
Trainees should review the PDP and curriculum progress with their educational supervisor using evidence from the e-portfolio. Specific concerns may be highlighted from this appraisal. The end of attachment appraisal form should record the areas where further work is required to overcome any shortcomings. Further evidence of competence in certain areas
Immunology Oct 09 Page 57 of 94
may be needed, such as planned workplace-based assessments, and this should be recorded. If there are significant concerns following the end of attachment appraisal then the programme director should be informed.
7 Managing Curriculum Implementation
7.1 Intended Use of Curriculum by Trainers and Trainees
This curriculum and ePortfolio are web-based documents which are available from the Joint Royal Colleges of Physicians Training Board (JRCPTB) website www.jrcptb.org.uk . The educational supervisors and trainers can access the up-to-date curriculum from the JRCPTB website and will be expected to use this as the basis of their discussion with trainees. Both trainers and trainees are expected to have a good knowledge of the curriculum and should use it as a guide for their training programme. Each trainee will engage with the curriculum by maintaining a portfolio. The trainee will use the curriculum to develop learning objectives and reflect on learning experiences. Development of the 2009 curriculum has been facilitated by a national educational workshop on the curriculum and assessment methods for educational supervisors and trainers held by the JRCPTB at the Royal College of Physicians on 26th June 2009. Local mechanisms for curriculum implementation will be overseen by the relevant schools of medicine under the aegis of postgraduate deaneries. Regular feedback from trainee representatives on the SAC in Immunology at JRCPTB, the SAC in Immunology at the Royal College of Pathologists and the Intercollegiate Joint Committee on Immunology and Allergy will ensure that trainees’ views on curriculum implementation are adequately represented.
7.2 Recording progress
On enrolling with JRCPTB trainees will be given access to the ePortfolio for Immunology (under development). The ePortfolio allows evidence to be built up to inform decisions on a trainee’s progress and provides tools to support trainees’ education and development. The trainee’s main responsibilities are to ensure the ePortfolio or relevant paper copies are kept up to date, arrange assessments and ensure they are recorded, prepare drafts of appraisal forms, maintain their personal development plan, record their reflections on learning and record their progress through the curriculum. The supervisor’s main responsibilities are to use ePortfolio or paper-based evidence such as outcomes of assessments, reflections and personal development plans to inform appraisal meetings. They are also expected to update the trainee’s record of progress through the curriculum, write end-of-attachment appraisals and supervisor’s reports. Trainees will be expected to document acquisition of laboratory immunology competencies by recording progress in the Laboratory Training Manual (Laboratory logbook).
8 Curriculum Review and Updating The curriculum will remain under regular review as a standing item on the agenda for meetings of the SAC in Immunology at JRCPTB held 3 times a year. Trainee and lay representation on the committee will enable the SAC to respond to any issues raised by these groups. In addition to these meetings, the SAC will formally review the curriculum at its joint annual meeting with Regional Specialty Advisors. These meetings will ensure that the
Immunology Oct 09 Page 58 of 94
curriculum remains relevant to current practice and that the SAC responds swiftly to advances in basic and applied immunological science which impact on the quality of care provided to patients with immune-mediated disease.
9 Equality and Diversity The Royal Colleges of Physicians will comply, and ensure compliance, with the requirements of equality and diversity legislation, such as the:
• Race Relations (Amendment) Act 2000
• Disability Discrimination Act 1995
• Human Rights Act 1998
• Employment Equality (Age) Regulation 2006
• Special Educational Needs and Disabilities Act 2001
• Data Protection Acts 1984 and 1998 The Federation of the Royal Colleges of Physicians believes that equality of opportunity is fundamental to the many and varied ways in which individuals become involved with the Colleges, either as members of staff and Officers; as advisers from the medical profession; as members of the Colleges' professional bodies or as doctors in training and examination candidates. Accordingly, it warmly welcomes contributors and applicants from as diverse a population as possible, and actively seeks to recruit people to all its activities regardless of race, religion, ethnic origin, disability, age, gender or sexual orientation. Deanery quality assurance will ensure that each training programme complies with the equality and diversity standards in postgraduate medical training as set by GMC. Compliance with anti-discriminatory practice will be assured through:
• monitoring of recruitment processes;
• ensuring all College representatives and Programme Directors have attended appropriate training sessions prior to appointment or within 12 months of taking up post;
• Deaneries must ensure that educational supervisors have had equality and diversity training (at least as an e learning module) every 3 years
• Deaneries must ensure that any specialist participating in trainee interview/appointments committees or processes has had equality and diversity training (at least as an e module) every 3 years.
• ensuring trainees have an appropriate, confidential and supportive route to report examples of inappropriate behaviour of a discriminatory nature. Deaneries and Programme Directors must ensure that on appointment trainees are made aware of the route in which inappropriate or discriminatory behaviour can be reported and supplied with contact names and numbers. Deaneries must also ensure contingency mechanisms are in place if trainees feel unhappy with the response or uncomfortable with the contact individual.
• monitoring of College Examinations;
• ensuring all assessments discriminate on objective and appropriate criteria and do not unfairly disadvantage trainees because of gender, ethnicity, sexual orientation or disability (other than that which would make it impossible to practise safely as a physician). All efforts shall be made to ensure the participation of people with a disability in training.
59
10 Appendix A
Laboratory Training Manual and
Record for Specialty Registrars in
Immunology
60
NAME: NTN Number: LABORATORY ADDRESS: TELEPHONE NUMBER: EMAIL ADDRESS: PRINCIPAL LABORATORY SUPERVISOR’S NAME: START DATE: FINAL SUBMISSION DATE:
61
INTRODUCTION
This manual outlines the JRCPTB Laboratory Training program for trainees in Immunology. The Training Programme Director and consultant supervisor will be responsible for the continuous assessment of the trainee. This will be achieved by regular contact between the trainee and their supervisor to assess progress using the record made in their training manual. Sections in the training manual will be signed by the person supervising the training (BMS 1 or Higher, or Clinical Scientist of B Grade or Higher). The log book will be reviewed together with other relevant records like 360 degree assessments at ARCP meetings. Satisfactory completion of laboratory training will be assessed and certified at the PYA, as a mandatory part of the process. Differences exist in the type and size of individual training departments and secondments to other units may be necessary to achieve competence in some procedures. Training aims are for the trainee to gain an understanding of immunological mechanisms and apply this knowledge to the investigation and diagnosis of disease processes. The trainee will develop the expertise needed to advise on the application of laboratory investigations to diseases of the immune system, to interpret the results generated by such investigations, to be aware of the limitations of laboratory assays, to initiate appropriate research and development in diagnostic laboratory immunology and to understand the managerial organisation within the NHS. The Sections highlighted in bold italics are regarded as core areas with which the trainee is expected to be fully conversant and demonstrate a level of competence required for independent practice.
USE OF THE TRAINING MANUAL This manual covers the areas in which a trainee should gain experience over the 4-year training course. It provides a record of continuous assessment. The supervisor and trainee should indicate the dates on which the trainee has studied a topic and where relevant, the level of competence achieved. It is envisaged that a higher level will be assigned as more experience is gained. At present there is no standard way of electronically validating signatures. Therefore a printed certified version should be included in your portfolio for inspection at ARCP assessments. The training manual should be augmented with any additional information which will document the training received and the levels reached. The completed record of training will be used ultimately to assess the successful completion of the training.
The Manual is divided into sections Section 1 Laboratory Management Section 2 Analytical Techniques and Instrumentation Section 3 Interpretation of Immunology tests Section 4 Research and Development Section 5 Meetings attended Section 6 Presentations given
62
SECTION 1 LABORATORY MANAGEMENT
This section gives the trainee an insight into the functional organisation of a laboratory, a hospital and the National Health Service. The trainee should also understand the importance of quality assurance, clinical governance and Health and Safety aspects of laboratory management. An appreciation of the organisation of the analytical and reporting process should also be obtained. The understanding of theoretical aspects and practical experience should be recorded.
Management and Professional Structures Date Covered Comments
NHS Organisation and Management
Hospital Management Structure
Laboratory structure
63
Handling of Information Date Covered Comments
Initiation of request by clinician
Types of patient records: eg. Paper based, Electronic
Patient confidentiality and consent
Laboratory computer system
Use of a Personal Computer including common programmes (eg. Word Processing , database, Statistical analysis, Bibliography)
Data protection Act
Reporting of Results
Telephone Enquiries
64
Sample Handling Date
Covered Has reached level of competence required for independent practice
Comments
Specimen collection and transport
Transportation through the post
Sample handling and storage in laboratory
Disposal of clinical waste
High Risk Samples
Spillage and containment
65
Quality Assurance Date
Covered Has reached level of competence required for independent practice
Comments
The SOP
Document control
Sample requirements
Specimen identity checks
Determining Normal ranges
Internal quality control
External quality control
Quality assurance
QC interpretation
Laboratory accreditation: CPA
Statutory Registration of Laboratory Staff
Laboratory Audit
66
Health and Safety Date
Covered Has reached level of competence required for independent practice
Comments
The laboratory safety policy
Risk management
Health and safety at work act
Fire safety
Dealing with biological hazards in the laboratory
Disinfection and decontamination
Vaccination policy
Chemical hazards including COSHH
Mechanical hazards (including sharps)
Dealing with needle-stick injuries
Electrical hazards
Ionising radiation
Laser/UV hazards
Genetic manipulation policy
Incident handling
Waste disposal
Safe Storage of Chemicals
67
Basic Laboratory Management Date Covered Comments
Business planning
Bidding for new services/equipment
Finance control
Staffing and Personnel Issues
Disciplinary Procedures
Organising Research & Development
68
SECTION 2: ANALYTICAL TECHNIQUES AND INSTRUMENTATION / LABORATORY PROCEDURES The purpose of this section is to allow the trainee to become familiar with a range of techniques encountered in the Immunology laboratory and to gain an understanding of the assay principles and their application. For each entry in this section the competence of the trainee is assessed as follows:
• Level 0: Procedure unavailable in laboratory or opportunity for training not available.
• Level 1: Observed a demonstration.
• Level 2: Technique preformed under supervision and has a basic understanding of the theory behind the procedure and can rectify any problems that occur.
• Level 3: Technique performed without supervision and has a comprehensive understanding of the theoretical concepts and application of the assay.
• Level 4: Extensive experience of technique and where relevant, has a knowledge of the clinical interpretation of the results generated.
Wide experience rather than in-depth knowledge of a limited number of techniques should be aimed for (i.e. level 4 is not expected in all topics). Where essential procedures are unavailable, secondment to a laboratory performing those assays should be offered. This should be noted in the secondments section.
69
ANALYTICAL TECHNIQUES AND INSTRUMENTATION A. BASIC LABORATORY TECHNIQUES Operation of Basic Laboratory Equipment Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Liquid handling using Pipettes
Liquid handling using robotics
Balances
Centrifuges
pH meters, Concept of buffers
Water purification
Microscopy, types of microscopes
Preparation of sections for microscopy
Fixation and Embedding
Operation of Cryostats
Spectrophotometric and related techniques
(manual and automated equipment)
Visible and UV spectrophotometry
Nephelometry / Turbidimetry
Densitometry
Enzyme Linked immunosorbent assay and similar immunoassay techniques
Level and date
Level and date
Level and date
Level and date
Has reached level of competence required for independent practice
Isotopic Techniques
Beta counters
Gamma counters
70
Radioimmunoassay
71
Gel Phase and Electrophoretic Techniques Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Radial immunodiffusion
Double diffusion
Zonal Electrophoresis
Immunoelectrophoresis
Polyacrylamide gel electrophoresis
Two-dimensional electrophoresis
Isoelectric focusing
Western blotting
Immunofixation
Capillary zone electrophoresis
Gel Staining Methods
Chromatographic Techniques
Column chromatography
Gel filtration
Ion-exchange chromatography
Affinity chromatography
72
Cellular and Tissue Immunology Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Tissue culture / aseptic technique
Cell and tissue storage
Viability assays
Cellular analysis including cell counting
Flow cytometry
Light/ Fluorescence Microscopy
73
Molecular Biology Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Principles of DNA extraction and DNA analysis
Restriction enzymes
DNA probes
Southern blotting
Polymerase chain reaction
Hybridisation techniques
Others: please specify below
74
B. SPECIFIC LABORATORY PROCEDURES Cellular Immunology Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Leucocyte separation techniques
• Lymphocytes
• Monocytes
• Neutrophils
Phagocyte functions
• NBT
• Flow cytometry
Cell proliferation assays and their applications
Flow cytometry, principles, practise, applications
Use of Flow cytometry for the diagnosis of Immunodeficiency
Broad principles of Diagnosis and classification of lymphoid neoplasms
75
MHC and Tissue Typing Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
HLA typing
Cellular Assays
DNA techniques
Antibody screening
Principles of Tissue matching for Renal , Solid Organ and BM transplantation
Other techniques: Specify below
76
Protein Analysis Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Immunoglobulins (G, A, M, D, E)
Immunoglobulin fragments : Heavy chains, Light chains
Cryoglobulins
Methods for assessing specific antibody responses including limitations
Paraproteins
Beta 2 microglobulin
Immunoglobulin subclasses
Other proteins
Precipitins (avian, fungal)
Specific IgE
Tryptase
C-Reactive protein
77
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Complement: C3, C4 Other components
Functional complement assays: CH50 \CH100 AP50\AP100
C3 nephritic factor
C1 inhibitor: Immunochemical and Functional
Cytokine detection
78
Autoantibody Analysis Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Rheumatoid factor
Antinuclear antibodies
Anti- ds.DNA antibodies
Extractable nuclear antigens: Ro, La, Sm, RNP, Jo1, Scl 70
Antineutrophil cytoplasmic antibodies :c-ANCA, p-ANCA Anti-MPO, PR3
Smooth Muscle antibodies
Glomerular basement membrane antibodies
Mitochondrial antibodies
Antibodies used to diagnose celiac disease
Gastric parietal cell antibodies
Intrinsic factor antibodies
Thyroid autoantibodies
Pancreatic islet cell antibodies
Steroid cell antibodies (adrenal, ovarian, testis)
Level and date
Level and date
Level and date
Level and date
Has reached level of competence required for independent practice
Cardiolipin antibodies
Liver autoantibodies
• Neural auto-antibodies:
79
Cerebellar antibodies (Yo, Hu), Ganglioside antibodies,
• Glutamic acid decarboxylase antibodies,
• Myelin associated glycoprotein antibodies
80
Immunohistology
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Analysis by immunofluorescence techniques
Principles of immunohistochemistry
Histology of the immune system
Renal disease
Skin disease
81
C. SECONDMENTS
Secondment site
Dates Comments including reason for secondment
82
SECTION 3 INTERPRETATION OF IMMUNOLOGY TESTS A Clinical Immunologist must be able to interpret laboratory results for communication to other clinical colleagues. The trainee is required to develop an understanding of how the immune system responds to different disease processes and how these changes can be used in the laboratory for monitoring and diagnosis. Essential to the interpretive process is an understanding of the assays performed and their limitations. The trainee should have a good knowledge of how patient reports are generated and when additional comments or telephone communication may be required. The immunologist should be to advise clinical colleagues on relevant tests for a given clinical situation. Sections below are provided for recording progress.
83
STATISTICAL METHODS USED FOR INTERPRETING LABORATORY DATA
Measures of central tendency Date Covered Comments
Parametric and non-parametric ways of comparing data
Sensitivity and specificity
prior and posterior probability
Negative and Positive Predictive Value
Receiver operated characteristic curves
Understanding of the impact of prior and posterior probability
Difference between performance of tests to screen for disease versus diagnosis
84
Interpretation of Laboratory Data Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Autoantibody tests
85
Interpretation of Laboratory Data Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Protein tests
86
Interpretation of Laboratory Data Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Cellular tests
87
Interpretation of Laboratory Data Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Allergy tests
88
INTERPRETATION OF LABORATORY DATA Laboratory Investigations by Disease Level of
competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Immunodeficiency:
• Antibody deficiency
• Phagocyte
deficiency
• Defective Cell-mediated immunity
• Complement
deficiency
89
Laboratory Investigations by Disease
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
• Systemic Autoimmunity:
• Systemic lupus
erythematosus • Rheumatoid arthritis • Antiphospholipid
syndrome • Scleroderma • Sjögrens syndrome • Systemic vasculitis • Seronegative
spondyloarthropathies • Dermatomyositis
• Overlap syndromes
90
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Level of competence attained and date
Has reached level of competence required for independent practice
Allergy:
• Food allergy
• Inhalant allergy
• Drug allergy
• Skin prick testing
• Patch testing
• Heaf Test
• Anaphylaxis
Lymphoproliferative Disease
Myelomatosis
91
SECTION 4 - RESEARCH and DEVELOPMENT A. The Scientific Literature Dates Comments Journals
Multidisciplinary Immunological - Scientific Immunological - Medical
Library facilities
Medline and other Databases:
Searching Clinical databases Genetic Databases (eg.OMIM)
B. Research Technique Ethical issues and approval Hypothesis Background Aims and Objectives Methods Recording Results Handling the data Statistics Presentation Preparing a poster Preparing a talk Powerpoint Routes to publication Writing a paper Refereeing
92
C. The Funding of Research NHS research and development Charities - project grants Government funding A Research Grant Refereeing process
93
SECTION 5 - MEETINGS/ SEMINARS ATTENDED DATE DETAILS
94
SECTION 6 - PRESENTATIONS GIVEN DATE DETAILS
ANEXO V.2.- PROGRAMAS FORMATIVOS EN INMUNOLOGÍA CLÍNICA Y DE
LABORATORIO DIAGNÓSTICO VIGENTES EN ITALIA.
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
1A
NN
OD
I BA
SET
AF
Dis
cipl
ine
gene
rali
per
la fo
rmaz
ione
del
lo sp
ecia
lista
AM
BIT
OC
FUT
IPO
BIO
/11
BIO
LOG
IA
MO
LEC
OLA
RE
Acq
uisi
re le
con
osce
nze
fond
amen
tali
rela
tive
a:
mod
alità
di a
ttiva
zion
e de
i lin
foci
ti e
di a
ltre
cellu
le c
oinv
olte
nei
feno
men
i im
mun
itari
e al
lerg
ici;
prin
cipa
li m
etod
i mol
ecol
ari p
er lo
st
udio
in v
itro
ed in
viv
o de
lle re
azio
ni
imm
unol
ogic
he, i
mm
unop
atol
ogic
he e
d al
lerg
iche
1L
BIO
LO
GIA
MO
LE
CO
LA
RE
A
PPL
ICA
TA
AL
LE
MA
LA
TT
IE D
I IN
TE
RE
SSE
IM
MU
NO
AL
LE
RG
OL
OG
ICO
ex B
IOL
OG
IA M
OL
EC
OL
AR
E:
APP
LIC
AT
A A
LL
E M
AL
AT
TIE
DI
INT
ER
ESS
E
IMM
UN
OA
LL
ER
GO
LO
GIC
O
0081
0A01
BIO
11L0
1
MED
/01
STA
TIST
ICA
MED
ICA
Sape
r ese
guire
stud
i sta
tistic
i ed
epid
emio
logi
ci
nel c
ampo
del
le m
alat
tie a
llerg
iche
e
imm
unol
ogic
he.
1L
STA
TIS
TIC
A M
ED
ICA
APP
LIC
AT
A
AL
LE
MA
LA
TT
IE D
I IN
TE
RE
SSE
IM
MU
NO
AL
LE
RG
OL
OG
ICO
ex S
TA
TIS
TIC
A M
ED
ICA
: A
PPL
ICA
TA
AL
LE
MA
LA
TT
IE D
I IN
TE
RE
SSE
IM
MU
NO
AL
LE
RG
OL
OG
ICO
0081
0A01
MED
01L0
1
MED
/04
PATO
LOG
IA
GEN
ERA
LEA
cqui
sire
con
osce
nze
sui p
rinci
pali
mec
cani
smi
di d
anno
loca
le e
sis
tem
ico
caus
ato
dalle
reaz
ioni
im
mun
olog
iche
.
1L
IMM
UN
OL
OG
IA E
D
IMM
UN
OPA
TO
LO
GIA
1
ex P
AT
OL
OG
IA G
EN
ER
AL
E:
IMM
UN
OL
OG
IA E
D
IMM
UN
OPA
TO
LO
GIA
0081
0A01
MED
04L0
1
CA
RA
TT
ER
IZZA
NT
I-T
RO
NC
O C
OM
UN
ET
AF
Clin
ico
AM
BIT
OC
FUT
IPO
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
di 2
1
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Clin
ico
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
App
rend
ere
la g
estio
ne d
el p
azie
nte
inte
rnis
tico,
vi
sto
non
tant
o da
l�pu
nto
di v
ista
spec
ialis
tico
ma
nella
sua
acce
zion
e gl
obal
e ed
olis
tica�
qual
e qu
ella
def
inita
dal
la m
edic
ina
inte
rna.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie e
d am
bula
tori
del r
epar
to m
edic
o cu
i è
asse
gnat
o ed
aff
ianc
are
il tu
tor a
sseg
nato
, ac
quis
endo
aut
onom
ia n
ella
ges
tione
dei
rico
vera
ti e
pa
zien
ti am
bula
toria
li.
AP
Azi
enda
/ Uni
vers
ità
Pado
va:
C
linic
a M
edic
a I,
Clin
ica
Med
ica
2,
Clin
ica
Med
ica
3, C
linic
a M
edic
a 4,
Clin
ica
Med
ica
5
30T
ME
DIC
INA
INT
ER
NA
(TIR
OC
INIO
)
ex T
IRO
CIN
IO I
N M
ED
ICIN
A
INT
ER
NA
0081
0B02
MED
09T3
0
MED
/15
MA
LATT
IE D
EL
SAN
GU
EA
tti m
edic
i e sp
ecia
listic
i rel
ativ
i al
l'inq
uadr
amen
to, a
llo st
udio
ed
alla
tera
pia
di
pazi
enti
con
mal
attie
imm
unol
ogic
he e
d al
lerg
olog
iche
affe
rent
i a re
parti
di E
mat
olog
ia.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
em
atol
ogic
o cu
i è
asse
gnat
o, a
ffia
ncan
do il
tuto
r ass
egna
to e
d,
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e
pazi
enti
ambu
lato
riali.
AP
2T
MA
LA
TT
IE D
EL
SA
NG
UE
(T
IRO
CIN
IO)
ex M
AL
AT
TIE
DE
L S
AN
GU
E
0081
0B02
MED
15T0
2
M-P
SI/0
8 PS
ICO
LOG
IA C
LIN
ICA
Acq
uisi
zion
e di
com
pete
nze
psic
olog
iche
ne
cess
arie
alla
form
azio
ne d
ello
spe
cial
izza
ndo.
1L
PSIC
OL
OG
IA C
LIN
ICA
0081
0B02
MPS
I08L
01
Dia
gnos
tico
AM
BIT
OC
FUT
IPO
BIO
/12
BIO
CH
IMIC
A C
LIN
ICA
E
BIO
LOG
IA M
OLE
CO
LAR
E C
LIN
ICA
App
rend
imen
to d
elle
met
odol
ogie
bio
chim
iche
in
uso
per l
a di
agno
stic
a e
la ri
cerc
a ne
lle p
rinci
pali
pato
logi
e di
inte
ress
e in
tern
istic
o.
1L
BIO
CH
IMIC
A C
LIN
ICA
E
BIO
LO
GIA
MO
LE
CO
LA
RE
CL
INIC
A
0081
0B03
BIO
12L0
1
MED
/03
GEN
ETIC
A M
EDIC
AC
onos
cenz
a de
i prin
cipi
gen
etic
i alla
bas
e de
lla
pato
gene
si d
elle
pat
olog
ie d
i int
eres
se in
tern
istic
o.1
LG
EN
ET
ICA
ME
DIC
A
0081
0B03
MED
03L0
1
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 2
di 2
1
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dia
gnos
tico
AM
BIT
OC
FUT
IPO
MED
/07
MIC
RO
BIO
LOG
IA E
M
ICR
OB
IOLO
GIA
CLI
NIC
AA
cqui
sizi
one
di c
ompe
tenz
e ne
ll'am
bito
del
la
mic
robi
olog
ia n
eces
sarie
alla
form
azio
ne d
ello
sp
ecia
lizza
ndo.
1L
MIC
RO
BIO
LO
GIA
E
MIC
RO
BIO
LO
GIA
CL
INIC
A
0081
0B03
MED
07L0
1
Em
erge
nza
e pr
onto
socc
orso
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Prep
arar
e lo
spec
ializ
zand
o al
la g
estio
ne n
on so
lo
delle
urg
enze
in a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
ma
anch
e al
le si
tuaz
ioni
di c
ritic
ità le
gate
a
prob
lem
atic
he d
i urg
enza
non
spe
cial
istic
a qu
ale
si p
uò ri
scon
trare
in q
uals
iasi
paz
ient
e ric
over
ato.
Ges
tione
del
le p
roce
dure
e d
elle
prim
e cu
re q
ualo
ra
si ri
scon
trino
le u
rgen
ze in
tern
istic
he d
i com
une
risco
ntro
in p
ront
o so
ccor
so.
AP
Azi
enda
/ Uni
vers
ità P
adov
a:
Pron
to S
occo
rso
6T
ME
DIC
INA
INT
ER
NA
: E
ME
RG
EN
ZE
(TIR
OC
INIO
)
ex M
ED
ICIN
A D
'UR
GE
NZA
0081
0B04
MED
09T0
6
CA
RA
TT
ER
IZZA
NT
I - D
ISC
IPL
INE
SPE
CIF
ICH
ET
AF
Dis
cipl
ine
spec
ifich
e de
lla ti
polo
gia
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Acq
uisi
re c
onos
cenz
e su
lle c
arat
teris
tiche
dei
pr
inci
pali
alle
rgen
i am
bien
tali,
sul
la d
iagn
ostic
a al
lerg
olog
ica
e su
i mec
cani
smi e
ziop
atog
enet
ici
delle
pat
olog
ie Ig
E-m
edia
te.
2L
EZ
IOPA
TO
GE
NE
SI E
DIA
GN
OSI
D
EL
LE
MA
LA
TT
IE A
LL
ER
GIC
HE
ex M
ED
ICIN
A IN
TE
RN
A :
EZ
IOPA
TO
GE
NE
SI D
EL
LE
M
AL
AT
TIE
AL
LE
RG
ICH
E
0081
B23
5MED
09L0
2
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 3
di 2
1
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
spec
ifich
e de
lla ti
polo
gia
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n pa
tolo
gia
imm
unol
ogic
a od
al
lerg
ica.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie,
ambu
lato
ri e
labo
rato
ri di
agno
stic
i del
re
parto
con
atti
vità
di a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
cui è
ass
egna
to,
affia
ncan
do il
tuto
r e
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e de
i paz
ient
i am
bula
toria
li, c
osì c
ome
nella
es
ecuz
ione
e re
ferta
zion
e de
gli e
sam
i e te
st
alle
rgol
ogic
i ed
imm
unol
ogic
i
APO
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia e
d Im
mun
olog
ia
Clin
ica
13T
IMM
UN
OL
OG
IA C
LIN
ICA
ED
A
LL
ER
GO
LO
GIA
1
ex IM
MU
NO
LO
GIA
CL
INIC
A E
D
AL
LE
RG
OL
OG
IA 1
0081
B23
5MED
09T1
3
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 4
di 2
1
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
2A
NN
OD
I BA
SET
AF
Dis
cipl
ine
gene
rali
per
la fo
rmaz
ione
del
lo sp
ecia
lista
AM
BIT
OC
FUT
IPO
BIO
/14
FAR
MA
CO
LOG
IAC
onos
cere
il m
ecca
nism
o d’
azio
ne d
ei p
rinci
pali
farm
aci i
mm
unos
oppr
esso
ri, a
ntia
llerg
ici e
im
mun
omod
ulan
ti e
com
unqu
e i f
amac
i in
uso
per l
e m
alat
tie im
mun
oalle
rgic
he.
1L
FAR
MA
CO
LO
GIA
0082
0A01
BIO
14L0
1
MED
/04
PATO
LOG
IA
GEN
ERA
LEA
cqui
sire
con
osce
nze
sui p
rinci
pali
mec
cani
smi
di d
anno
loca
le e
sis
tem
ico
caus
ato
dalle
reaz
ioni
im
mun
olog
iche
.
1L
IMM
UN
OL
OG
IA E
D
IMM
UN
OPA
TO
LO
GIA
2
ex P
AT
OL
OG
IA G
EN
ER
AL
E:
IMM
UN
OL
OG
IA E
D
IMM
UN
OPA
TO
LO
GIA
0082
0A01
MED
04L0
1
CA
RA
TT
ER
IZZA
NT
I-T
RO
NC
O C
OM
UN
ET
AF
Clin
ico
AM
BIT
OC
FUT
IPO
MED
/10
MA
LATT
IE
DEL
L'A
PPA
RA
TO
RES
PIR
ATO
RIO
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n m
alat
tie im
mun
olog
iche
affe
rent
i a
repa
rti d
i Pne
umol
ogia
.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
pne
umol
ogic
o cu
i è
asse
gnat
o, a
ffia
ncan
do il
tuto
r ass
egna
to e
d ,
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e
pazi
enti
ambu
lato
riali.
AP
Azi
enda
/ Uni
vers
ità P
adov
a:
Pneu
mol
ogia
, Fis
iopa
tolo
gia
Res
pira
toria
4T
MA
LA
TT
IE D
EL
L'A
PPA
RA
TO
R
ESP
IRA
TO
RIO
(TIR
OC
INIO
)
ex M
AL
AT
TIE
DE
LL
'APP
AR
AT
O
RE
SPIR
AT
OR
IO
0082
0B02
MED
10T0
4
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 5
di 2
1
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Clin
ico
AM
BIT
OC
FUT
IPO
MED
/15
MA
LATT
IE D
EL
SAN
GU
EA
tti m
edic
i e sp
ecia
listic
i rel
ativ
i al
l'inq
uadr
amen
to, a
llo st
udio
ed
alla
tera
pia
di
pazi
enti
con
mal
attie
imm
unol
ogic
he e
d al
lerg
olog
iche
affe
rent
i a re
parti
di E
mat
olog
ia.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
em
atol
ogic
o cu
i è
asse
gnat
o, a
ffia
ncan
do il
tuto
r ass
egna
to e
d ,
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e
pazi
enti
ambu
lato
riali.
AP
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia4
TE
MA
TO
LO
GIA
ED
IM
MU
NO
LO
GIA
C
LIN
ICA
(TIR
OC
INIO
)
ex M
AL
AT
TIE
DE
L S
AN
GU
E
0082
0B02
MED
15T0
4
MED
/16
REU
MA
TOLO
GIA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n m
alat
tie im
mun
olog
iche
ed
alle
rgol
ogic
he a
ffer
enti
a re
parti
di R
eum
atol
ogia
.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
reum
atol
ogic
o cu
i è
asse
gnat
o, a
ffia
ncan
do il
tuto
r ass
egna
to e
d ,
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e
pazi
enti
ambu
lato
riali.
AP
Azi
enda
/ Uni
vers
ità P
adov
a:
Reu
mat
olog
ia4
TR
EU
MA
TO
LO
GIA
(TIR
OC
INIO
)
ex R
EU
MA
TO
LO
GIA
0082
0B02
MED
16T0
4
MED
/18
CH
IRU
RG
IA
GEN
ERA
LEFo
rnire
i ru
dim
enti
teor
ici r
elat
ivi a
lle p
roce
dure
, ed
alle
eve
ntua
li co
mpl
ican
ze, d
ei p
rinci
pali
inte
rven
ti di
chi
rurg
ia g
ener
ale.
1L
CH
IRU
RG
IA G
EN
ER
AL
E
0082
0B02
MED
18L0
1
MED
/35
MA
LATT
IE C
UTA
NEE
E
VEN
EREE
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n m
alat
tie im
mun
olog
iche
ed
alle
rgol
ogic
he a
ffer
enti
a re
parti
di D
erm
atol
ogia
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
der
mat
olog
ico
cui è
as
segn
ato,
aff
ianc
ando
il tu
tor a
sseg
nato
ed
, ac
quis
endo
aut
onom
ia n
ella
ges
tione
dei
rico
vera
ti e
pa
zien
ti am
bula
toria
li.
AP
Azi
enda
/ Uni
vers
ità P
adov
a:
Der
mat
olog
ia4
TM
AL
AT
TIE
CU
TA
NE
E E
VE
NE
RE
E
(TIR
OC
INIO
)
ex M
AL
AT
TIE
CU
TA
NE
E E
V
EN
ER
EE
0082
0B02
MED
35T0
4
Dia
gnos
tico
AM
BIT
OC
FUT
IPO
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 6
di 2
1
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dia
gnos
tico
AM
BIT
OC
FUT
IPO
MED
/08
AN
ATO
MIA
PA
TOLO
GIC
A F
orni
re le
com
pete
nze
anat
omop
atol
ogic
he
teor
iche
bas
ilari
nece
ssar
ie a
lla c
ompr
ensi
one
della
fisi
opat
olog
ia d
elle
prin
cipa
li pa
tolo
gie
a ca
ratte
re in
tern
istic
o.
1L
AN
AT
OM
IA P
AT
OL
OG
ICA
0082
0B03
MED
08L0
1
MED
/36
DIA
GN
OST
ICA
PER
IM
MA
GIN
I E R
AD
IOTE
RA
PIA
Forn
ire, a
ttrav
erso
sim
ulaz
ioni
ese
mpl
ifica
tive,
le
com
pete
nze
tecn
iche
alla
bas
e de
ll'in
terp
reta
zion
e de
lle c
omun
i met
odic
he d
i dia
gnos
tica
per
imm
agin
i
1L
DIA
GN
OST
ICA
PE
R IM
MA
GIN
I E
RA
DIO
TE
RA
PIA
0082
0B03
MED
36L0
1
Em
erge
nza
e pr
onto
socc
orso
AM
BIT
OC
FUT
IPO
MED
/41
AN
ESTE
SIO
LOG
IAFo
rnire
i ru
dim
enti
teor
ici d
elle
pro
cedu
re e
del
le
even
tual
i com
plic
anze
del
le p
ratic
he
anes
tesi
olog
iche
rela
tive
ai p
rinci
pali
inte
rven
ti di
ch
irurg
ia
1L
AN
EST
ESI
OL
OG
IA
0082
0B04
MED
41L0
1
CA
RA
TT
ER
IZZA
NT
I A S
CE
LT
A D
EL
LO
ST
UD
EN
TE
TA
FD
isci
plin
e el
ettiv
e pe
r le
tipo
logi
e de
lla c
lass
eA
MB
ITO
CFU
TIP
O
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 7
di 2
1
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
elet
tive
per
le ti
polo
gie
della
cla
sse
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n pa
tolo
gia
imm
unol
ogic
a
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie,
ambu
lato
ri e
labo
rato
ri di
agno
stic
i del
re
parto
con
atti
vità
di a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
cui è
ass
egna
to,
affia
ncan
do il
tuto
r e
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e de
i paz
ient
i am
bula
toria
li, c
osì c
ome
nella
es
ecuz
ione
e re
ferta
zion
e de
gli e
sam
i e te
st
imm
unol
ogic
i.
APE
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia e
d Im
mun
olog
ia
Clin
ica
4T
IMM
UN
OL
OG
IA E
D
AL
LE
RG
OL
OG
IA C
LIN
ICA
1
ex IM
MU
NO
LO
GIA
CL
INIC
A 1
0082
B13
7MED
09T0
4
MED
/11
MA
LATT
IE
DEL
L'A
PPA
RA
TO
CA
RD
IOV
ASC
OLA
RE
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n m
alat
tie im
mun
olog
iche
affe
rent
i a
repa
rti d
i Car
diol
ogia
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
di C
ardi
olog
ia c
ui è
as
segn
ato,
aff
ianc
ando
il tu
tor
ed ,
acqu
isen
do
auto
nom
ia n
ella
ges
tione
dei
rico
vera
ti e
paz
ient
i am
bula
toria
li.
APE
Azi
enda
/ Uni
vers
ità P
adov
a:
Car
diol
ogia
, Clin
ica
Med
ica
4
1T
MA
LA
TT
IE D
EL
L'A
PPA
RA
TO
C
AR
DIO
VA
SCO
LA
RE
ED
IM
MU
NO
LO
GIA
CL
INIC
A
0082
B13
7MED
11T0
1
CA
RA
TT
ER
IZZA
NT
I - D
ISC
IPL
INE
SPE
CIF
ICH
ET
AF
Dis
cipl
ine
spec
ifich
e de
lla ti
polo
gia
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n pa
tolo
gia
imm
unol
ogic
a od
al
lerg
ica.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie,
ambu
lato
ri e
labo
rato
ri di
agno
stic
i del
re
parto
con
atti
vità
di a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
cui è
ass
egna
to,
affia
ncan
do il
tuto
r e
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e de
i paz
ient
i ric
over
ati,
così
com
e ne
lla e
secu
zion
e e
refe
rtazi
one
degl
i esa
mi e
test
alle
rgol
ogic
i ed
imm
unol
ogic
i
APO
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia e
d Im
mun
olog
ia
Clin
ica
31T
IMM
UN
OL
OG
IA C
LIN
ICA
ED
A
LL
ER
GO
LO
GIA
2
ex IM
MU
NO
LO
GIA
CL
INIC
A E
D
AL
LE
RG
OL
OG
IA 2
0082
B23
5MED
09T3
1
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 8
di 2
1
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
spec
ifich
e de
lla ti
polo
gia
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Acq
uisi
re c
onos
cenz
e re
lativ
e al
la c
orre
lazi
one
tra ri
spos
ta d
el si
stem
a im
mun
itario
e p
ossi
bile
in
sorg
enza
di p
atol
ogie
aut
oim
mun
i.
2L
PAT
OG
EN
ESI
DE
LL
E M
AL
AT
TIE
A
UT
OIM
MU
NI
ex M
ED
ICIN
A IN
TE
RN
A :
PAT
OG
EN
ESI
DE
LL
E M
AL
AT
TIE
A
UT
OIM
MU
NI
0082
B23
5MED
09L0
2
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 9
di 2
1
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
3A
NN
OC
AR
AT
TE
RIZ
ZAN
TI-
TR
ON
CO
CO
MU
NE
TA
FC
linic
oA
MB
ITO
CFU
TIP
O
MED
/09
MED
ICIN
A IN
TER
NA
Acq
uisi
zion
e di
con
osce
nze
fond
amen
tali
per l
a ge
stio
ne d
i paz
ient
i affe
tti d
a m
alat
tie a
pa
toge
nesi
imm
unol
ogic
a ed
alle
rgol
ogic
a
1L
AL
LE
RG
OL
OG
IA E
IM
MU
NO
LO
GIA
CL
INIC
A
ex M
ED
ICIN
A IN
TE
RN
A
MED
/10
MA
LATT
IE
DEL
L'A
PPA
RA
TO
RES
PIR
ATO
RIO
Acq
uisi
zion
e di
con
osce
nze
fond
amen
tali
per l
a ge
stio
ne d
i paz
ient
i affe
tti d
a pa
tolo
gie
dell'
appa
rato
resp
irato
rio
1L
MA
LA
TT
IE D
EL
L'A
PPA
RA
TO
R
ESP
IRA
TO
RIO
MED
/11
MA
LATT
IE
DEL
L'A
PPA
RA
TO
CA
RD
IOV
ASC
OLA
RE
Acq
uisi
zion
e di
con
osce
nze
fond
amen
tali
per l
a ge
stio
ne d
i paz
ient
i affe
tti d
a pa
tolo
gie
del
sist
ema
card
iova
scol
are
1L
MA
LA
TT
IE D
EL
L'A
PPA
RA
TO
C
AR
DIO
VA
SCO
LA
RE
MED
/14
NEF
RO
LOG
IAA
cqui
sizi
one
di c
onos
cenz
e fo
ndam
enta
li pe
r la
gest
ione
di p
azie
nti a
ffetti
da
pato
logi
e re
nali
1L
NE
FRO
LO
GIA
MED
/17
MA
LATT
IE IN
FETT
IVE
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n m
alat
tie im
mun
olog
iche
ed
alle
rgol
ogic
he a
ffer
enti
a re
parti
di M
alat
tie
Infe
ttive
.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
di M
alat
tie In
fetti
ve
cui è
ass
egna
to,
affia
ncan
do il
tuto
r ed
acq
uise
ndo
auto
nom
ia n
ella
ges
tione
dei
rico
vera
ti.
AP
Azi
enda
/ Uni
vers
ità P
adov
a:
Mal
attie
infe
ttive
e tr
opic
ali
4T
MA
LA
TT
IE IN
FET
TIV
E
(TIR
OC
INIO
)
ex M
AL
AT
TIE
INFE
TT
IVE
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
0 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Clin
ico
AM
BIT
OC
FUT
IPO
MED
/26
NEU
RO
LOG
IAA
tti m
edic
i e sp
ecia
listic
i rel
ativ
i al
l'inq
uadr
amen
to, a
llo st
udio
ed
alla
tera
pia
di
pazi
enti
con
mal
attie
imm
unol
ogic
he e
d al
lerg
olog
iche
aff
eren
ti a
repa
rti d
i Neu
rolo
gia.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
di N
euro
logi
a cu
i è
asse
gnat
o, a
ffia
ncan
do il
tuto
r ass
egna
to e
d ac
quis
endo
aut
onom
ia n
ella
ges
tione
dei
rico
vera
ti.
AP
Azi
enda
/ Uni
vers
ità P
adov
a:
Clin
ica
Neu
rolo
gica
4
TN
EU
RO
LO
GIA
(TIR
OC
INIO
)
ex N
EU
RO
LO
GIA
CA
RA
TT
ER
IZZA
NT
I A S
CE
LT
A D
EL
LO
ST
UD
EN
TE
TA
FD
isci
plin
e el
ettiv
e pe
r le
tipo
logi
e de
lla c
lass
eA
MB
ITO
CFU
TIP
O
MED
/09
MED
ICIN
A IN
TER
NA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n pa
tolo
gia
imm
unol
ogic
a
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie,
ambu
lato
ri e
labo
rato
ri di
agno
stic
i del
re
parto
con
atti
vità
di a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
cui è
ass
egna
to,
affia
ncan
do il
tuto
r e
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e de
i paz
ient
i am
bula
toria
li, c
osì c
ome
nella
es
ecuz
ione
e re
ferta
zion
e de
gli e
sam
i e te
st
imm
unol
ogic
i
APE
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia e
d Im
mun
olog
ia
Clin
ica
3T
IMM
UN
OL
OG
IA E
D
AL
LE
RG
OL
OG
IA C
LIN
ICA
2
ex IM
MU
NO
LO
GIA
CL
INIC
A 2
MED
/12
GA
STR
OEN
TER
OLO
GIA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n m
alat
tie im
mun
olog
iche
affe
rent
i a
repa
rti d
i Gas
troen
tero
logi
a
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
di G
astro
ente
rolo
gia
cui è
ass
egna
to,
affia
ncan
do il
tuto
r ass
egna
to e
d ac
quis
endo
aut
onom
ia n
ella
ges
tione
dei
rico
vera
ti.
APE
Azi
enda
/ Uni
vers
ità P
adov
a:
Gas
troen
tero
logi
a, C
linic
a M
edic
a 5
1T
GA
STR
OE
NT
ER
OL
OG
IA E
D
IMM
UN
OL
OG
IA E
D
AL
LE
RG
OL
OG
IA C
LIN
ICA
ex G
AST
RO
EN
TE
RO
LO
GIA
ED
IM
MU
NO
LO
GIA
CL
INIC
A
CA
RA
TT
ER
IZZA
NT
I - D
ISC
IPL
INE
SPE
CIF
ICH
ET
AF
Dis
cipl
ine
spec
ifich
e de
lla ti
polo
gia
AM
BIT
OC
FUT
IPO
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
1 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
spec
ifich
e de
lla ti
polo
gia
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Inse
gnar
e al
lo sp
ecia
lizza
ndo
la p
atog
enes
i e la
ge
stio
ne c
linic
a de
l paz
ient
e co
n in
ters
tizio
patie
po
lmon
ari.
3L
ME
DIC
INA
INT
ER
NA
: D
IAG
NO
STIC
A E
TE
RA
PIA
DE
LL
E
INT
ER
STIZ
IOPA
TIE
PO
LM
ON
AR
I A
PA
TO
GE
NE
SI IM
MU
NIT
AR
IA
ex M
ED
ICIN
A IN
TE
RN
A :
DIA
GN
OST
ICA
E T
ER
API
A D
EL
LE
IN
TE
RST
IZIO
PAT
IE P
OL
MO
NA
RI
A P
AT
OG
EN
ESI
IMM
UN
ITA
RIA
MED
/09
MED
ICIN
A IN
TER
NA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n pa
tolo
gia
imm
unol
ogic
a od
al
lerg
ica.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie,
ambu
lato
ri e
labo
rato
ri di
agno
stic
i del
re
parto
con
atti
vità
di a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
cui è
ass
egna
to,
affia
ncan
do il
tuto
r e
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e de
i paz
ient
i am
bula
toria
li, c
osì c
ome
nella
es
ecuz
ione
e re
ferta
zion
e de
gli e
sam
i e d
ei te
st
alle
rgol
ogic
i ed
imm
unol
ogic
i.
APO
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia e
d Im
mun
olog
ia
Clin
ica
36T
IMM
UN
OL
OG
IA C
LIN
ICA
ED
A
LL
ER
GO
LO
GIA
3
AFF
INI,
INT
EG
RA
TIV
E E
INT
ER
DIS
CIP
LIN
AR
IT
AF
Inte
graz
ioni
inte
rdis
cipl
inar
iA
MB
ITO
CFU
TIP
O
MED
/06
ON
CO
LOG
IA M
EDIC
AA
cqui
sire
con
osce
nze
sulla
ges
tione
del
le
pato
logi
e on
colo
gich
e co
n pr
oble
mat
iche
al
lerg
iche
ed
imm
unol
ogic
he.
1L
ON
CO
LO
GIA
ME
DIC
A
MED
/30
MA
LATT
IE A
PPA
RA
TO
VIS
IVO
Con
osce
re, d
iagn
ostic
are
e tra
ttare
le p
rinci
pali
pato
logi
e de
ll’oc
chio
di i
nter
esse
imm
unoa
llerg
ico.
1L
MA
LA
TT
IE A
PPA
RA
TO
VIS
IVO
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
2 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Inte
graz
ioni
inte
rdis
cipl
inar
iA
MB
ITO
CFU
TIP
O
MED
/31
OTO
RIN
OLA
RIN
GO
IATR
IAIn
segn
are
allo
spec
ializ
zand
o la
ges
tione
del
le
pato
logi
e di
inte
ress
e ot
orin
olar
ingo
iatri
co su
bas
e im
mun
oalle
rgic
a.
1L
OT
OR
INO
LA
RIN
GO
IAT
RIA
MED
/38
PED
IATR
IA
GEN
ERA
LE E
SPE
CIA
LIST
ICA
Sape
r ric
onos
cere
i si
ntom
i ed
i seg
ni c
linic
o-fu
nzio
nali
con
cui s
i pre
sent
ano
le m
alat
tie
imm
unoa
llerg
iche
in e
tà p
edia
trica
e la
cor
rela
ta
gest
ione
del
la te
rapi
a.
1L
PED
IAT
RIA
GE
NE
RA
LE
E
SPE
CIA
LIS
TIC
A
Sani
tà p
ubbl
ica,
man
agem
ent s
anita
rio,
stat
istic
a ed
epi
dem
iolo
gia
AM
BIT
OC
FUT
IPO
MED
/44
MED
ICIN
A D
EL
LAV
OR
OC
onos
cere
, dia
gnos
ticar
e e
tratta
re le
prin
cipa
li m
alat
tie a
llerg
iche
su b
ase
prof
essi
onal
e.1
LM
ED
ICIN
A D
EL
LA
VO
RO
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
3 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
4A
NN
OC
AR
AT
TE
RIZ
ZAN
TI-
TR
ON
CO
CO
MU
NE
TA
FC
linic
oA
MB
ITO
CFU
TIP
O
MED
/09
MED
ICIN
A IN
TER
NA
Acq
uisi
zion
e di
con
osce
nze
fond
amen
tali
per l
a ge
stio
ne d
i paz
ient
i affe
tti d
a pr
oble
mat
iche
di
tipo
inte
rnis
tico
gene
rale
1L
ME
DIC
INA
INT
ER
NA
MED
/12
GA
STR
OEN
TER
OLO
GIA
Acq
uisi
zion
e di
con
osce
nze
fond
amen
tali
per l
a ge
stio
ne d
i paz
ient
i affe
tti d
a pa
tolo
gie
del t
ratto
ga
stro
ente
rolo
gico
1L
GA
STR
OE
NT
ER
OL
OG
IA
MED
/13
END
OC
RIN
OLO
GIA
Acq
uisi
zion
e di
con
osce
nze
fond
amen
tali
per l
a ge
stio
ne d
i paz
ient
i affe
tti d
a pa
tolo
gie
endo
crin
olog
iche
1L
EN
DO
CR
INO
LO
GIA
ex E
ND
OC
RIN
OL
OG
IA
CA
RA
TT
ER
IZZA
NT
I A S
CE
LT
A D
EL
LO
ST
UD
EN
TE
TA
FD
isci
plin
e el
ettiv
e pe
r le
tipo
logi
e de
lla c
lass
eA
MB
ITO
CFU
TIP
O
MED
/09
MED
ICIN
A IN
TER
NA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n pa
tolo
gia
imm
unol
ogic
a
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie,
ambu
lato
ri e
labo
rato
ri di
agno
stic
i del
re
parto
con
atti
vità
di a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
cui è
ass
egna
to,
affia
ncan
do il
tuto
r e
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e de
i paz
ient
i am
bula
toria
li, c
osì c
ome
nella
es
ecuz
ione
e re
ferta
zion
e de
gli e
sam
i e te
st
alle
rgol
ogic
i ed
imm
unol
ogic
i
APE
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia e
d Im
mun
olog
ia
Clin
ica
3T
IMM
UN
OL
OG
IA E
D
AL
LE
RG
OL
OG
IA C
LIN
ICA
3
ex IM
MU
NO
LO
GIA
CL
INIC
A 3
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
4 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
elet
tive
per
le ti
polo
gie
della
cla
sse
AM
BIT
OC
FUT
IPO
MED
/10
MA
LATT
IE
DEL
L'A
PPA
RA
TO
RES
PIR
ATO
RIO
Inse
gnar
e al
lo sp
ecia
lizza
ndo
la g
estio
ne d
elle
pa
tolo
gie
polm
onar
i su
base
imm
unol
ogic
a.1
LM
AL
AT
TIE
DE
LL
'APP
AR
AT
O
RE
SPIR
AT
OR
IO E
D
IMM
UN
OL
OG
IA C
LIN
ICA
ex M
AL
AT
TIE
DE
LL
'APP
AR
AT
O
RE
SPIR
AT
OR
IO e
IMM
UN
OL
OG
IA
CL
INIC
A
MED
/10
MA
LATT
IE
DEL
L'A
PPA
RA
TO
RES
PIR
ATO
RIO
Inse
gnar
e al
lo sp
ecia
lizza
ndo
la g
estio
ne d
elle
pa
tolo
gie
polm
onar
i su
base
alle
rgic
a.1
LM
AL
AT
TIE
DE
LL
'APP
AR
AT
O
RE
SPIR
AT
OR
IO E
AL
LE
RG
OL
OG
IA
MED
/13
END
OC
RIN
OLO
GIA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n m
alat
tie e
ndoc
rine
con
prob
lem
atic
he
imm
unol
ogic
he a
ffere
nti a
repa
rti d
i En
docr
inol
ogia
.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità e
co
rsie
ed
ambu
lato
ri de
l rep
arto
di E
ndoc
rinol
ogia
cu
i è a
sseg
nato
, af
fianc
ando
il tu
tor
ed a
cqui
send
o au
tono
mia
nel
la g
estio
ne d
ei ri
cove
rati.
APE
Azi
enda
/ Uni
vers
ità P
adov
a:
Endo
crin
olog
ia, M
alat
tie d
el
Met
abol
ism
o
1T
EN
DO
CR
INO
LO
GIA
ED
IM
MU
NO
LO
GIA
CL
INIC
A
MED
/15
MA
LATT
IE D
EL
SAN
GU
EA
cqui
sire
con
osce
nze
sulla
ges
tione
del
le
prob
lem
atic
he tr
asfu
sion
ali i
n co
rso
delle
pr
inci
pali
pato
logi
e im
mun
olog
iche
.
1L
MA
LA
TT
IE D
EL
SA
NG
UE
E
PRO
BL
EM
AT
ICH
E
TR
ASF
USI
ON
AL
I
ex M
AL
AT
TIE
DE
L S
AN
GU
E E
A
LL
ER
GO
LO
GIA
MED
/15
MA
LATT
IE D
EL
SAN
GU
EA
cqui
sire
con
osce
nze
sulla
ges
tione
del
le
prin
cipa
li pa
tolo
gie
emat
olog
iche
su b
ase
imm
unol
ogic
a
1L
MA
LA
TT
IE D
EL
SA
NG
UE
ED
IM
MU
NO
LO
GIA
CL
INIC
A
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
5 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
elet
tive
per
le ti
polo
gie
della
cla
sse
AM
BIT
OC
FUT
IPO
MED
/16
REU
MA
TOLO
GIA
Acq
uisi
re c
onos
cenz
e su
lla g
estio
ne d
elle
pr
inci
pali
pato
logi
e re
umat
olog
iche
a c
ompo
nent
e im
mun
olog
ica
RIV
ED
ER
E D
EN
OM
INA
ZIO
NE
1L
RE
UM
AT
OL
OG
IA E
D
IMM
UN
OL
OG
IA C
LIN
ICA
ex R
EU
MA
TO
LO
GIA
ED
IM
MU
NO
LO
GIA
CL
INIC
A
MED
/16
REU
MA
TOLO
GIA
Acq
uisi
re c
onos
cenz
e su
lla g
estio
ne d
elle
pr
oble
mat
iche
rela
tive
all'u
tiliz
zo d
i far
mac
i bi
olog
ici
in c
orso
del
le p
rinci
pali
pato
logi
e re
umat
olog
iche
su b
ase
imm
unita
ria.
RIV
ED
ER
E D
EN
OM
INA
ZIO
NE
1L
RE
UM
AT
OL
OG
IA E
FA
RM
AC
I B
IOL
OG
ICI
ex R
EU
MA
TO
LO
GIA
ED
A
LL
ER
GO
LO
GIA
MED
/42
IGIE
NE
GEN
ERA
LE E
A
PPLI
CA
TAC
onos
cere
la v
alen
za e
pide
mio
logi
ca d
elle
m
alat
tie a
llerg
iche
1L
EPI
DE
MIO
LO
GIA
DE
LL
E
MA
LA
TT
IE A
LL
ER
GIC
HE
MED
/42
IGIE
NE
GEN
ERA
LE E
A
PPLI
CA
TAC
onos
cere
la v
alen
za e
pide
mio
logi
ca d
elle
m
alat
tie i
mm
unol
ogic
he.
1L
EPI
DE
MIO
LO
GIA
DE
LL
E
MA
LA
TT
I IM
MU
NO
LO
GIC
HE
CA
RA
TT
ER
IZZA
NT
I - D
ISC
IPL
INE
SPE
CIF
ICH
ET
AF
Dis
cipl
ine
spec
ifich
e de
lla ti
polo
gia
AM
BIT
OC
FUT
IPO
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
6 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
spec
ifich
e de
lla ti
polo
gia
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n pa
tolo
gia
imm
unol
ogic
a od
alle
rgic
a.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie,
ambu
lato
ri e
labo
rato
ri di
agno
stic
i del
re
parto
con
atti
vità
di a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
cui è
ass
egna
to,
affia
ncan
do il
tuto
r e
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e de
i paz
ient
i am
bula
toria
li, c
osì c
ome
nella
es
ecuz
ione
e re
ferta
zion
e de
gli e
sam
i e te
st
alle
rgol
ogic
i ed
imm
unol
ogic
i
APO
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia e
d Im
mun
olog
ia
Clin
ica
47T
IMM
UN
OL
OG
IA C
LIN
ICA
ED
A
LL
ER
GO
LO
GIA
4
AL
TR
E A
TT
IVIT
A'
TA
FA
ltre
attiv
itàA
MB
ITO
CFU
TIP
O
L Li
n/12
LIN
GU
A E
TR
AD
UZI
ON
E - L
ING
UA
IN
GLE
SE
Acq
uisi
zion
e ab
ilità
ling
uist
iche
nel
l'am
bito
del
la
lingu
a in
gles
e p
er la
com
pren
sion
e di
test
i e
parte
cipa
zion
e a
conf
eren
ze
2L
ING
LE
SE S
CIE
NT
IFIC
O 1
ex IN
GL
ESE
SC
IEN
TIF
ICO
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
7 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
5A
NN
OC
AR
AT
TE
RIZ
ZAN
TI-
TR
ON
CO
CO
MU
NE
TA
FC
linic
oA
MB
ITO
CFU
TIP
O
MED
/15
MA
LATT
IE D
EL
SAN
GU
EA
cqui
sizi
one
di c
onos
cenz
e fo
ndam
enta
li pe
r la
gest
ione
di p
azie
nti a
ffetti
da
pato
logi
e em
atol
ogic
he
1L
EM
AT
OL
OG
IA
ex M
AL
AT
TIE
DE
L S
AN
GU
E
MED
/16
REU
MA
TOLO
GIA
Acq
uisi
zion
e di
con
osce
nze
fond
amen
tali
per l
a ge
stio
ne d
i paz
ient
i affe
tti d
a pa
tolo
gie
di
inte
ress
e re
umat
olog
ico
1L
RE
UM
AT
OL
OG
IA
MED
/17
MA
LATT
IE IN
FETT
IVE
Acq
uisi
zion
e di
con
osce
nze
fond
amen
tali
per l
a ge
stio
ne d
i paz
ient
i affe
tti d
a pa
tolo
gie
infe
ttive
1L
MA
LA
TT
IE IN
FET
TIV
E
MED
/35
MA
LATT
IE C
UTA
NEE
E
VEN
EREE
Acq
uisi
zion
e di
con
osce
nze
fond
amen
tali
per l
a ge
stio
ne d
i paz
ient
i affe
tti d
a pa
tolo
gie
derm
atol
ogic
he
1L
MA
LA
TT
IE C
UT
AN
EE
E V
EN
ER
EE
ex M
AL
AT
TIE
CU
TA
NE
E E
V
EN
ER
EE
CA
RA
TT
ER
IZZA
NT
I A S
CE
LT
A D
EL
LO
ST
UD
EN
TE
TA
FD
isci
plin
e el
ettiv
e pe
r le
tipo
logi
e de
lla c
lass
eA
MB
ITO
CFU
TIP
O
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
8 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
elet
tive
per
le ti
polo
gie
della
cla
sse
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Inse
gnar
e al
lo sp
ecia
lizza
ndo
la g
estio
ne d
elle
va
scul
iti e
mal
attie
gra
nulo
mat
ose
sist
emic
he,
dalla
pat
ogen
esi,
alla
dia
gnos
i ed
alla
tera
pia.
1L
VA
SCU
LIT
I E M
AL
AT
TIE
G
RA
NU
LO
MA
TO
SE S
IST
EM
ICH
E
MED
/09
MED
ICIN
A IN
TER
NA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n pa
tolo
gia
imm
unol
ogic
a
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie,
ambu
lato
ri e
labo
rato
ri di
agno
stic
i del
re
parto
con
atti
vità
di a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
cui è
ass
egna
to,
affia
ncan
do il
tuto
r e
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e de
i paz
ient
i am
bula
toria
li, c
osì c
ome
nella
es
ecuz
ione
e re
ferta
zion
e di
egli
esam
i e te
st
imm
unol
ogic
i
APE
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia e
d Im
mun
olog
ia
Clin
ica
3T
IMM
UN
OL
OG
IA E
D
AL
LE
RG
OL
OG
IA C
LIN
ICA
4
ex IM
MU
NO
LO
GIA
CL
INIC
A 4
MED
/09
MED
ICIN
A IN
TER
NA
Inse
gnar
e al
lo sp
ecia
lizza
ndo
la g
estio
ne d
elle
im
mun
odef
icie
nze
prim
itive
e se
cond
arie
, dal
la
pato
gene
si ,
alla
dia
gnos
i ed
alla
tera
pia.
1L
ME
DIC
INA
INT
ER
NA
: IM
MU
NO
DE
FIC
IEN
ZE P
RIM
ITIV
E
E S
EC
ON
DA
RIE
MED
/14
NEF
RO
LOG
IAA
cqui
sire
con
osce
nze
sull'
inqu
adra
men
to,
stud
io
e te
rapi
a di
paz
ient
i con
mal
attie
rena
li e
pr
oble
mat
iche
imm
unol
ogic
he
1T
NE
FRO
LO
GIA
ED
IMM
UN
OL
OG
IA
CL
INIC
A
MED
/17
MA
LATT
IE IN
FETT
IVE
Acq
uisi
re c
onos
cenz
e su
i mec
cani
smi
pato
gene
tici e
le im
plic
azio
ni im
mun
olog
iche
ne
lle p
rinci
pali
mal
attie
infe
ttive
con
par
ticol
are
rifer
imen
to a
lla in
fezi
one
da H
IV.
1L
MA
LA
TT
IE IN
FET
TIV
E E
D
IMM
UN
OL
OG
IA C
LIN
ICA
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 1
9 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
elet
tive
per
le ti
polo
gie
della
cla
sse
AM
BIT
OC
FUT
IPO
MED
/17
MA
LATT
IE IN
FETT
IVE
Acq
uisi
re c
onos
cenz
e su
lla g
estio
ne d
elle
m
anife
staz
ioni
alle
rgic
he d
i com
une
osse
rvaz
ione
in
cor
so d
i ter
apia
del
le m
alat
tie in
fetti
ve
1L
MA
LA
TT
IE IN
FET
TIV
E: R
EA
ZIO
NI
AL
LE
RG
ICH
E A
FA
RM
AC
I A
NT
IMIC
RO
BIC
I
ex M
AL
AT
TIE
INFE
TT
IVE
ED
A
LL
ER
GO
LO
GIA
MED
/26
NEU
RO
LOG
IASa
per c
onos
cere
i si
ntom
i ed
i seg
ni c
linic
o-fu
nzio
nali
con
cui s
i pre
sent
ano
le v
ascu
liti d
el
sist
ema
nerv
oso
e la
cor
rela
ta g
estio
ne d
ella
te
rapi
a.
1L
NE
UR
OL
OG
IA: V
ASC
UL
ITI D
EL
SI
STE
MA
NE
RV
OSO
ex N
EU
RO
LO
GIA
ED
IM
MU
NO
LO
GIA
CL
INIC
A
MED
/26
NEU
RO
LOG
IAA
cqui
sire
con
osce
nze
sui s
into
mi e
d i s
egni
cl
inic
o-fu
nzio
nali
e te
rapi
a de
lle m
alat
tie
neur
omus
cola
ri e
neur
oim
mun
olog
iche
a
pato
gene
si im
mun
itaria
.
1L
NE
UR
OL
OG
IA: M
AL
AT
TIE
N
EU
RO
IMM
UN
OL
OG
ICH
E
ex N
EU
RO
LO
GIA
ED
A
LL
ER
GO
LO
GIA
MED
/31
OTO
RIN
OLA
RIN
GO
IATR
IAIn
segn
are
allo
spec
ializ
zand
o la
ges
tione
del
le
pato
logi
e di
inte
ress
e ot
orin
olar
ingo
iatri
co su
bas
e im
mun
olog
ica.
1L
OT
OR
INO
LA
RIN
GO
IAT
RIA
ED
IM
MU
NO
LO
GIA
CL
INIC
A
MED
/31
OTO
RIN
OLA
RIN
GO
IATR
IAIn
segn
are
allo
spec
ializ
zand
o la
ges
tione
del
le
pato
logi
e di
inte
ress
e ot
orin
olar
ingo
iatri
co su
bas
e al
lerg
ica.
1L
OT
OR
INO
LA
RIN
GO
IAT
RIA
ED
A
LL
ER
GO
LO
GIA
CA
RA
TT
ER
IZZA
NT
I - D
ISC
IPL
INE
SPE
CIF
ICH
ET
AF
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 2
0 di
21
SSD
Alle
rgol
ogia
ed
imm
unol
ogia
clin
ica
- PIA
NO
FO
RM
AT
IVO
A.A
. 200
8/09
- D
EN
OM
INA
ZIO
NE
OB
IET
TIV
I FO
RM
AT
IVI
AT
TIV
ITA
'/CO
MPE
TE
NZE
PR
OFE
SSIO
NA
LI
TIP
OL
O-G
IAST
RU
TT
UR
E
RE
TE
Dis
cipl
ine
spec
ifich
e de
lla ti
polo
gia
AM
BIT
OC
FUT
IPO
MED
/09
MED
ICIN
A IN
TER
NA
Atti
med
ici e
spec
ialis
tici r
elat
ivi
all'i
nqua
dram
ento
, allo
stud
io e
d al
la te
rapi
a di
pa
zien
ti co
n pa
tolo
gia
imm
unol
ogic
a od
alle
rgic
a.
Lo sp
ecia
lizza
ndo
dovr
à fr
eque
ntar
e co
n as
sidu
ità
cors
ie,
ambu
lato
ri e
labo
rato
ri di
agno
stic
i del
re
parto
con
atti
vità
di a
llerg
olog
ia e
d im
mun
olog
ia
clin
ica
cui è
ass
egna
to,
affia
ncan
do il
tuto
r e
acqu
isen
do a
uton
omia
nel
la g
estio
ne d
ei ri
cove
rati
e de
i paz
ient
i am
bula
toria
li, c
osì c
ome
nella
es
ecuz
ione
e re
ferta
zion
e de
gli e
sam
i e te
st
alle
rgol
ogic
i ed
imm
unol
ogic
i
APO
Azi
enda
/ Uni
vers
ità P
adov
a:
Emat
olog
ia e
d Im
mun
olog
ia
Clin
ica
30T
IMM
UN
OL
OG
IA C
LIN
ICA
ED
A
LL
ER
GO
LO
GIA
5
PRO
VA
FIN
AL
ET
AF
Prov
a fin
ale
AM
BIT
OC
FUT
IPO
Dis
cuss
ione
di u
n el
abor
ato
su d
ati s
perim
enta
li o
su p
robl
emat
iche
clin
iche
lega
te a
ll'A
llerg
olog
ia
ed Im
mun
olog
ia C
linic
a.
15T
AT
TV
ITA
' FIN
AL
IZZA
TA
AL
LA
PR
OV
A F
INA
LE
5 A
NN
O
AL
TR
E A
TT
IVIT
A'
TA
FA
ltre
attiv
itàA
MB
ITO
CFU
TIP
O
L Li
n/12
LIN
GU
A E
TR
AD
UZI
ON
E - L
ING
UA
IN
GLE
SE
Acq
uisi
re e
/o p
erfe
zion
are
le c
onos
cenz
e de
lla
lingu
a in
gles
e p
er la
com
pren
sion
e di
test
i e
parte
cipa
zion
e a
conf
eren
ze
3L
ING
LE
SE S
CIE
NT
IFIC
O 2
ex IN
GL
ESE
SC
IEN
TIF
ICO
mar
tedì
1 fe
bbra
io 2
011
Pagi
na 2
1 di
21
ANEXO V.3 PROGRAMA DE FORMACIÓN EN INMUNOLOGÍA BÁSICA Y CLÍNICA DE ALEMANIA
ANEXO V.3 PROGRAMA DE FORMACIÓN EN INMUNOLOGÍA BÁSICA Y CLÍNICA DE ALEMANIA El programa de Formación en Inmunología Básica y Clínica de la Sociedad Alemana de Inmunología (DGfI) se encuentra en el link del correspondiente Website de la DGfI. http://dgfi.org/web/aus-und-fortbildung. En resumen, existe un programa que llaman "Academy in Immunology" el cual en esencia combina tres tipos de Training mediante Cursos: (i) uno "Basico" (para enseñar aspectos básicos de la inmunología actual; (ii) otro "Avanzado" (enseña conceptos avanzados de inmunología); y (iii) otro "Traslacional" (que provee información actualizada sobre aspectos de inmunología clínica que incluyen las terapias innovadoras). Además tienen establecido un Curriculum específico que provee un certificado como "Specialist in Immunology" ("Fach-Immunologe"), que implica Training en Inmunología Básica y Clínica durante varios años y que posteriormente se evalúa mediante un exámen oral. La Sociedad Alemana de Inmunología (DGfI) ha creado Centros para la Formación en Inmunología Clínica. Como indica el presidente de la DGfI en su carta, que se trascribe más abajo, este programa solo está disponible en el idioma alemán.
From: Kabelitz, Dietrich (Prof. Dr. med.) To: Fernandez Cruz Perez.Eduardo Subject: Letter of support form the German Society for Immunology (DGfI) Dear Professor Fernandez-Cruz, Please find attached a letter of support from the DGfI concerning your plans to establish a Training Program in Clinical Immunology in Spain. With best wishes, sincerely yours, Dieter Kabelitz President, German Society for Immunology Prof. Dr. Dieter Kabelitz Institute of Immunology UKS-H Campus Kiel Arnold-Heller-Str. 3 Haus 17 D-24105 Kiel Germany http://www.immunologie-kiel.uk-sh.de <http://www.immunologie-kiel.uk-sh.de/> the link to the corresponding website of our national society is as follows: http://dgfi.org/web/aus-und-fortbildung Unfortunately, it is currently available only in German language